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SUMMARY
Tuberculosis accounts for 7% of global deaths annually, and more than one in four preventable 
deaths in developing countries. According to the World Health Organisation (WHO), South Africa 
remains one of the twenty-three countries most affected by the tuberculosis epidemic. In countries 
of high prevalence, tuberculosis occurs frequently in children and young adults, contrasting with the 
current epidemiology in much of the developed world. During the initial infection with 
Mycobacterium tuberculosis, bacilli disseminates to different organs and tissues, often resulting in 
tuberculosis lymphadenitis particularly in paediatric patients. Granuloma formation, in response to 
infection, is an essential component of the anti-mycobacterial defence as it is within these structures 
that T-cell-macrophage co-operation can take place, which allows macrophages to display effective 
bactericidal activities.
In this study, we employed the immunohistochemistry technique to analyse the immune response in 
granulomatous lymph nodes from paediatric patients (n = 6) with tuberculosis by analysing the 
expression pattern of the type 1 cytokines (IL-12, IFN-y, TNF-a) and type 2 cytokines (IL-4 and EL­
IO). One of these patients had received 2 days anti-tuberculosis therapy prior the biopsy. Comparing 
the cytokine profiles from the different patients demonstrated a predominant ThO response in the 
lymph node granulomas. This implies a balance in the expression of type 1 and type 2 cytokines. 
This balance was not altered during the initial phase of treatment. Significant co-ordinated 
expression correlations were identified between IL-4 and EL-10 (p = 0.0000006), IL-10 and EL-12 
(p = 0.021) and between IL-10 and TNF-a (p = 0.0054). The expression of IL-10 and TNF-a was 
also significantly associated with the presence of caseous necrosis in granulomas (p = 0.000046 and 
p = 0.0041, respectively).
M  tuberculosis bacilli in the granulomas were detected using the DNA:DNA in situ hybridisation 
technique. Mycobacterial DNA was detected in six patients, in contrast to the ZN staining where 
only 5 o f the patients were positive for acid-fast bacilli. This suggests that the hybridisation 
technique is more sensitive than the standard ZN staining, and could be possibly used for the 
diagnosis of tuberculosis infection.
RNA:RNA in situ hybridisation was done in order to identify transcription state of the bacilli at the 
site of disease. A series of riboprobes were used to analyse the expression of specific genes either 
involved in mycobacterial metabolism that are key targets for anti-tuberculosis drugs (rpoB, katG), 
as well as genes thought to contribute to the survival of bacilli in host cells under conditions of
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stress (ncirX, id , mblB, relMth). The mycobacterial genes analysed in this study also included two 
potential immunodominant antigens (esat-6, PPE Rv3018c). A rapid bacillary response to the anti­
tuberculosis drugs was observed in the granulomas of the treated patient, where the drug targets for 
rifampin and isoniazid (rpoB and katG, respectively) were significantly downregulated. The 
presence of RNA transcripts of certain genes within the necrosis confirms that the mycobacteria 
detected in the necrotic region represent transcriptionally active cells.
The absence of rpoB and mbtB in these restrictive granuloma regions suggests that the development 
of caseous necrosis inhibited active bacterial growth. Statistical assessment of the mycobacterial 
gene expression data identified co-ordinated expression correlations between katG and id  (p = 
0.008), katG and rel^th (p = 0.0106), id  and relutb (p = 0.00003), katG and PPE Rv3018c (p = 
0.008) and i d  and narX (p = 0.00003). An inverse expression pattern was observed between esat-6 
and i d  (p = 0.043) and between esat-6 and mbtB (p = 0.026). We identified subpopulations of 
bacilli that occurred in different phases of growth in the individual granulomas. We hypothesise that 
the different environments in the granulomas determines the expression profiles of these 
subpopulations. A significant association was observed between the expression of narX and the 
presence o f caseous necrosis (p = 0.0062).
The stratification of the combined host cytokine and mycobacterial gene expression data also 
identified significant associations between the host response and M  tuberculosis gene expression. A 
co-ordinated expression pattern was identified between IL-4 and mbtB (p = 0.005) and IL-12 and 
esat-6 (p = 0.043). An inverse expression correlation was observed between IL-12 and relutb (p = 
0.005). Stratifying the data according to mode of transcription (passive vs. active) identified 
significant correlations between IL-4 and mbtB (p = 0.020) in the rpoB negative (passive) subgroup. 
An inverse expression pattern was identified between IL-12 and relMlb in both the passive and active 
transcribing granuloma subgroups (p = 0.05 and p = 0.021, respectively). Significant correlations 
were observed between IL-4 and katG (p = 0.049) and between IL-10 and narX (p = 0.026) in the 
active transcribing subgroup, and an inverse expression pattern was identified between IL-12 and 
mbtB (p = 0.035). The techniques used in this study thus allowed us to demonstrate the interaction 
between host factors, M. tuberculosis survival mechanisms, as well as the interaction between the 
host and pathogen within the tuberculosis granulomas.
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OPSOMMING
Tuberkulose is die oorsaak van 7% wereldwye sterftes jaarliks en 25% voorkombare sterftes in 
ontwikkelde lande. Suid-Afrika is volgens die Wereld Gesondheids Organisasie (WGO) een van 23 
lande wat die meeste geaffekteer word deur die tuberkulose epidemie. In teenstelling met 
ontwikkelde lande, is die insidens van tuberkulose hoog onder kinders en jong volwassenes in 
onderontwikkelde lande met ‘n hoe tuberkulose voorkoms. In jong kinders veral, lei infeksie met 
Mikobakterium tuberkulose tot disseminasie van die bakterium na verskillende organe en weefsel. 
Dit word tuberkulose limfadenitis genoem. Granuloom vorming is ‘n noodsaaklike komponent van 
die immuunsisteem in ‘n poging om die infeksie te bekamp. T sel en makrofaag interaksie binne 
granulome help makrofage om meer effektiewe bakterie-dodende aktiwiteite uit te voer.
In die studie is immunohistochemie aangewend om die immuunrespons in granuloom bevattende 
limfnodes van kinders (n=6) met tuberkulose te analiseer. Daar is gekyk na tipe I sitokiene (IL-12, 
IFN-y en TNF-a) en tipe II sitokiene (IL-4 en IL-10). Een van die pasiente het vir twee dae anti- 
tuberkulose behandeling ontvang voor die limfnode biopsie. Die resultate van die studie het 
aangetoon dat ‘n T-helper 0 immuunrespons die dominante respons in limfnode granulome van 
kinders is. Dit is aanduidend van ‘n balans tussen die uitdrukking van tipe I en tipe II sitokiene. ‘n 
Beduidende korrellasie is geidentifiseer tussen die uitdrukking van IL-4 en IL-10 (p=0.0000006), 
IL-10 en IL-12 (p=0.021) en TNF-a en IL-10 (p= 0.0054). Die uitdrukking van TNF-a en IL-10 is 
ook beduidend geassosieer met verkasende nekrose in granulome (p=0.000046 en p=0.0041, 
onderskeidelik).
DNS:DNS in situ hibridisasie is gebruik om M. tuberkulose bakterie in granulome te identifiseer. 
Mikobakeriele DNS is gevind in al 6 pasiente terwyl Ziehl-Neelsen (ZN) kleuring suurvaste 
bakterie aangedui het in 5 pasiente. Die resultate stel voor dat die hibridisasie tegniek meer 
sensitief is as die ZN kleuring en moontlik gebruik kan word vir diagnose van tuberkulose infeksie.
RNS:RNS in situ hibridisasie is uitgevoer om die transkripsie status van die mikobakterie in die 
gei'nfekteerde weefsel te bepaal. ‘n Reeks ribo-oligonukleotied peilers is gebruik om die uitdrukking 
van spesifieke gene te analiseer. Van die gene is betrokke by mikobakteri'ele metabolisme wat 
teikens is van anti-tuberkulose middels (ropB, katG), ander is gene wat belangrik is vir oorlewing 
van die basilli in die gasheerselle tydens stres toestande (narX, icl, mbtB, re/m ,). Ander 
mikobakteri'ele gene wat geanaliseer is, sluit twee potensiele immunodominante antigene, esat-6 en 
PPE (Rv3018c), in. Die uitdrukking van katG en rpoB, teikens van rifampin en isoniasied, is
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betekenisvol onderdruk in die granulome van die behandelde pasient wat aanduidend is van ‘n 
vinnige anti-mikobakteriele respons na slegs twee dae van behandeling. Die teenwoordigheid van 
RNS transkripte van sekere gene binne in die nekrose van nekrotiserende granulome is aanduidend 
van transkripsioneel aktiewe mikobakterie.
Die afwesigheid van rpoB en mbtB in die nekrose stel voor dat verkasende nekrose bakteriele groei 
inhibeer. Statistiese analises van die mikobakteriele geen uitdrukking dui op gekoordineerde 
uitdrukking tussen katG en id  (p=0.008), katG en reluib (p=0.0106), id  en relm, (p=0.00003), katG 
en PPE Rv3018c (p=0.008) en id  en narX (p=0.00003). ‘n Omgekeerde uitdrukkings patroon is 
waargeneem tussen esat-6 en id  (p=0.043) en tussen esat-6 en mbtB (p=0.026). Subpopulasies van 
basilli in verskillende groeifases is geidentifiseer in die verskillende granulome. Ons hipotiseer dat 
die verskillende omgewings in granulome die uitdrukkingsprofiele van die subpopulasies bepaal. ‘n 
Betekenisvolle assosiasie is gemaak tussen die uitdrukking van narX en die teenwoordigheid van 
verkasende nekrose (p=0.0062).
Stratifikasie van die gekombineerde gasheer sitokien en mikobakteriele geen uitdrukkings data het 
assosiasies geidentifiseer tussen die gasheer immuunrespons en M. tuberki/lose geen uitdrukking. ‘n 
Gekoordineerde uitdrukkingspatroon is geidentifiseer tussen IL-4 en mbtB (p=0.005) en IL-12 en 
esat-6 (p=0.043). ‘n Omgekeerde uitdrukkings korrellasie is waargeneem tussen IL-12 en relMtb (p= 
0.005). Stratifikasie van die data ten opsigte van aktiewe en passiewe transkripsie het betekenisvolle 
korrellasies geidentifiseer tussen IL-4 en mbtB (p=0.020) in die rpoB negatiewe (passiewe) 
populasie. ‘n Omgekeerde uitdrukkings patroon is geidentifiseer tussen IL-12 en relutb in beide 
passiewe en aktiewe transkripsie granuloom subpopulasies (p=0.05 en p=0.021, onderskeidelik). 
Betekenisvolle korrellasies tussen IL-4 en katG (p=0.049) en tussen IL-10 en narX (p=0.026), 
sowel as ‘n omgekeerde uitdrukkingspatroon tussen IL-12 en mbtB (p=0.035), is waargeneem in die 
aktiewe transkripsie populasie. Die tegnieke wat in die studie gebruik is het ons toegelaat om die 
interaksie tussen die gasheer faktore, M. tuberkulose oorlewings meganismes, sowel as die 
interaksie tussen die gasheer en patogeen in tuberkulose granulome te bestudeer.
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31.1 GLOBAL BURDEN OF TUBERCULOSIS
"If the number o f  victims which a disease claims is the measure o f its significance, then all 
diseases, particularly the most dreaded infectious disease, must rank far behind tuberculosis. 
Statistics teach that one-seventh o f all human beings die o f tuberculosis, and that i f  one considers 
only productive middle-age groups, tuberculosis carried away one-third and often more o f these... ”
Robert Koch, 1880
Tuberculosis is an ancient disease with the earliest definitive evidence in Egypt dating back as far as 
the Dynastic period, which started about 3 400 BC. An example of this is the mummy of a five- 
year-old child with evidence of pulmonary and vertebral tuberculosis (Zimmerman, 1979). The 
burden of ill health and death caused by tuberculosis makes it one of the most important diseases in 
the history of human society. There has been no other single disease which has been so prevalent 
and widespread over such an extensive period in time.
Tuberculosis remains a major global problem today. The causative agent, Mycobacterium 
tuberculosis, was recognised over 100 years ago, and effective treatment has now been available for 
over 50 years (Dolin et al, 1994). However, TB programmes are still struggling to control one of the 
world’s most important infectious diseases. The breakdown in health services, the spread of 
HIV/AIDS and the emergence of multi drug-resistant TB are contributing to the worsening impact 
of this disease. In 1993, the World Health Organisation (WHO) took an unprecedented step and 
declared tuberculosis a global emergency, so great was the concern about the modem TB epidemic. 
This disease accounts for 7% of global deaths annually and more than one in four preventable 
deaths in developing countries (Murray etal, 1990).
In 1999, 171 countries reported to the WHO a total of 3 689 822 cases (62 per 100 000 population), 
of which 1 485 783 (40%) were sputum-smear positive (Table 1.1) (WHO report 2001). The 
African (17%), South-East Asia (41%) and Western Pacific Regions (22%) together accounted for 
80% of all notified cases and similar proportions of sputum-smear positive cases (Figure 1.1). 
Tuberculosis notification data reflect health services coverage and the efficiency of case finding and 
reporting activities of national tuberculosis control programs. Often poor performance of these 
programs results in considerable under-detection and under-reporting of cases. In addition, case 
definitions vary among countries and case notification data often include all cases, both new and 
retreatment cases. Nevertheless, case notifications under stable program conditions in any country 
may provide useful data on the trend of incidence and for obtaining rates by age, sex and risk group.
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Table 1.1. Summary of Notifications by WHO region, 1999
4
Regions Number of Notifications
New Sputum-Smear 
Positives
Africa 644 972 321 260
America 233 823 133 363
Eastern Medditerranean 
Region 156 637 67 135
Europe 362 532 86 271
S.E. Asian Region 1 469 672 485 7901
Western Pacific Region 822 177 391 964
Global 3 689 813 1 485 783
(a)
(b)
WPR
22%
AMR
6%
EMR
4%
SEAR
41%
AMR
9%
EMR
5%
WPR
26%
SEAR
32%
Figure 1.1. Proportions of all (a) notified cases, and (b) smear-positive cases, by WHO, 1999. 
AFR: African region; EMR: Eastern Mediterranean Region; EUR: European Region; SEAR: 
South-East Asian Region; WPR: Western Pacific Region
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Because of the limitations of case notification data, alternatives to case notification are necessary 
for estimating incidence and size of the tuberculosis disease burden. The estimated number of new 
tuberculosis cases globally (Table 1.2) was 8.42 million for 1999 (WHO Report 2001), with twenty- 
three countries accounting for 80% of all the new cases. The global total rose from 7.96 million in 
1997 to an 8.42 million in 1999. Of the 8.42 million cases in 1999, an estimated 3 .67 million were 
smear positive. These totals are larger than previously forecast by mathematical modelling (Dye et 
al, 1998). The four African countries, Nigeria, Ethiopia, DR Congo and Kenya, as well as Russia, 
are now ranked higher than in 1997, with Mozambique now included in the league of high-burden 
countries, and Peru dropping off the list in the year 2000.
The total numbers of cases are predicted to increase in all regions up to 2005 (Figure 1.2), except in 
those with established market economies, with an expected decline of 2 -  3% per year (Appendix 7 
lists the groups of countries where incidence was estimated using regional trends). The rate of 
increase is 3% per year globally, but much higher in the African countries that are most affected by 
HIV/AIDS (10%), and in Eastern Europe (8%). If present trends continue, a total of 10.2 million 
cases are expected in 2005. Africa will have more cases (3.4 million) than any other WHO region 
by 2005, followed by South East Asia with an expected total of 3.2 million cases.
Case notification is the cornerstone for any effective TB programme. However, the 3 689 813 cases 
of tuberculosis notified in 1999 represent 44% of the 8.42 million estimated cases. The total of 1 
485 783 new smear positives is 40% of the 3.72 million estimated smear positive cases. Case 
detection rates in 1999 (Figure 1.3) were grossly underscored and were lowest in the Eastern 
Mediterranean Region.
Statistics show that tuberculosis remains an enormous health and economic problem in the 
developing world. In these countries of high prevalence, tuberculosis occurs frequently in children 
and young adults, contrasting with the current epidemiology in much of the developed world. In 
1990, Murray and colleagues reported that 15% of the total numbers of cases in the developing 
countries were children younger than 15 years of age. Of the deaths from tuberculosis in the 
developed and developing countries, 10% - 20% were also among children under 15 years of age.
5
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Table 1.2. Estimated Incidence of TB: 23 high-burden countries, 1999
6
Number Estimated
All cases Smear Positive cases
Country (ranked 
by burden)
Population
(1000s) Thousands
Rate per 
100 000 
pop
Thousands
Rate per 
100 000 
pop
Cumulative
Incidence
(%)
in Rank
97 -  99*
1 India 998 056 1 847 185 827 83 22 0
2 China 1 266 838 1 300 103 584 46 37 0
3 Indonesia 209 255 590 282 265 127 44 0
4 Nigeria 108 945 327 301 142 130 48 2
5 Bangladesh 126 947 306 241 138 108 52 -1
6 Pakistan 152 331 269 177 121 79 55 -1
7 Phillipines 74 454 234 314 105 141 58 0
8 Ethiopia 61 095 228 373 96 157 61 1
9 South Africa 39 900 197 495 80 201 63 -1
10 Russian Fed. 147 196 181 123 81 55 65 1
11 DR Congo 50 335 151 301 65 130 67 1
12 Viet Nam 78 705 149 189 67 85 69 -2
13 Kenya 29 549 123 417 51 173 70 2
14 Brazil 167 988 118 70 53 31 72 -1
15 UR Tanzania 32 793 112 340 47 145 73 -1
16 Thailand 60 856 86 141 38 62 74 0
17 Mozambique 19 286 79 407 33 169 75 9
18 Myanmar 45 059 76 169 34 76 76 -1
19 Uganda 21 143 72 343 31 146 77 0
20 Afghanistan 21 923 71 325 32 146 77 -2
21 Zimbabwe 11 529 65 562 26 226 78 0
22 Cambodia 10 945 61 560 27 251 79 0
23 Peru 25 230 58 228 26 102 80 -3
Total, 23 high- 
burden countries 3 760 358 6 700
178 2 969 79 80
Global Total 5 975 045 8 417 141 3724 62 100
*change in rank resulting from re-estimation of incidence. A positive value indicates that a country has moved up the 
table
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Figure 1.2. Estimated numbers of TB cases in 1995 (blue), 1999 (yellow) and 2005 
(green), by region.
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Figure 1.3. Detection rates of smear-positive (green bars) and all TB cases (blue bars) by 
WHO Region, 1999. Abbreviations as in Figure 1.1
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81.2 TUBERCULOSIS IN SOUTH AFRICA
1.2.1 Development of Tuberculosis in South Africa
Tuberculosis is a relatively new disease in southern Africa, although it had been endemic in Europe 
and Asia for millennia. It is unlikely that it occurred to any great extent among races native to 
southern Africa prior to the era of European colonization, which began in the southwestern Cape in 
the mid-seventeenth century. Knowledge of the extent and prevalence of tuberculosis in South 
Africa prior to the 20th century is very limited as the compilation of health statistics is a relatively 
recent innovation. The introduction of compulsory registration of deaths in the Cape Colony in 
1895 enabled tuberculosis mortality rates to be calculated for the first time (Metcalf, 1991).
Historically it appears that the initial spread of tuberculosis among the different people native to 
South Africa was closely related to their degree of European contact (McVicar N., 1932). In the 
early nineteenth century tuberculosis was reported to be a problem among Hottentots who lived in 
the southwestern parts of South Africa. The black people who remained geographically separate for 
a longer period were apparently relatively free of tuberculosis until later in the century.
It is unlikely that tuberculosis was ever absent from Europeans in South Africa. However, 
promoting South Africa as a health resort for “Consumptive Invalids” during the last quarter of the 
19th century undoubtedly boosted the pool o f infection (Metcalf, 1991). This resulted in an influx of 
consumptive people fleeing to South Africa, hoping to be cured by the climate. Its dry interior was 
recommended as being suitable for “limited non-progressive disease”. Towns in South Africa which 
were popular among diseased immigrants included Beaufort West, Kimberley, Bloemfontein, 
Harrismith, Cradock and Middelberg, with Cape Town being the main port of entry. However, 
many people arrived in such an advanced stage of tuberculosis that they were not able to travel into 
the interior. The 1912 Tuberculosis Commission found that tuberculosis was three times as 
prevalent in towns as in rural areas, and that it was most prevalent in the large coastal and industrial 
towns, on the mines and in those places previously favoured by the consumptives.
1.2.2 Present Tuberculosis Epidemic in South Africa
According to the WHO, South Africa remains one of 23 countries worst affected by the tuberculosis 
epidemic (Table 1.2). It is expected to contribute at least 15% of the total tuberculosis caseload for 
Africa (Fourie and Weyer, 2000) yet it accounts for only about 7% of the continents total 
population.
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The incidence of tuberculosis, based on figures from national tuberculosis quarterly reports, has 
shown a steady increase over the four-year period between 1995 and 1998 (Figure 1.4). The 
incidence rates in South Africa averaged at 392 per 100 000 members of the population in 1997. 
The tuberculosis epidemic in South Africa, in contrast to the industrialised countries, mainly affects 
the economically active age group (The South African Tuberculosis Control Programme, 2000) 
where 86.6% of tuberculosis patients reported in 1999 were in the age group of 20 -  59 years 
(Figure 5). Interestingly, 80% of the notified tuberculosis cases in the industrialised countries are 
aged 50 years and older (Kochi, 1991). South Africa also has a fatality rate of 166 per 100 000, a 
rate which is five times higher than the global tuberculosis fatality average of 32 per 100 000, and is 
second to Zimbabwe’s world wide (Dye el al, 1999).
Prompt identification, and therefore case finding, remains the cornerstone of effective tuberculosis 
programs (Diagnostic techniques summarised in Appendix 3). As with many other developing 
countries, case notifications in South Africa often represent only a fraction of the true incident cases 
where only a minority of the population has access to effective tuberculosis care. The low reporting 
rates continue to be a major impediment to accurate estimation of the tuberculosis epidemic in 
South Africa (Table 1.3). Complete case reporting for South Africa in 1999 (37%) declined to 
nearly half of that of the previous year (71.6%). The actual number of cases reported for 1999 (87 
566) represented a mere 40% of the estimated new cases for that year (236 665), assuming 100% 
reporting rate.
The WHO and the International Union Against Tuberculosis and Lung Disease advocate use of the 
DOTS strategy to control tuberculosis. DOTS, which stands for Direct Observed Treatment, Short- 
course, is an internationally recognised health care management system, and was implemented in 
South Africa in 1996. The principle cornerstone of the DOTS strategy is a patient-centred approach 
which provides support to TB patients by observing them as they swallow their TB drugs and 
ensuring that they complete their treatment. DOTS also follow a passive case-finding method in 
South Africa. However, the low case-reporting rate for South Africa in 1999 indicates that this 
strategy of case finding is not very successful in this country.
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Figure 1.4. Reported Incidence of Tuberculosis in South Africa 1995 - 1998
Figure 1.5. Age distribution of TB patients in South Africa in 1999
Table 1.3. Reporting Completeness for South Africa (1995 -  1999)
Year
% Reporting 
Facilities
TB Cases 
Reported
Estimated Cases 
(assuming 100% 
report rate)
1995 45.3 73 917 164 260
1996 68.0 109 328 160 776
1997 62.7 118 741 188 478
1998 71.6 135 904 188 756
1999 37.0 87 566 236 665
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1.2.3 TB “Hotspots” in South Africa
Within South Africa, certain areas can be singled out as “TB hotspots”, or places where tuberculosis 
levels are the highest in the country. The tuberculosis epidemic in the Western Cape is one of the 
most alarming ever documented. The Western Cape had an estimated 559 tuberculosis cases per 
100 000 in 1996 (Table 1.4) (MRC TB Report, 1998). In comparison, countries struggling with 
heavy tuberculosis burdens had an average number of tuberculosis cases in approximately 200 per 
100 000. The problem is most severe in areas such as the Cape Flats, which were black and 
coloured townships during the apartheid era, as well as recently established informal settlements 
(squatter camps). In the Western Cape, tuberculosis has been an especially vicious killer among the 
coloured population, for a variety of reasons including urbanisation, population dynamics, and 
treatment programmes which while accessible, fail to cure tuberculosis. Tuberculosis is also very 
high in the wine lands of the Western Cape where this disease is extensive among the farm workers. 
South Africans in the Eastern Cape Province suffer the second highest reported tuberculosis rates in 
the country at 504 per 100 000 (Table 1.4).
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Table 1.4. TB Hotspots in South Africa for 1996
Province
Estimated Cases in 1996 
(per 100 000)
Western Cape 559
Eastern Cape 504
KwaZulu-Natal 381
Gauteng 375
Northern Cape 340
Mpumalanga 286
Free State 282
North West 271
Northern Province 260
In South Africa, as in many other countries in the Sub-Saharan Africa region, the epidemic is 
compounded by the effect of the rapidly growing spread of the HIV infection. It is currently 
estimated that South Africa has a TB/HIV co-infection rate of 2 540 per 100 000 (for established 
TB patients). The synergy between a disease of antiquity and a newer pathogen has resulted in up to 
47% of tuberculosis patients in South Africa being co-infected with HIV (The South African
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Tuberculosis Control Programme, 2000). The prevalence of HIV infection among TB patients 
varies according to province (Table 1.5), with KwaZulu-Natal (64.5%) and Mpumalanga (59.1%) 
provinces reporting the highest co-infection rates. Interestingly, the Western Cape that reported the 
highest incidence rates of tuberculosis has the lowest co-infection rates (31.1%). Poverty, rather 
than the HIV/AIDS epidemic, appears to be largely responsible for the heavy tuberculosis burden in 
this province. The Medical Research Council estimated that for the year 2000, HIV co-infection 
caused an excess of 123 616 new cases of tuberculosis in South Africa, which would otherwise not 
have occurred. The pandemic of HIV/AIDS has thus caused a marked increase in the tuberculosis 
notifications in South Africa.
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Table 1.5. Estimated Tuberculosis Caseloads per Province and Proportion Expected to be HIV Co­
infected in 2000
Province Total TB Cases
Proportion HIV Positive 
(%)
KwaZulu-Natal 65 695 64.6
Mpumalanga 15 657 59.1
Free State 14 654 51.7
North West 15 549 45.5
Gauteng 45 598 44.8
Eastern Cape 56 495 40.0
Northern Province 23 338 36.3
Northern Cape 4 649 33.2
Western Cape 34211 31.6
South Africa 273 365 47.6
1.3 CLINICAL TUBERCULOSIS
It was first thought that for tuberculosis patients to be infectious, they must have pulmonary 
tuberculosis with the sputum containing acid-fast bacilli visible on direct microscopy (Louden et at, 
1958). However, Behr and colleagues (1999) reported that patients with established pulmonary 
tuberculosis, which did not stain positive for acid-fast bacilli in their sputum, were also highly 
infectious. The likelihood of developing disease is greatest immediately following infection and
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declines exponentially from that point (Chiba and Kuriahar, 1979). The incidence of clinically 
significant disease within the first year after infection is approximately 1.5%. Within the first 5 
years after infection the cumulative risk of disease is between 5% and 10%. The majority of people 
infected with M. tuberculosis do not develop disease, but have a lifetime risk of approximately 5% 
(Figure 1.6).
Usually, the first event to occur following infection (within 12 weeks after contact with the 
infectious case) is the conversion of the tuberculin skin test. In most individuals, systematic 
response to the infection includes a slight rise in temperature, possibly accompanied by flu-like 
symptoms. A minority of people who become infected with tuberculosis develop primary disease 
(Figure 1.6).
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For the twenty five percent of individuals infected with M. tuberculosis, that does not progress to 
disease development, the infection is localized in the lung and the regional lymph nodes within the 
chest and generally resolves without treatment. In a small proportion of patients with primary 
tuberculosis, complications may occur. These include local extensions and cavitations, the phase of 
infection referred to as progressive primary tuberculosis. Dissemination throughout the body may 
also occur, leading to miliary tuberculosis, which is often accompanied by tuberculosis meningitis. 
With miliary tuberculosis, in addition to general symptoms, headache from co-existent tuberculous
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meningitis frequently occurs. Cough, dyspnoea (laboured respiration) and haemoptysis 
(expectoration of blood from the respiratory tract) are less common symptoms.
In high incidence areas, tuberculous lymphadenitis / scrofula (inflammation of the nodes) is the 
most common form of extrapulmonary disease (Humphries et al, 1994) and occurs quite early 
following infection. Although the most common presentation is pulmonary disease, extrapulmonary 
tuberculosis is also an important manifestation. Tuberculosis can obviously affect virtually any 
organ in the body and may present in a variety of ways.
1.3.1 Childhood Tuberculosis
Tuberculosis remains a disease resulting in significant morbidity and mortality in children of many 
developing countries. Tuberculous symptoms are often mild and non-specific and cannot be easily 
differentiated from many other childhood illnesses. Primary infection occurs when a child is 
exposed to tubercle bacilli by prolonged, close contact with an adult who has untreated open 
pulmonary tuberculosis.
During the initial infection, bacilli disseminate to different organs and tissues resulting in different 
clinical forms of tuberculosis at varying periods after the primary infection. This can result in 
miliary tuberculosis and / or tuberculous meningitis, which along with pulmonary tuberculosis and 
tuberculous lymphadenitis, are the most common clinical forms of childhood tuberculosis. Children 
younger than 4 years of age have a higher risk of mortality and morbidity since early dissemination 
occurs more commonly in this age group (Humphries et al, 1994).
In populations with high prevalence, tuberculous lymphadenitis has its greatest incidence in early 
childhood (Humphries et al, 1994), and occurs shortly after the primary infection. Lymphatic 
involvement is thought to be an integral part of tuberculous infection with generalised lymphatic 
and haematogenous spread rather than a localized disease process. Lymph node tuberculosis occurs 
predominantly in the cervical region. The lymph node swelling is usually of insidious onset and is 
painless, although it may be tender early in the infection when it is enlarging more rapidly. Initially 
the lymph nodes are discrete and firm, but later they become matted together and fluctuant. The 
overlying skin may break down with abscess formation and chronic sinuses (Sheffield, 1994).
In childhood pulmonary tuberculosis, the radiological hallmark is hilar or paratracheal 
lymphadenopathy. The infected patient may have an occasional cough or low-grade fever. In
14
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younger children and infants, the hilar lymph nodes can be large enough to cause bronchial 
obstruction, resulting in localized hyperaeration and eventually atelectasis (collapse of expanded 
lung). Pleural effusion is also a common finding in children with pulmonary tuberculosis. 
Progressive primary tuberculosis and chronic pulmonary tuberculosis are, however, rare in the 
paediatric population.
1.4 EPIDEMIOLOGICAL TYPING OF M. TUBERCULOSIS
Understanding the tuberculosis epidemic in adults and children has been greatly advanced by the 
advent o f epidemiological typing of M  tuberculosis clinical isolates. This provides essential data 
that improves the efficacy of efforts to control tuberculosis. Following primary infection with 
tubercle bacilli, a proportion of people develop tuberculosis quite soon, but in a substantial majority 
the initial challenge is overcome without symptoms and the bacilli then lie dormant. Post primary 
tuberculosis can then result either from endogenous reactivation of the original infection following 
a waning of immunity or from a further exogenous reinfection. The relative contribution of the two 
mechanisms is not known because the clinical result is identical and most isolates of M  
tuberculosis could not be distinguished from each other. An increase in tuberculosis among children 
is considered a definite indication that transmission is occurring in the community. Social 
conditions in poor urban areas where tuberculosis remains prevalent, combined with high rates of 
HIV infection, may facilitate the development of tuberculosis disease after infection with M  
tuberculosis (Nardell, 1993). However, not only has the virus affected the chance of disease 
development by causing an increase in both susceptibility to infection (Daley et al, 1992), it also 
increases the risk of reactivation (Selwyn et al, 1989).
Molecular techniques that are able to differentiate between isolates of M. tuberculosis can therefore 
help to answer not only fundamental questions about the pathogenesis of tuberculosis, but also more 
pragmatic ones about clusters of infection and likely routes of transmission. Molecular 
fingerprinting by restriction-fragment-length-polymorphism (RFLP) analysis yields a unique, 
strain-specific pattern of bands that is stable for at least two years. Strains isolated from patients 
who were infected from a common source would have matching band profiles (Takahashi et al,
1993). Molecular fingerprinting has revealed thatM  tuberculosis can be transmitted during contact 
between persons who do not live or work together (Genevein et al, 1993). These studies suggest 
that patients with the same M  tuberculosis RFLP pattern constitute an epidemiologically linked 
cluster. Furthermore, because tuberculosis developed during a relatively short period in patients in a
15
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cluster, the clustering is an indication of recent infection, and rapid progression to clinical illness 
(Chevrel-Dellagi et al, 1993). Small and colleagues (1994) reported that 40% of the patients studied 
(n = 473) appeared to have active tuberculosis as a result of recent infection. Similarly, Alland and 
colleagues (1994) found that in the inner city of New York, recently transmitted tuberculosis 
accounted for approximately 40% of the incident cases, and almost two thirds of the drug-resistant 
cases. In the communities of Ravensmead and Uitsig, Cape Town, South Africa, Warren and 
colleagues (1996) observed an unexpected and unexplained low rate of transmission (30%), but as 
in New York, also found clustering of drug-resistant strains. This suggests that transmission, rather 
than lack of compliance, drives the spread of antibiotic resistance in the study target communities.
Since clustering has been equated with recent transmission, considerable caution should be 
exercised in conducting and interpreting these studies. Groups of strains may be identical for 
reasons other than recent transmission, depending, for example, on the stability of the marker and 
the number of strains in the population over time. Cases actually due to recent transmission may not 
be seen as clustered if they are new immigrants to the population or if not all cases in the population 
are included in the study (Glynn, 1999).
1.4.1 Strain Typing ofM  tuberculosis
The presence of repetitive genetic insertional elements in M  tuberculosis permits the identification 
of individual strains by DNA fingerprinting with RFLP analysis. The list of repetitive elements that 
have been applied for strain typing M  tuberculosis includes insertion sequences (IS6110 (Thierry et 
a!, 1990)), the major polymorphic tandem repeat (MPTR (Hermans et al, 1992)), the direct repeat 
(DR (Hermans et al, 1991)) and the (GTG)s sequence (Wiid et al, 1994). The most widely used of 
the repetitive elements for typing strains of M  tuberculosis andM  bovis is IS6110. The number of 
copies and exact locus of insertion varies for different M  tuberculosis strains.
A standardised methodology for exploitation of IS 6 //0  related polymorphisms have been published 
(van Embden et al, 1993). This IS6110 typing method by Southern blot is very reliable and highly 
reproducible. In fact, it has become the standard against which other systems are judged. IS6110 
typing methods have been used to perform community based studies in which all available strains 
isolated within a given population and time frame are analysed (Alland et al, 1994; Small et al, 
1994; Chevrel-Dellagi et al, 1993). Strains carrying five or more copies of the element that exhibit 
indistinguishable band profiles can usually be shown to have a close epidemiological association. 
The proportion of strains that cluster by IS6110 profiling can thus be used to estimate the extent to
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which the transmission of tuberculosis is occurring within the target community. Non-clustered 
cases are assumed to result largely from reactivation of pre-existing disease.
A very small number of strains have been found that do not contain IS6110 elements. Le and 
colleagues (2000) found that only 1.8% of the isolated strains (n = 168) contained no IS6//0 
elements. Secondary typing methods, employed in conjunction with IS6110, are generally used in 
community-based studies. Oligonucleotide (GTG)5 probes were used to genotype geographically 
linked strains o f M  tuberculosis previously shown to have identical IS6110 patterns. This allowed 
subclassification of lS tf//0  defined clusters into composites of smaller clusters and unique strains. 
Fingerprinting of the polymorphic GC-rich repetitive sequence genes as secondary typing 
procedures for M. tuberculosis isolates having fewer than six copies of \S6J10 were found to 
enhance the accuracy of epidemiological studies (Yang et al, 2000).
1.5 THE PATHOLOGY OF TUBERCULOSIS
The pathology of tuberculosis takes into account the inherent virulence of the organism, the 
immunity of the person infected, the development of hypersensitivity and the formation of 
epitheloid granulomata. Primary tuberculosis is the first infection of an unsensitised host. Tubercle 
bacilli usually enter the lung via the airways, whereby droplet nuclei containing one to three bacilli 
(particle size < 5 (im) gain access to alveoli (Dannenberg, 1980; Lurie, 1964; Riley, 1959). When 
inhaled, only these fine particles are capable of starting the infection because they remain 
suspended in the airstreams that enter the alveolar spaces. The heavier bacillary particles, 
containing more bacilli and / or bits of caseous material, impinge upon the mucosal surfaces of both 
the nasal passages and the bronchial tree, and do not cause disease. These bacilli are phagocytosed 
and the majority o f the organisms are killed. However, a proportion of bacilli survives and replicate 
within macrophages and cause cell death. Additional monocytes are recruited from the circulation 
and transform into macrophages, but unless they are activated, they are inefficient at destroying the 
tubercle bacilli. Tubercle bacilli are transported via the lymphatics to regional lymph nodes 
(Sheffield, 1994).
Lymph nodes are a major site of interaction between antigen and the immune system, and are 
involved in a broad spectrum of disease processes, including tuberculosis infection (Byren, 1999). 
Cervical lyniphadenopathy was found to be almost always secondary to tuberculosis infection in 
children. Afferent lymph from the circulation containing antigens, microorganisms and 
macrophages are processed in lymph nodes. The lymph node structure includes the paracortex,
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cortex and medulla. The paracortex is the major site of T cell localisation, of which 80% are CD4+ 
T helper cells and 20% are CD8+ cytotoxic T cells. The cortex contains primary lymphoid follicles 
which, on exposure to afferent lymph, develop into secondary lymphoid follicles, containing 
germinal centres which are the major site of B cell proliferation. The medulla consists of 
macrophage rich sinuses. Lymphatic channels are distributed regionally, and this anatomical 
consistency results in predictable patterns of lymph node enlargement. The infectious causes of 
lymphadenopathy are characterised by the infiltration of inflammatory and phagocytic cells.
Once the tubercle bacilli are transported to lymph nodes, epitheloid cell granulomas develop. 
Granulomas develop typical central necrosis as delayed-type hypersensitivity (DTH) to the bacilli 
develops. The number of viable bacilli becomes stationary because their growth is inhibited by the 
immune response to antigens released from the bacilli (Dannenberg, 1991). The lesion then contains 
a solid caseous centre within which the (now extracellular) bacilli do not multiply (Dannenberg,
1994). Surrounding this centre are immature / nonactivated macrophages that permit intracellular 
bacillary multiplication, and partly activated macrophages (immature epitheloid cells) produced by 
cell-mediated immunity (CMI). The disease regresses if a strong CMI response develops, activating 
the macrophages to kill or inhibit the intracellular bacteria. However, an inefficient CMI results in 
the non-inhibition of bacillary growth in the macrophages, and as a result, the tissue damaging DTH 
response again kills the bacilli laden macrophages, causing an enlargement of the caseous centre.
1.6 HOST IMMUNE RESPONSE TO TUBERCULOSIS
The chances of an infected individual developing clinical tuberculosis are approximately 2 -  23% 
during their lifetime. Although the case notification of tuberculosis patients is staggering, if viewed 
in the opposite light, these figures indicate that for most exposed or infected individuals the immune 
system is capable of preventing the development of clinical disease. This observation raises a key 
question: what is the difference between the response of those who succumb to disease and those 
that remain infected but non-symptomatic? The key element(s) that determine the development of 
protective immunity in the absence of disease are as yet unknown.
1.6.1 Tuberculous Granulomas
Granuloma formation, a critical event in the immune response against M. tuberculosis, is an 
essential component of normal host defence (Kaufmann, 1993; Sheffield, 1994). The formation of 
granulomas can also contribute to the destruction of normal tissues and thereby participate in the
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pathogenesis o f the disease. Granulomas are dynamic structures composed of multiple cell types 
with different activities o f cells in varying regions of the granuloma. The predominant cells in all 
granulomata are non-lymphoid mononuclear cells, including blood monocytes and tissue 
macrophages (Figure 1.7). Giant cells o f the predominantly Langerhans type also occur. The nuclei 
of these giant cells are arranged in an arc around central granular cytoplasm. Lymphocytes, the 
majority of which are T cells, are also present in the tuberculous granuloma. These lymphocytes are 
seen in close association with the activated macrophage / monocyte cells. A higher proportion of 
CD4+ helper cells are present in the centre of tuberculous granulomata (Modlin et al, 1984), while 
CD8+ and B cells tend to be associated with epitheloid cells at the periphery (van den Oord et al, 
1984).
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Figure 1.7. Schematic Representation of a Necrotic Granuloma 
1.6.1.1 Granuloma Function
In tuberculosis granuloma, Thl cytokines (including IFN-y and TNF-a), are produced which 
activate the surrounding macrophages. In the classical theory of cell-mediated immunity to 
mycobacteria, antigens o f the pathogens are specifically recognised by helper T cells (Thl), which 
then activate macrophages so that they are able to destroy the intracellular pathogen. However, it so 
happens that activated macrophages may be unable to inhibit / destroy the ingested tubercle bacilli. 
While the isolated macrophage may be of limited effectiveness against tubercle bacilli, collectively 
they may form a powerful defence in the form of the granuloma. Typical central necrosis may then 
result as the tissue damaging DTH develop which further inhibits the intracellular pathogen, by 
killing the bacilli laden macrophages (Sheffield, 1994). Mycobacteria are thought to proliferate 
poorly in the anoxic caseous material, and the appearance of caseous necrosis was shown to 
correlate temporally with the end of log phase growth of the bacilli in guinea pigs (Dannenberg,
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1991). Thus, the host locally destroys its own tissues to control the uninhibited growth of bacilli 
within non-activated macrophages. The initial focus of caseous necrosis together with the 
lymphadenopathy is known as the Ghon complex (Sheffield, 1994).
A wide spectrum of granulomatous reactions can be seen in patients with tuberculosis. At one 
extreme are individuals who develop a weak granulomatous response in which extensive tissue 
necrosis and large numbers of mycobacteria are present. At the other end of the spectrum are 
patients with indolent paucibacillary forms of tuberculosis characterised by the presence of florid 
noncaseating granulomatous reactions containing few detectable organisms. It is generally assumed 
that granuloma formations provide the framework whereby T cells (which produce the cytokines) 
and activated macrophages are able to maintain the close apposition necessary for effective 
macrophage activation. These cellular accumulations could also possibly serve to circumscribe the 
toxic environment. A third potentially crucial function of the granuloma is to limit dissemination of 
the infection from the lungs (Saunders et al, 1999). The initiation of the correct type of granuloma 
could be crucial to limiting bacterial growth, and also tissue damage and dissemination, two key 
components o f mycobacterial disease.
Bergeron and colleagues (1997) analysed the cytokine profiles in tuberculous granulomas in adult 
lymph node tissue and showed that a number of cytokines were increased in these 
microenvironments. The tuberculous granulomas expressed either a Thl or ThO profile. A ThO 
response, incidentally, is the simultaneous release of Thl and Th2 cytokines This can be attributed 
to the simultaneous activation of Thl and Th2 cells, or to the activation of ThO cells that are capable 
of releasing a spectrum of type 1 and type 2 cytokines. Similarly, Fenhalls and colleagues (2000) 
analysed the cytokine expression in adult granulomas in lung tissue of haemoptysis patients and 
observed a predominant Thl response, although some patients also presented a few ThO 
granulomas. These results are consistent with prior evidence for heterogeneity in the pattern of 
cytokines produced in response to M  tuberculosis.
1.6.1.2 Granuloma Formation
The factors controlling granuloma formation are only partially defined, but studies using a variety 
of animal models indicate that cytokines play a prominent role. In response to M. tuberculosis 
infection, the production of Thl cytokines (IFN-y and TNF-a) has been found to be dominant 
(Kindler el al, 1989; Chensue et al, 1995). The role of IFN-y in granuloma formation is 
overshadowed by the importance of this molecule in limiting mycobacterial growth. In IFN-y 
knockout mice, an increase in granulocytic cells with a high percentage of eosinophils entering the
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lung was observed (Pearlman et al, 1999). IFN-y may also therefore play a role in limiting early 
granulocyte accumulation to the inflammatory site. In TNF-a knockout mice, death 4 - 5  weeks 
after aerosol infection was associated with a massive bacterial load in the lungs and widespread 
dissemination to other tissues (Bean et al, 1999). The striking feature of this model is the failure of 
T cells and macrophages to form granulomas. T cells are recruited across the endothelium and 
accumulate in the perivascular regions of the lung, but fail to migrate into the infected tissue. TNF- 
a  is thus crucial for the migration and aggregation of lymphocytes and mononuclear phagocytes to 
form granulomas. The absence of y/5 T cells, while not affecting bacterial growth, also leads to 
disrupted granulomatous lesions with a marked increase in neutrophillic influx (De Souza, 1999), 
suggesting that the main function of these cells is controlling lesion formation.
1.6.2 The Role of Macrophages in Host Defence
Macrophages are the hosts’ first line of defence when confronted with M  tuberculosis. This cell is 
capable of inhibiting growth of the bacillus through phagocytosis, which usually begins with the 
engulfing of the invading microbe in a membrane-bound tight vacuole (Riley, 1996). The creation 
of this vacuole, or phagosome, is accompanied by binding of the organism to the phagocyte through 
complement receptors CR1, CR3 and CR4, as well as mannose receptors (Schlesinger, 1994). Once 
inside the macrophages, the mycobacteria are killed by several different mechanisms. The 
macrophage is capable of producing reactive oxygen and nitrogen species that are crucial in growth 
inhibition (Flesch and Kaufmann, 1991).
A number o f complicated interactions, mediated by cytokines can also cause growth inhibition or 
killing of these intracellular pathogens. Keane and colleagues (1997) reported that alveolar 
macrophages undergo apoptosis in response to intracellular infection by a TNF-a-dependent 
mechanism. Apoptosis of infected cells may benefit the host by eliminating a supportive 
environment for mycobacterial growth.
1.6.3 Antigen Presenting Cells (APCs)
Macrophages are also capable of participating in a broader context of cellular immunity through the 
process of antigen presentation and recruitment of T-lymphocytes, which further stimulate the 
APCs to inhibit growth or kill infecting mycobacteria.
Other APCs, such as dendritic cells are also present in large numbers in the airways. Dendritic cells 
are considered the most potent APC and play a crucial role in the initiation and development of the
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acquired immune response. This initiation depends on the interaction of APCs and naive T cells, 
which occurs in lymphoid organs, including lymph nodes. Dendritic cells are motile and therefore 
capable of homing from the peripheral tissues to the lymphoid organs after phagocytosing liveM  
tuberculosis bacteria (Austyn, 1996). Dendritic cells process antigens and migrate to the draining 
mediastinal lymph nodes where they activate T lymphocytes. Infected dendritic cells, as well as 
macrophages, are capable of producing interleukin (IL)-12 (Hsieh et al, 1993; Macatonia et al,
1995) that stimulates naive and immune T cells to produce interferon (IFN)-y (Gonzdez-Juarrera 
and Orme, 2001), which in response, stimulates the bactericidal activity of the APCs.
Bodnar and colleagues (2001) have shown that activation of dendritic cells and macrophages with 
IFN-y inhibited the growth of intracellular mycobacteria. However, while this activation enabled 
macrophages to kill the intracellular bacteria, the M  tuberculosis bacilli within the activated 
dendritic cells were not killed. Thus, dendritic cells could restrict the growth of the intracellular 
bacteria, but were less efficient than macrophages at eliminating the infection.
1.6.4 T Lymphocytes
There is a role for many types of T lymphocytes in the host defence against M. tuberculosis. These 
include the T lymphocytes that express the y/5 T cell receptor (y/8 T cells) and more importantly the 
a/p  T lymphocytes that comprise the T-helper cells, which express the surface protein CD4 (CD4+ 
T cells) and the T-cytotoxic cells which express the CD8 marker (CD8+ T cells). These 
lymphocytes have been shown to react to mycobacterial antigens and also expand in numbers 
within infected lungs (Orme, 1987; Boom, 1992; Feng and Britton, 2000).
1.6.4.1 CD4+ T lymphocytes
The major effector cell in cell-mediated immunity in tuberculosis is the CD4+ T lymphocytes 
(Boom, 1992; Boesan, 1995). CD4+ T cells are involved in recognition of antigens that have been 
processed in phagosomes and presented as small peptide fragments in the context of Major- 
Histocompatibility-Complex (MHC) class 11 molecules These molecules occur on the surface of 
antigen presenting cells such as monocytes, macrophages or dendritic cells. In general, CD4+ cells 
help to amplify the host immune response by activating effector cells and recruiting additional 
immune cells to the site of disease.
It was in an effort to elucidate the role of T helper lymphocytes in the induction of the delayed-type 
hypersensitivity (DTH) reaction that Mosmann and colleagues (1986) first described the existence 
of subpopulations of CD4+ cells known as T helper type 1 (Thl) and T helper type 2 (Th2)
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lymphocytes. This paradigm was initially developed in the murine model, but has now accumulated 
a substantial amount of support in a variety of human disease studies. By assaying cytokine 
production of CD4+ T helper cells from inbred mice, investigators were able to divide the T cell 
clones into two phenotypes. It was found that Thl cells produced IL-12, IFN-y and lymphotoxin 
(LT)-a, and conversely, Th2 cells produced IL-4 and other cytokines that had yet to be 
characterised. It has since been shown that cytokines secreted by mature Th2 cells include IL-5, IL- 
9, IL-10 and IL-13 (Seder and Paul, 1994; Del Prete, 1994). In humans, this division is not as 
stringent as in inbred mice. For example, some human Thl cells secrete IL-10 (Yssel et al, 1992) 
and IL-13 (de Waal et al, 1995). In part because of such overlap of cytokine secretion, the 
conventional definition of a Thl or Th2 cell depends strictly on the secretion of IFNy or IL-4, 
respectively.
There is also a subset of T helper cells that have been described which produces cytokine patterns 
distinct from the canonical Thl or Th2 sets, and are referred to as ThO cells (Firenstein et al, 1989). 
These T helper cells are capable of producing, among others, both IL-4 and IFN-y. All T helper 
lymphocytes start out as naive ThO cells, which, after being activated, differentiate into either Thl 
or Th2 effector cells (Sad and Mosmann, 1994). T cells in lymph nodes do not differentiate until 
they are exposed to specific cytokine milieus after travelling to peripheral effector sites, which 
occur two to three days following activation in the lymph nodes. Thus, Thl or Th2 differentiation 
may not occur until an activated T cell arrives at the site of danger and samples the local cytokine 
milieu to determine if an inflammatory or antibody response is appropriate (Sad and Mosmann,
1994).
Both the CMI and DTH are immunological responses dependent on the Thl type T cells. The CMI 
can be defined as a beneficial host response characterised by an expanded population of specific T 
lymphocytes, the Thl T cell, that in the presence of microbial antigens, produce cytokines (IFN-y, 
TNF-a) (Dannenberg, 1991). These cytokines attract monocytes / macrophages from the 
bloodstream into the lesion and activate them. Activated macrophages produce reactive nitrogen 
and oxygen intermediates, and other factors that kill and digest tubercle bacilli. DTH is 
immunologically the same process of CMI, involving Th-1 type T cells and their cytokines. DTH 
results in the death of local macrophages nearby tissues (caseous necrosis) and is often referred to 
as tissue damaging DTH or cytotoxic DTH. Such necrosis develops locally wherever the 
tuberculin-like antigens from the bacillus reach excessive concentrations (Dannenberg, 1991). The 
tissue damaging DTH inhibit bacilli growth (multiplication) by destroying bacilli-laden, non­
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activated macrophages and nearby tissues, thereby eliminating the intracellular environment that is 
so favourable for bacillary growth.
1.6.4.2 CD8+ T lymphocytes
CD8+ cells recognize antigens that have been processed in the cytosol and that are presented in the 
context of MHC class I molecules on the cell surface of most nucleated cells. CD8+ T cytotoxic 
lymphocytes are known to mediate lysis of autologous cells infected by intracellular pathogens. The 
importance of CD8+ T cells in the control against tuberculosis is controversial. Contributing to the 
controversy has been the extreme difficulty in isolating and characterisation of mycobacteria- 
specific CD8+ T cells from infected mice and humans.
There are several studies that support the idea that stimulation of the CD8+ T cell population must 
be considered in vaccine design. Mice deficient in (3-2-microglobulin (P-2m'/'), a component of 
MHC class I molecules, exhibit increased susceptibility to tuberculosis, implying that MHC class I 
restricted cells are important in control of tuberculosis (Flynn et al, 1992). In another study, CD8+ 
T cells, from mice and humans, stimulated with M. tuberculosis candidate antigens (Ag85, 38K, 
19K and ESAT-6) were found to be able to lyse target cells expressing the candidate antigens, as 
well as produce IFN-y upon stimulation (Mohagheghpour et al, 1998; Zhu et al, 1997; Lalvani, 
1998). Similarly, Lewinsohn and colleagues (1998) described human CD8+ T cells recognising M  
tuberculosis infected dendritic cells that were isolated preferentially from M. tuberculosis infected 
subjects. These T cells too produced IFN-y upon stimulation with infected cells, but lysis of infected 
targets was low.
Several other groups have attempted to characterise the role of CD8+ cells in the blood and lung in 
patients with pulmonary tuberculosis. Faith and colleagues (1992) and Nowakowski and colleagues 
(1992) each found a decreased CD4/CD8 ratio in bronchoalveolar lavage (BAL) cells from patients 
with pulmonary tuberculosis, whereas the ratio on peripheral blood cells was not nearly so 
depressed. In a similar study where lung lavage cells of tuberculosis patients were compared to that 
of normal control subjects, a normal CD4/CD8 ratio was observed in both study groups (Hoheisel et 
a!, 1994). These data, although not consistent from study to study, support the hypothesis that MHC 
class I-restricted CD8+ T cells are required for control of tuberculosis.
1.6.4.3 y/5 T lymphocytes
The y/5 T cells are large granular lymphocytes that can develop a dendritic morphology in lymphoid 
tissues and comprise less than 10% of circulating T lymphocytes (Kaufmann, 1996). These y/5 T
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lymphocytes are prominent in organs directly exposed to antigens from the outside environment, 
such as the lung, intestine and skin (Boismenu and Havron, 1997). They seem to be a major type of 
lymphocyte involved in the early primary response to mycobacterial antigens (Bendelac and 
Fearon, 1997; Boismenu and Havron, 1997; Barnes et al, 1992; Boom et al, 1992). The y/5 T 
lymphocytes, in general, are non-MHC-restricted. In other words, y/5 T cells do not require antigen 
processing or the presentation of antigenic peptides in a class I or class II MHC restricted manner 
(Boismenu and Havron, 1997). Unlike the oc/p T cells, antigen-specific y/5 T-receptors are able to 
combine directly with peptides while they are still part of intact antigens (Chien et al, 1996). y/5 T 
lymphocytes are activated by IL-12, secreted by infected macrophages, and produce EFN-y and EL- 
12 (Boismenu and Havron, 1997). Therefore, these lymphocytes are important in host defence 
against the early stages of tuberculosis. M  tuberculosis reactive y/5 T cells were found in the 
peripheral blood of tuberculin-positive healthy subjects, and those cells were found to be cytotoxic 
for monocytes pulsed with mycobacterial antigens (Munk et al, 1990). It is suggested that the y/5 T 
lymphocytes, by means of their cytokines, influence and help regulate macrophages, the Thl and 
Th2 responses of a/(3 T lymphocytes, and the production of the IgE and IgG production of B- 
lymphocytes. Their cytotoxic effects on nonactivated macrophages containing tubercle bacilli might 
play an important role in limiting the symbiotic stage of tuberculosis.
1.6.5 Cytokines
The most important factors in Thl or Th2 phenotype development are the IL-12 and IL-4 cytokines, 
respectively (Constant and Bottomly, 1997). Thl cells are the principal regulators of type-1 
immunity that has been shown to be protective against mycobacteria, and other various intracellular 
pathogens. Development of Thl responses depends on IL-12 produced by macrophages and 
dendritic cells during early stages of an infection (Hsieh et al, 1993; Macatonia et al, 1995), which 
as stated before, stimulates both naive and immune T cells to produce IFN-y (Gonzdez-Juarrera and 
Orme, 2001). Unlike Thl cells and naive T cells that absolutely require IL-12 for activation and 
proliferation (Kurt-Jones, 1987), Th2 cells are perfectly capable of proliferating without IL-12 if IL-
4 (Kurt-Jones, 1987; Fernandez-Botran, 1986) and / or IL-1 (Chang et al, 1990; Litchtman, 1988) 
are present. Therefore, in situations where IL-12 is in limited supply, only Th2 cells will be able to 
proliferate in response to antigenic exposure. Also, when the immune system is “in doubt” about 
whether Thl or Th2 cells should be generated, Th2 outcomes are favoured. For instance, if both IL- 
12 and IL-4 are present at the time of T cell activation, IL-4 dominates, and the T lymphocytes 
differentiate to become Th2 effectors (Seder et al, 1993; Hsieh et al, 1993; Perez et al, 1995).
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The cytokine chiefly responsible for the proinflammatory effect of the type 1 immunity is IFN-y. 
Patients suffer from increased susceptibility to mycobacteria due to the lack of functional IL-12 
(Frucht and Holland, 1996) or EL-12-receptor (IL-12R) (Altare et al, 1998) which results in an 
impaired IFN-y production. EFN-y stimulates phagocytosis (Livingston, 1989), the oxidative burst 
(Johnston and Kitagawa, 1985), and intracellular killing of M. tuberculosis bacilli. IFN-y also 
upregulates expression of class I (Lapierre et al, 1988; Johnson et al, 1990), and class II MHC 
molecules (Volk et al, 1986; Male et al, 1987) on a variety of cells, thereby stimulating antigen 
presentation to T cells. Both IFN-y and lymphotoxin-a induce other cell types, including non­
leukocytes such as endothelial cells (Goebeler et al, 1997), keratinocytes (Teunissen et al, 1998), 
and fibroblasts (Rathanaswami et al, 1993; Teran et al, 1999), to secrete proinflammatory cytokines 
such as TNF-a and chemokines (Nickoloff et al, 1994). TNF-a is synthesised by a wide range of 
cell types, including macrophages and lymphocytes, and exhibits an extensive range of pro- 
inflammatory and macrophage-activating functions (Britton et al, 1998). Murine knockout models 
of the 55kD TNF receptor have revealed the importance of TNF-a for survival against M  
tuberculosis infection, probably through induction of reactive nitrogen species (Flynn et al, 1995). 
Macrophages were also reported to undergo apoptosis in response to intracellular infection by a 
TNF-a-dependent mechanism (Keane et al, 1997). TNF-a was shown to be crucial to 
antimycobacterial immunity, with TNF knockout mice being as susceptible to an aerogenic 
infection with M  tuberculosis infection as IFN-y knockout mice (Flynn et al, 1995). It is clear that 
IFN-y participates in protective immunity in synergy with other factors such as TNF-a. Th2 cells, 
conversely, stimulate high titres of antibody production. In particular, EL-4, IL-10 and IL-13 
activate B cell proliferation, antibody production, and class switching between antibodies 
(Lundgren et al, 1989; Punnomen and de Vries, 1994).
In addition to their stimulatory effects, Thl and Th2 cells cross-regulate one another (Gajewski et 
al, 1988; D’Andrea et al, 1993). The IFN-y secreted by Thl cells directly suppresses IL-4 secretion 
and thus inhibits differentiation of naive ThO cell into Th2 cells (Gajewski et al, 1988). Conversely, 
IL-4 and IL-10 inhibit the secretion of IL-12 and IFN-y, thereby blocking the ability of ThO cells to 
differentiate into Thl cells (D’Andrea et al, 1993). IL-10 is perhaps the most anti-inflammatory 
cytokine known (Rennick et al, 1995). It inhibits the secretion of proinflammatory cytokines 
(Fiorentino et al, 1991), suppresses phagocytosis (Laichalk et al, 1996), the oxidative burst 
(Romani et al, 1994), intracellular killing (Oswald et al, 1992), and inhibits antigen presentation to 
T cells (Enk el al, 1993). It is important to produce enough of a proinflammatory type 1 response to
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keep the intracellular infection under control, while producing at the same time just enough of a 
type 2 response to prevent the type 1 response from causing damage to the host.
It is generally accepted that type 1 cytokines are expressed during the protective phase of an 
immune response. A switch is made to expression of type 2 cytokines during the resolution phase 
and to re-establish homeostasis once the infection is under control. Orme and colleagues (1993) 
studied the evolution of an immune response to tuberculosis in infected mice and obtained results 
that were in concordance with this theme. It was reported that during early infection in mice, and 
peaking with the time of maximum protective inflammation, IFN-y dominated the cytokine 
response. When the infection had been contained ( 3 - 5  weeks later), EL-4 and IL-10 dominated the 
cytokine profile, and IFN-y was markedly suppressed. However, there is a dichotomy between a 
high humoral response (induced by type 2 cytokines) and high DTH response (induced by type 1 
cytokines) among patients infected w ithM  tuberculosis (Lenzini et al, 1977). Patients with active 
tuberculosis have been shown to have diminished DTH reactions, cell proliferation and IFN-y 
production in response to PPD, as well as higher levels of antimycobacterial antibodies than normal 
PPD-positive, uninfected case control subjects (Sanchez et al, 1994). In addition, patients with 
active disease were found to produce higher levels of IL-4 (Seah et al, 2000). These data are 
consistent with the notion that active M. tuberculosis infection was related to dominant type-2 
immunity, whereas protected patients mounted type 1 immune responses to the organism.
1.7 BIOLOGY O FM  TUBERCULOSIS
Mycobacteria are intracellular pathogens that survive and grow in host macrophages. Following 
phagocytosis, sustained intracellular bacterial growth depends on its ability to avoid destruction by 
macrophage-mediated host defences. The ability of M. tuberculosis to survive within macrophages 
and granulomas, as well as the onslaught of anti-tuberculosis drugs, is likely to depend upon its 
ability to mount an effective response to these hostile environments. However, all conventional 
anti-tuberculosis drugs have one thing in common: they target cellular processes involved in cell 
growth and division, such as cell wall biogenesis and DNA replication. The magnitude of the 
widening tuberculosis epidemic underscores the inadequate effectiveness of the current treatment. 
An improved understanding of the pathogenesis of this highly infectious disease is thus crucial if 
we are to develop new and improved strategies to prevent its further spread. Understanding the 
bacterial roles of the various M  tuberculosis genes identified is vital to achieve this aim.
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1.7.1 Metabolic Factors / Drug Targets
1.7.1.1 rpoB
Rifampin (RIF) is one of the most potent drugs used in the treatment of tuberculosis and has proven 
to be an effective agent against susceptible strains. The molecular mechanism of RIF activity 
involves inhibition of the DNA-dependent RNA polymerase, by binding to the P subunit of this 
enzyme (Musser, 1995). This multifunctional enzyme carries out the principal biochemical steps of 
gene transcription, including specific promoter binding, melting of the DNA double helix, template- 
directed de novo initiation, processive elongation, and release of RNA at terminators. The 
purification of substantial amounts of RNA polymerase fromis. coli, have made it possible to study 
the structure of this enzyme.
The active enzyme molecule is a complex oligomer containing four different subunits, termed a , P’, 
P and a 70 (Zubay, 1993). A complex with the subunit structure of a 2PP’a 70 can carry out the 
functions necessary for correct and efficient synthesis of RNA and is referred to as the holoenzyme. 
The a 70 subunit only transiently associates with the core (012PP’) to catalyse transcription initiation 
at promoter sites, whereas the P subunit, which has a homolog in every living organism, has been 
implicated in each basic step of the RNA polymerase functional cycle (Kashlev et al, 1990). RIF 
binds to this subunit of the RNA polymerase holoenzyme and leads to abortive initiation of 
transcription (McClure and Cech, 1978).
The genes encoding subunits a, P, P’ and a 70 have been designated rpoA, rpoB, rpoC and rpoD, 
respectively. The rpoB gene of M. tuberculosis was found to have 57% homology with E. coli P 
subunit. Dykxhoorn and colleagues (1996) examined the expression of the rpoBC genes in response 
to varied intracellular concentrations of the RNA polymerase subunits, and found that elevated 
concentrations of either P or p’ repressed the expression of both rpoB and rpoC at the translational 
level. However, the elevated concentrations of all the subunits that comprise the holoenzyme also 
led to a reduction of rpoB and rpoC expression, but at the transcriptional level. It was also 
demonstrated that the assembly of the core enzyme (0C2PP’) was limited by the concentrations of the 
P and P’ subunits. The maximum transcriptional capacity of the cell therefore appears to be 
governed by the synthesis of P and P’. Mariani and colleagues (2000) also detected a change in the 
expression of rpoB between infected, non-activated macrophages and those macrophages activated 
with IFN-y and LPS. Messenger RNA for rpoB was detected in the non-activated macrophages, but 
not in the activated host cells. This suggests that the bacilli responded to the host response by down
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regulating the transcription of rpoB. Analysing the expression of the genes encoding the RNA 
polymerase enzyme subunits is thought to be a means of measuring the transcriptional activity of 
the bacilli, and could be an indication of the logarithmic growth phase.
1.7.1.2 katG
lsoniazid (INH), a widely used frontline anti-mycobacterial agent, requires oxidative activation 
before exerting a lethal effect (Barry, 1997). Catalase peroxidase, a heme protein encoded by the 
katG gene, is found in many microorganisms, including M. tuberculosis. This enzyme has high 
catalase and peroxidase activities that will allow it to oxidize a variety of electron donors (Johnsson 
et al, 1997). A broad range of studies has been directed at explaining the chemistry and biology of 
isoniazid action by establishing an association between the KatG enzyme and drug efficacy 
(Chouchane et al, 2000; Kiepiela et al, 2000, Heym et al, 1999).
Mycobacteria residing in macrophages are exposed to the reactive oxygen and nitrogen 
intermediates produced by phagolysosomal membranes. Little is known about the chemical 
processes that ensue in and around resident bacteria, but it has been shown that mycobacteria are 
relatively resistant to hydrogen peroxide and peroxynitrite (Yu et al, 1999). This resistance was 
believed to be mediated by the sole mycobacterial catalase peroxidase (KatG), a secreted protein 
(Sonnenberg and Belisle, 1997; Raynaud et al, 1998), and the alkyl hydroperoxide reductase protein 
(ahpC), respectively (Wengenack et al, 1999).
The effect of specific gene mutation associated with reduced susceptibility to INH on human 
virulence has not been thoroughly documented. The various investigations of the role of catalase 
peroxidase in the virulence of M. tuberculosis have produced conflicting results. Some investigators 
have observed no correlation between loss of KatG activity and virulence of M  tuberculosis in mice 
and guinea pigs (Jackett et al, 1978; O’Brien et al, 1991), and no correlation between KatG levels 
and susceptibility to killing by hydrogen peroxide (Jackett et al, 1978 (a)). However, others have 
found a strong correlation between KatG status and M  tuberculosis virulence (Manca et al, 1999; 
Li et al, 1998).. These studies have shown that both catalase and peroxidase activity levels correlate 
significantly with resistance of mycobacteria to hydrogen peroxide-mediated killing. These results 
suggest that mycobacterial resistance to oxidative metabolites may be an important mechanism of 
bacillary survival within the host phagocyte.
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1.7.2 Potential Persistent Factors
The current anti-tuberculosis drugs are highly effective against actively replicating cells, but they 
are less potent against cells in persistent phase. There is a long established observation that slow- 
and non-growing bacteria are phenotypically resistant or ‘tolerant’ to killing by antimicrobials. The 
Mitchison hypothesis (Figure 1.8), based on this observation, states that anti-tuberculosis drugs 
target distinct subpopulations of bacteria within tuberculous lesions (Mitchison, 1979). Rapidly 
growing bacteria are killed most effectively by INH, RIF and Streptomycin. Bacteria in the acidic 
environment o f the phagolysosome are killed by Pyrozinamde, and the intermittently active bacteria 
are killed by RIF. Evidently, none of the conventional drugs are efficient killers of non-growing or 
persistent bacteria. Therefore, improved understanding of the physiology and metabolism of 
bacteria in a non-replicating dormant phase would be crucial to the identification of new and 
potentially more relevant drug targets. Everyday “new” genes of the tubercle bacillus are assigned 
different functions, some of which are summarised in Table 1.6. However, most of these studies 
have focussed on genes required for in vitro growth or in animal model systems. These have been 
termed virulence genes.
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Figure 1.8. The Mitchison Hypothesis. A. RIF, INH and Streptomycin targets rapidly growing 
bacteria. B. PZA kills bacteria in the acidic phagolysome, C. RIF also targets intermittently 
growing bacteria, D. but no conventional drugs target dormant bacteria
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Table 1.6. Some Putative Virulence Genes of M. tuberculosis
Gene Function
Expression System 
used for Analysis References
ahpC
defence against oxidative stress 
and INH resistance
M. bovis in vitro culture
Wilson et al, 1998; Wilson etal, 
1997
eis
enhanced intracellular survival 
protein
infection of macrophage­
like cell line
Wei et al, 2000
erp involved multiplication of M.tb
infection of murine 
macrophages
Berthet et al, 1998
inhA
INH resistance; role in mycolic 
acid synthesis
guinea pig model Wilson et al, 1995
mceD
involved in cell invasion and 
persistence
invasion of HeLa cells Arruda et al, 1993
sigE
sigma factor involved in gene 
transcription
infection of cultured 
macrophages
Graham and Clarke-Curtiss, 
1999
sigH
sigma factor, involved in gene 
transcription
infection of cultured 
macrophages
Graham and Clarke-Curtiss, 
1999
drrC
Involved in the synthesis of 
PDIM
Standard liquid medium Camacho etal, 1999
fadD26 Lipid metabolism
Bone marrow macrophages 
from BALB/c mice
Camacho etal, 1999
fad30
biosynthesis and translocation of 
lipids
Bone marrow macrophages 
from BALB/c mice
Camacho etal, 1999
glnAJ cell wall synthesis
stationary phase broth 
cultures, THP-1 cells
Harth and Horwitz, 1999
UpF
lipid degradation; synthesis and 
transfer of diols in PDIM
standard liquid medium Camacho et al, 1999
mas
synthesis of PDIM; required for 
growth in lungs
B57BL/6 mice spleen and 
liver
Cox et at, 1999
mmpLl
involved in transport and 
biosynthesis of PDIM
bone marrow macrophages 
from BALB/c mice
Camacho eta l, 1999
mmpL2
transport and biosynthesis of 
PDIM
bone marrow macrophages 
from BALB/c mice
Camacho et a i  1999
mmpL4
involved in the transport of 
PDIM
B57BL/6 mice spleen and 
liver
Cox et al, 1999
pksb polyketide synthase
bone marrow macrophages 
from BALB/c mice
Camacho eta l, 1999
ppsA-E
synthesis of PDIM; required for 
growth in lung
B57BL/6 mice liver and 
spleen
Cox etal, 1999
PDIM -  Phthiocerol dimycocerosate. a cell wall lipid
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1.7.2.1 icl
The strategy for survival during chronic stages of infection entails a metabolic shift in the bacteria’s 
carbon source to C2 substrates generated by oxidation of fatty acids. Most microorganisms growing 
on acetate or fatty acids as the sole carbon source employ the glyoxylate bypass for the biosynthesis 
of cellular material (Kornberg, 1966).
The glyoxylate cycle effectively circumvents the loss of two CO2 of the tricarboxylic acid (TCA) 
cycle, thereby permitting net incorporation of carbon into cellular structures during growth on 
acetate and fatty acids (Umbarger and Zubay, 1993). It is an alternative pathway that, like the TCA, 
begins with citrate formation, but results in anabolism to the four-carbon level rather than 
catabolism to the one-carbon level. Isocitrate is split into two molecules, glyoxylate and succinate, 
rather than being oxidatively decarboxylated, as would occur in the TCA cycle. The reaction is 
catalysed by isocitrate lyase, an enzyme encoded by the icl gene. Even during the operation of the 
TCA cycle, many fatty acids are partially metabolised to acetyl-CoA, thus requiring the presence of 
ICL (Vanni et al, 1990).
Honer-Zu Bentrup and colleagues (1999) reported that in bothM  tuberculosis and M. avium, the 
production and activity of ICL was enhanced under minimal growth conditions, but only when 
supplemented with acetate or palmitate. It was recently demonstrated that disruption of /cl 
attenuates persistence of M  tuberculosis in mice and inflammatory macrophages (McKinney et al, 
2000). While the deletion of icl did not affect bacterial growth in immunocompetent mice during 
the acute phase of infection (0 - 2  weeks), significant reduction in bacterial loads and macroscopic 
lesions were observed during the chronic phase (2 - 6  weeks).
The glyoxylate-pathway enzymes are present in most prokaryotes, lower eukaryotes and plants, but 
have not been observed in vertebrates, making it a potential new drug target. Current anti­
tuberculosis drugs have traditionally been identified by their ability to suppress or kill replicating 
cultures of bacteria in vitro. Drug targeting ICL would have therefore been missed in traditional 
screens because this enzyme is non-essential under standard culture conditions. There is thus an 
urgent need for an improved understanding of the biology of bacteria growing in vivo.
1.7.2.2 narX
It is largely unknown how the bacteria survive during the persistent stage of infection. Disease 
progression is halted when an effective immune response is mounted and the bacilli become 
restricted to the characteristic tuberculous lesions. The bacillus can survive in the caseous necrotic
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centre of these lesions, but it apparently cannot multiply because of oxygen deprivation and other 
adverse conditions (Cunningham and Spreadbury, 1998). It is within this anaerobic environment 
consisting of caseous necrotic material that bacterial dormancy probably occurs (Wayne, 1994). It 
was shown that M  tuberculosis and its close relative M. bovis BCG are obligate aerobes (require 
oxygen for growth) but have the ability to adapt to and survive anaerobiosis by shifting down to a 
state of synchronised, non-replicating persistence (Wayne and Hayes, 1996). This suggested that the 
bacteria switch from an aerobic metabolism supporting growth to an anaerobic metabolism 
supporting non-growing persistence.
The M  tuberculosis genome project revealed the presence of enzymes that might be involved in 
anaerobic respiration and fermentation (Cole et al, 1998). Based on the genome sequence, Hutter 
and Dick (1999) carried out a Northern blot screen and found that narX, a putative fused nitrate 
reductase, was strongly upregulated in the anaerobic non-growing state ofM  bovis BCG. In aerobic 
growing bacilli, narX  transcripts were not detectable. The induction of narX indicated that the 
corresponding gene product might play a role in the dormant state of the late cycle of the bacilli. 
Wayne and Hayes (1998) also reported a rapid increase of nitrate reduction in M  tuberculosis 
cultures grown with nitrate during the shift down to anaerobic persistence. In addition, the presence 
of several putative transmembrane domains at the C-terminus indicated that NarX could be an 
integral membrane protein and might be associated with the electron transport chain. The structural 
features of the NarX protein together with the observation that narX expression appears to depend 
on anaerobiosis (Hutter and Dick, 1999), suggested that NarX might function as a respiratory nitrate 
reductase. This response may help the bacilli survive in oxygen depleted regions of inflammatory 
tissue where nitrate can occur as a degradation product of nitric oxide.
1.7.2.3 mbtB
The various defensive mechanisms expressed by the eukaryotic host include a dramatic restriction 
of available iron to support microbial growth (Kontoghiorghes and Weinberg, 1995). The 
mechanism that allows pathogenic bacteria to grow in such iron-limited environment is dependent 
on its ability to scavenge this limited metal. Mycobacteria produce and secrete specialised iron 
chelators known as siderophores (Gobin et al, 1995), and then specifically take up those complexed 
with ferric ion. M. tuberculosis synthesise two forms of mycobactin siderophores that have been 
proposed to have different physical properties, particularly regarding aqueous solubility, leading to 
the proposition that they have discrete biological roles. This slow growing pathogen produces the 
lipophilic, membrane-associated mycobactin T (Snow, 1970) and the water-soluble / hydrophilic 
mycobactin T, also referred to as exochelins (Macham and Ratledge, 1975). The hydrophilic
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mycobactin T has been proposed to be secreted into the aqueous growth medium for direct 
competition with iron-binding molecules of the environment. The membrane-associated mycobactin 
T has been proposed to operate as an ionophore to shuttle iron across the extremely hydrophobic 
cell wall after transfer of the iron from the extracellular siderophore (Gobin and Horwitz, 1996).
Mycobactins consists of a core hydroxyphenyloxazoline structure that is thought to be derived from 
salicyclic acid after condensation with a serine residue. The virulence-conferring mycobactins ofM  
tuberculosis have sufficient structural homology to other siderophores (Chambers et al, 1996). It 
was therefore suggested that they probably arose through a common biosynthetic strategy using 
comparable non-ribosomal peptide synthetase catalytic logic. Quadri and colleagues (1998) 
identified the gene cluster in M. tuberculosis responsible for mycobactin synthesis, which they 
named mbtA-J. This was in concordance with the publication of the complete M  tuberculosis 
genome by Cole and colleagues (1998), in which they suggested that these genes could encode 
mycobactin biosynthetic proteins.
This cluster encodes a mixed polyketide synthase / non-ribosomal peptide synthetase system 
(Quadri et al, 1998). The mbtB gene encodes an enzyme proposed to catalyse the initial steps in the 
mycobactin T biosynthetic pathway, the condensation of salicyclic acid with serine, and the 
formation of the hydroxyphenyloxazoline nucleus of these siderophores (De Voss et al, 1999). 
Analyses of siderophores by a AmbtB mutant revealed that biosynthesis of all salicylate-derived 
siderophores were interrupted (De Voss et al, 2000). This allowed investigators to establish that 
under conditions of iron limitation, siderophore production is essential for optimal growth of M  
tuberculosis. In addition, the AmbtB mutant was also unable to replicate in cultured macrophages, 
suggesting that siderophore production enhances growth in these host cells.
1.7.2.4 i*el\ith
Adaptation of bacilli to long-term survival with restricted access to nutrients or oxygen may be 
associated with coordinated alterations in patterns of gene expression in specific metabolic 
networks. In E. co/i, the stringent response is a broad transcriptional program encompassing 
approximately 80 genes that mediates adaptation to survival under conditions of starvation. 
Induction of the stringent response stimulates polyphosphate synthesis (Rao and Komberg, 1996), 
increases fatty acid cyclopropanation (Eichel et al, 1999), upregulates glycogen (Bridger et al, 
1978), as well as stationary-phase sigma factor RpoS synthesis (Loewen et al, 1998). This response 
also inhibits fatty acid, phospholipid (Heath et al, 1994) and RNA synthesis (Liang et al, 2000).
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Amino acid, carbon, nitrogen or phosphorous deficiency as well as fatty acid starvation (Seyfzadeh 
et al, 1993), were shown to induce the stringent response.
The stringent response is mediated by increased intracellular levels of hyperphosphorylated guanine 
nucleotides, specifically the 3’-pyrophosphate derivative of GDP (ppGpp), and the 3’- 
pyrophosphate derivative of GTP (pppGpp). Binding of (p)ppGpp (mixture of both derivatives) to 
RNA polymerase changes the structure of the polymerase so that it has a lowered affinity for rRNA 
tRNA and ribosomal protein promoters, and at the same time, a greater affinity for some other 
promoters (Zubay, 1993; Kvint et al, 2000). The stringent response utilizes hyperphosphorylated 
guanine as a signalling molecule to control bacterial gene expression involved in long-term survival 
under starvation conditions.
In gram negative bacteria, (p)ppGpp is produced by the activity of the related RelA and SpoT 
proteins. RelA is ribosome associated and is activated by binding uncharged tRNAs to the ribosome 
upon depletion of amino acids (Mitchison, 1992; Liang et al, 2000). SpoT is not associated with 
ribosomes and has both (p)ppGpp synthetic and hydrolytic activities (Heinemeyer et al, 1978). M  
tuberculosis only has a single RelA or SpoT homolog, designated RelMtb (Cole et al, 1998) and 
responds to nutrient starvation by producing (p)ppGpp (Ojha et al, 2000). Primm and colleagues 
(2000) demonstrated that there was a very low basal level of (p)ppGpp in log-phase wild-type M  
tuberculosis grown axenically on glucose, with accumulation starting in early stationary-phase 
cultures, and reaching a maximum in long-term stationary-phase cultures. It was consequently 
suggested that the RelMtb-mediated production of (p)ppGpp induced proteins are involved in 
stationary-phase survival. This assumption was supported when late-log phase cultures of the relMtb 
knockout M. tuberculosis H37Rv strain failed to reduce the amount of stable RNA and ribosomal 
proteins, and was, as anticipated, unable to adapt to the stationary phase (Primm et al, 2000). No 
(p)ppGpp was detected in these cultures. The ArelMtb mutant also displayed a significantly slower 
aerobic growth rate than the wild-type in synthetic liquid media, whether rich or minimal. The 
knockout model therefore shows that in the absence of the stringent response, M. tuberculosis fails 
to adapt to the stationary phase and long-term survival is severely compromised. The results also 
suggested that during aerobic growth under standard or enriched conditions, some level of 
(p)ppGpp is required for optimum growth.
1.7.3 Immunological Significant Antigenic Proteins
For the development of both new vaccines and diagnostic reagents to replace the tuberculin purified 
protein derivative (PPD), there is a need to identify and evaluate the human response against
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defined M  tuberculosis antigens. Several studies suggested that surface proteins and proteins 
actively secreted by M  tuberculosis are important targets for the immune system during the early 
phase of infection (Andersen et al, 1992; Andersen Heron, 1993; Andersen, 1994; Pal and Horwitz,
1992). In recent years, research has been focussed on antigens released by live M. tuberculosis into 
the culture media, as these antigens are believed to be at least partially responsible for the efficacy 
of live vaccines. Pools of such extracellular antigens have been tested in several laboratories as 
subunit vaccines and demonstrated to induce substantial levels of protection in animal models 
(Andersen et al, 1994; Pal and Horwitz, 1992).
1.7.3.1 esat-6
A novel protein, designated the 6-kDa early-secreted antigenic target (ESAT-6), was identified in 
culture filtrates of virulent M. tuberculosis (Sorensen et al, 1995; Harboe et al, 1996). ESAT-6 
expression was found to be restricted to the M  tuberculosis complex, whereas M. bovis BCG and 
the majority of environmental mycobacteria lack this antigen. The physiological role of ESAT-6 in 
M. tuberculosis remains to be established as well as how it is exported into the surrounding medium 
remains to be elucidated.
The ESAT-6 protein stimulates T cells from tuberculosis patients to proliferate and produce IFN-y 
(Ulrichs et al, 1998; Lalvani et al, 2001; Arend et al, 2000; Ravn et al, 1999). ESAT-6 has been 
considered a possible candidate for use in the diagnosis of tuberculosis because of its high 
specificity and sensitivity. Ulrichs and colleagues (1998) demonstrated thatM  tuberculosis ESAT-
6 can stimulate T cells from tuberculosis patients, but not T cells from tuberculin-positive healthy 
donors. These healthy PPD+ donors were assumed to be positive due to previous BCG vaccination. 
In a later study, Ulrich and colleagues (2000) reported that the number of IFN-y producing cells 
reactive to ESAT-6, were increased in tuberculosis patients, as well as recent converters to PPD 
positivity, but as in the previous study, no reactivity was observed in unvaccinated or vaccinated 
healthy donors. They proposed that ESAT-6 is a potential candidate for use in detection of active 
disease as well early tuberculosis. In addition, Lalvani and colleagues (1998) also demonstrated that 
the majority o f the healthy, tuberculin positive adults, with normal chest radiographs, harbour IFN-y 
secreting T cells specific for ESAT-6. These investigators also proposed that the ESAT-6 specific 
IFN-y secreting T cells could also be used to identify latently infected, tuberculin positive, healthy 
household contacts of patients with sputum-smear positive tuberculosis.
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1.7.3.2 PPE
The complete genome sequence of M  tuberculosis H37Rv (Cole et al, 1998) highlighted the 
existence of the large gene family, namely the PPE gene family that consists of 68 members. The 
PPE genes have a relatively conserved 180 amino acid (aa) N-terminal region in common (Cole et 
al, 1998) and range in size form 77 aa to 3 300 aa. The function of the glycine rich PPE proteins has 
not been established. It has been suggested that they may be of immunological significance, either 
by providing a source of antigenic variation in, what is considered, a genetically homogenous 
bacterium, or by antigen processing by host cells (Cole et al, 1998).
There is currently very limited knowledge of the PPE gene expression profiles. Rivera and 
colleagues (1998) provided the first proof of in vitro expression of PPE genes when they 
demonstrated the upregulation of the PPE gene Rv0755c in H37Ra relative to H37Rv. Similarly, 
the PPE gene Rv2770c was shown to be upregulated inM  tuberculosis H37Rv vs. H37Ra (Rindi et 
al, 1999). Rodriguez and colleagues (1999) recently reported the upregulation of the PPE gene 
Rv2123 under low iron conditions in vitro, and speculated that the gene product may be involved in 
iron uptake. Indirect evidence for in vivo expression of the PPE genes was provided by a study of a 
serine-rich antigen from M. leprae (Vega-Lopez et al, 1993), which was recognized by serum from 
both leprosy and tuberculosis patients. This protein is now known to be a member of the PPE gene 
family. It was recently shown that a mutant strain of M. tuberculosis with a transposon-generated 
knockout PPE gene Rv3018c is attenuated for growth in lungs of mice (Camacho et al, 1999). This 
implies a role for this gene in early infection, although in vivo expression in the human host of the 
gene was not confirmed.
1.8 AIMS OF STUDY
A major drawback of all the techniques utilised in the studies described above is that they do not 
allow for the detection of viable bacilli within its natural host environment, the granuloma. The 
aims of the study were to analyse M  tuberculosis gene expression and host cytokine expression in 
the human granulomas, from lymph node tissue from children. This was done in order to determine 
whether the bacterial gene expression profile responds to the host environment, or conversely, 
whether the host cytokine expression responds to the bacterial growth state. Lymph node child 
tissue was thought to be the ideal target material for analysis, in order to avoid the confounding 
effects of these drugs. The anti-tuberculosis drugs would influence bacterial gene expression, 
resulting in the killing of the bacilli, and would therefore also affect the host response. In this study 
we used in situ hybridisation to demonstrate that DNA from M  tuberculosis is present in a high
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proportion o f granulomas from TB patients. This technique allows for the localisation of the bacilli 
within the host tissue. This study also addressed the question of M  tuberculosis differential gene 
expression, specifically rpoB, katG, narX, icl, mbtB, relMtb, esat-6 and PPE Rv3018c, within the 
human granuloma in order to determine whether these genes were expressed within the granuloma 
microenvironment during host infection. Expression profiles of the infecting bacilli were 
investigated by RNA:RNA in situ hybridisation. We studied the host immune response induced by 
the infecting M. tuberculosis strains, by analysing the cytokine production in the human lymph 
node granuloma using immunohistochemistry. The cytokines analysed included type-1 cytokines 
IL-12, IFN-y and TNF-a, as well as type-2 cytokines IL-4 and IL-10. The data was then stratified to 
identify any correlations between M. tuberculosis gene expression and state of disease. The co­
localisation o f mycobacterial DNA and mRNA with host cytokines was a case study to identify any 
correlations between the bacterial growth phase and host response. The findings of this study 
present new opportunities for investigating the interaction between the pathogen and its host.
Stellenbosch University http://scholar.sun.ac.za/
39
CHAPTER TWO
MATERIALS AND METHODS
INDEX PAGE
2.1 TISSUE SPECIMENS
2.1.1 Lymph Node Biopsies 41
2.2 PREPARATION OF SLIDES FOR IN  SITU  HYBRIDISATION AND 
IMMUNOHISTOCHEMISTRY 41
2.3 PREPARATION OF PROBES FOR IN  SITU  HYBRIDISATION
2.3.1 DNA MTB484 Probe 41
2.3.2 Riboprobes 42
2.3.2.1 Recombinant Vectors Containing M. tuberculosis Gene Inserts 42
2.3.2.1.1 Preparation and Transformation of Competent E. coli Cells 44
2.3.2.1.2 Large Scale Isolation of Plasmid DNA 44
2.3.2.2 Polymerase Chain Reaction (PCR)
2 .3.2.2.1 Oligonucleotide Primers 45
2.3.2 .2.2 PCR Conditions 46
2 .3.2.3 Agarose Gel Electrophoresis 46
2.3.2.4 Purification of Amplified PCR Products 47
2 .3.2.5 Preparation of Biotinylated Riboprobes 47
2.4 IN  SIT U  HYBRIDISATION 49
2.4.1 Brief Description 49
2.4.2 Pretreatment of Tissue for/n Situ Hybridisation 49
2.4.3 Hybridisation of Biotinylated Probes 50
24.3.1 DNA:DNA Hybridisation 50
24.3.2 RNA:RNA Hybridisation 51
24.3.3 Hybridisation 51
2.4.4 Detection of Hybridised Probes 51
2.4.5 Counterstaining 52
Stellenbosch University http://scholar.sun.ac.za/
2.5 IMMUNOHISTOCHEMISTRY 52
2.5.1 Brief Description 52
2.5.2 Pretreatment of Tissue for Imraunohistochemistry 53
2.5.3 Binding of Primary and Secondary Antibodies 54
2.5.4 Detection of Bound Antibody Probes 54
2.5.5 Counterstaining 55
2 6 DUAL LABELING 55
2.6.1 Brief Description 5 5
2.6.2 Immunohi stochemistry Staining of CD68 Receptors
2.6.2.1 Pretreatment of Tissue 55
2.6.2.2 Binding of Primary and Secondary Antibody 55
2.6.2 In Situ Hybridisation 56
2.7 PHOTOGRAPHY 57
2.8 ASSESSMENT OF SLIDES 57
2.9 STATISTICAL EVALUATION OF DATA 57
2.10 DNA FINGERPRINTING OF ISOLATED CLINICAL STRAINS
FROM LYMPH NODE TISSUE 57
2.10.5 Brief Description 57
2.10.6 Extraction of Mycobacterial DNA 58
2.10.7 Restriction Enzyme Digestion of the DNA 59
2.10.8 Altering Concentrations of the Restricted DNA 60
2.10.9 Gel Electrophoresis of Restricted DNA 60
2.10.10 Southern Transfer of the Fingerprinting Gel 60
2.10.11 Labeling of Probes and Hybridisation 61
2.10.12 Data Analysis 62
Stellenbosch University http://scholar.sun.ac.za/
2.1 TISSUE SPECIMENS: LYMPH NODE BIOPSIES
41
Lymph node biopsy tissue was collected in a clean, sterile container. A portion of the lymph node 
of each patient was immersed in saline and was subsequently submitted for culture (BACTEC) for 
the isolation o f the infecting strain (Department of Medical Microbiology, Tygerberg Hospital, 
Cape Town, South Africa). The remaining portion of the infected node for each patient was 
immediately fixed in formalin (Appendix 1), processed and embedded in wax (Department of 
Anatomical Pathology, Tygerberg Hospital, Cape Town, South Africa). Sections of the embedded 
tissue were used for histological analysis and ZN staining, while culture was requested for 
confirmation o f tuberculosis lymphadenitis.
Informed consent was obtained from a parent / guardian of all the patients (Appendix 2), and the 
study was approved by the Stellenbosch University Ethical Review Committee.
2.2 PREPARATION OF SLIDES FOR IN  SITU  HYBRIDISATION AND 
IMMUNOHISTOCHEMISTRY
Retention o f cells on the slides requires pretreating the slides with an appropriate agent for 
increasing cell adhesion, as samples would otherwise be lost from untreated slides. Precleaned 
slides (Sigma, USA) were incubated overnight in chromic acid (Appendix 1), which was carefully 
decanted, after which the slides were rinsed thoroughly in tap water to remove residual acid. The 
slides were then rinsed (x5) with distilled H2O (dH20) and then incubated for 30 minutes in dH20. 
The water was poured off and the slides were immersed in acetone (Merck, UK) for 30 minutes. 
This was followed by incubating the slides in 2% 3-aminopropyltriethoxysilane (Sigma, USA) in 
acetone for a further 30 minutes. The slides were dried at 70°C for 1 hour, and then incubated in 
diethyl-pyrocarbonate (Sigma, USA) treated water (DEPC-dH20) for 2 hours. The slides were 
baked at 70°C overnight and finally stored in a dust-free box at room temperature.
2.3 PREPARATION OF PROBES FOR IN  SITU  HYBRIDISATION
2.3.1 DNA MTB484 Probe
The plasmid pMTB484 containing PGRS repeat sequences (Warren et al, 1996) was digested with 
Hiiifl and electrophoretically fractionated through a 0.8% agarose gel (lx TBE pH8). A 4.5 kb DNA
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fragment was purified using the DNA purification system (Promega, USA) according to the 
manufacturers instructions. The purified fragment was biotinylated with Bio-11-dUTP according to 
the nick translation method (Sambrook et al, 1989). Briefly, the DNA fragments (lg), DNase I (1 
U) and DNA polymerase (5 U) were added to a solution containing lx  BSA, lx  DNase I buffer and 
10 mM dNTP mix (dATP, dCTP, dGTP and Bio-11-dUTP). The labeling reaction was incubated at 
16C for 1 hour, after which 0.01 M EDTA pH8.0 was added. The biotinylated labeled DNA was 
then desalted over 950 M Sephradex equilibrated in STE pH8.0.
2.3.2 Riboprobes
2.3.2.1 Recombinant Vectors Containing M. Tuberculosis Gene Inserts
Regions complementary to the M. tuberculosis genes rpoB, ICL, narX, relA, mbtB, ESAT-6, PPE 
and katG (Table 2.1, 2.2) had been cloned into pGEM-T easy vector systems (Promega, UK) 
(Figure 2.1) in the Department o f Medical Biochemistry, University of Stellenbosch, Tygerberg, 
South Africa. All the plasmids were sequenced to confirm the presence of the correct M 
tuberculosis sequence as well as to determine the orientation of the cloned fragments. These 
recombinant plasmids were transformed into E. coli JM109 cells in order to generate more plasmids 
for the synthesis o f riboprobes.
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Figure 2.1. Schematic representation of the pGEM-T easy vector containing Mtb gene fragments 
cloned between the T7 and SP6 promoters
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Table 2.1 Size o fM  tuberculosis gene inserts cloned into pGEM-T easy vector systems
M. tuberculosis Gene Gene Code Size of Insert (bp)
rpoB Rv0667 393
narX Rvl763c 452
icl Rv467 466
relMtb Rv2583c 442
mbtB Rv2383c 429
esat-6 Rv0282 295
PPE Rv3018c 403
katG Rvl908c 412
Table 2.2 Prim er sequences for the amplification o f the M  tuberculosis genes from H37Rv genome
M tb■. r [ft 1 . ■; •
Genes Forw ard P rim er Reverse P rim er
- - . •
rpoB TGGTCCGCTTGCACGAGGGTCAGA ATGTGCCCGATCGAAACCCCTGAG
narX AGTTCGCCCATCATGTCACC AACTCACGGCAACTCGGCAC
i d AAGACGTAGCCGCCACTCAG TGATAA ACGGGCGGAAGTC
relMtb CCTGTCGATCTTGCAGCGAG GGTGCAATGACTTCCAACGTC
mbtB AGCAGGTCGACGTCTGGATG ATGAGCTACCGCATCTTGCTG
esat-6 GAGCAGCAGTGGAATTTCGC TCCCAGTGACGTTGCCTTC
PPE ATTCGGCGGTGCT AAGTGC AACTCAGCACTGGGACCCTG
katG ATGGCCGCGGCGGTCGACATT GGGGTCGTTGACCTCCCACCCGAC
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2.3.2.1.1 Preparation and Transformation of Competent E. coli Cells
The method o f  Draper el al. (1988) was used for the transformation of E. coli JM109 cells.
A 1 ml aliquot o f  an overnight culture was placed into 100 ml o f Luria Bertani (LB) broth 
(Appendix 1), and was grown with shaking at 37°C until the optimal density (OD) of the cells 
measured at 600 nm (ODcoo) reached 0.35. The OD was determined in a Milton Roy series 120i 
spectrophotometer (USA). The culture was transferred into a sterile GSA bottle and chilled on ice 
for 15 minutes. Cells were pelleted by centrifugation at 4°C for 5 minutes at 3000 rpm in a Sorvall 
RC-5B refrigerated super-speed centrifuge (rotor GSA). The supernatant was decanted and the cells 
were gently resuspended in ice-cold 21 ml TFB1 solution (Appendix 1), and incubated on ice for 90 
minutes. The cells were again pelleted at 3000 rpm for 5 minutes at 4°C, and the supernatant 
removed. Cells w ere gently resuspended in 3.5 ml chilled TFB2 (Appendix 1) and the competent 
cells w ere either used immediately for transformation, or frozen in liquid nitrogen and stored at 
-80°C.
Plasmid DNA (10 ng) in TE buffer (Appendix 1) was added to 100 pi o f competent cells in a sterile 
Eppendorf microfuge tubes, and incubated on ice for 15 minutes. The cells were heat shocked by 
placing the tubes in a 45°C water bath for 60 seconds, then returned immediately to the ice for a 
further 2 minutes. LB broth (800 pi) was added to each Eppendorf microfuge tube, which was then 
incubated at 37°C for 30 minutes. Cell aliquots o f 100 pi were plated onto LB agar plates 
(Appendix 1) containing 50 pg/ml o f ampicillin (Appendix 1).
2.3.2.1.2 Large Scale Isolation of Plasmid DNA (Nucleobond Kit)
The procedure as outlined by Machery-Nagel was followed for the preparation o f plasmid DNA.
A single colony from a freshly streaked bacterial plate was inoculated into 5 ml LB broth, 
containing 50 pg/m l ampicillin, and grown at 37°C until the ODeoo reached 0.35. One ml o f the 
starter culture w as then inoculated into 100 ml prewarmed LB broth (1/100 dilution) containing 
ampicillin (50 pg/m l) and incubated overnight at 37°C.
The cells were transferred to a sterile GSA bottle, and were harvested in a Sorvall RC-5B 
refrigerated super speed centrifuge (GSA rotor) at 5000 rpm for 5 minutes at 4°C. The supernatant 
was decanted and the pellet was resuspended in 4 ml o f buffer SI. The cells were disrupted by 
adding 4 ml o f  buffer S2, mixing the contents by gently inverting the tube 6 - 8  times, then 
incubating for a maximum time of 5 minutes at room temperature. Buffer S3 (4 ml) was added; the 
contents were mixed again by inverting the tube 6 - 8  times and incubated on ice for 5 minutes.
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Centrifugation at 15 000 rpm for 40 minutes at 4°C was done to pellet the cell and protein debris. 
The nucleobond cartridge was equilibrated with 2 ml o f  buffer N2, and the supernatant of the 
previous step was loaded onto the AX100 column. The supernatant was allowed to flow through the 
column, followed by two successive wash steps using 4 ml of N3 buffer per wash. The plasmid 
DNA w as eluted from the column with 2 ml o f buffer N5 and precipitated with 0.7 volume of 
isopropanol (Merck, UK). After incubating at room temperature for 60 minutes, the plasmid DNA 
was pelleted by centrifugation in a benchtop microcentrifuge at top speed (13 000 rpm) for 30 
minutes at 4°C. The pellet was washed with 70% ethanol (Appendix 1) and centrifuged at 13 000 
rpm for 10 minutes at 4°C. The ethanol was carefully decanted and the pellet was air dried for 15 to 
20 minutes before being resuspended in 50 pil 1M Tris-EDTA (TE) buffer (Appendix 1).
The OD o f  the DNA was determined in a Milton Roy series 120i spectrophotometer (USA) at 260 
nm ( O D 26o) with absorbance of TE buffer (standard) at 0. The concentration o f the purified DNA 
was determined by diluting 10 ^1 o f plasmid DNA in 490 |il o f TE buffer, and the measured OD260 
was multiplied by a factor o f 2.5 (1/20 x OD260 x 50 (dilution factor)). This provided the DNA 
concentration in ng/pil. The purity o f the DNA was determined by calculating the ratio o f the OD260 
and the OD2X0, which should be approximately 1.8 for pure DNA.
2.3.2.2 Polymerase Chain Reaction (PCR)
2.3.2.2.1 Oligonucleotide Primers
Oligonucleotide primers are homologous to the unique sequence flanking the area being amplified, 
which makes the PCR very specific. Taq DNA polymerase is capable o f locating the region to 
which the primers bind to the denatured single stranded DNA, and proceed from this point to 
synthesise a complementary DNA strand in the 5’ to 3 ’ direction (Figure 2.2). T7 and SP6 promoter 
regions flank the multiple cloning sites o f the pGEM-T easy vectors. The T7 and SP6 primers 
(Table 2.3) were designed using the DNAMAN (Lynnon Biosoft Copyright®) computer program. 
These primers were complementary to the regions flanking the T7 and SP6 phage promoters, and 
were thus designed to amplify the various M. tuberculosis genes cloned (Table 2.1) in this region 
(Figure 2.1). The oligonucleotide primers were synthesized according to standard phosporamidite 
methodology (GibcoBRL, Switzerland).
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Table 2.3. T7 and SP6 Primer Sequences.
P rim er
Length
- -- , ------------------ ---------- ------ :----;-------
Sequence
Tm °C
(bp) (5’ to3’)
SP6 20 CAC TTT ATG CTT CCG GCT CG 62
T7 21 GCG ATT AAG TTG GGT AAC GCC 65
2.3.2.2.2 PCR Conditions
PCR amplification was performed using 100 ng plasmid DNA, i.e. pGEM-T easy vectors 
containing various M  tuberculosis genes were aliquoted into sterile 0.5 ml Eppendorf microfuge 
tubes. One micromolar o f  each primer, 200 fj.M of dNTP mixture (Appendix 1), 1.5 mM MgCh, 5 
fj.1 o f  a lOx Taq DNA polymerase buffer (Roche, Germany), 0.5 U Taq DNA polymerase (Roche, 
Germany) and d d t^O  to a final volume o f  50 (j.1 was added to the plasmid DNA. The reaction 
mixture was subsequently overlaid with 30 |il mineral oil (Sigma, USA) to prevent evaporation 
during thermal cycling. Amplification was carried out in a Hybaid Touchdown Thermal Cycler 
(Hybaid Ltd, UK), with the PCR conditions for the amplification reactions summarised in Table
2.4.
Table 2.4. PCR conditions for the amplification o f A/, tuberculosis gene fragments
T em pera tu re  (°C) Time Cycles
.
94 4 minutes 1
94 30 seconds
60 60 seconds 35
72 60 seconds
72 5 minutes 1
2.3.2.3 Agarose Gel Electrophoresis
Agarose gels, made with high purity wide range agarose (Whitehead Scientific, RSA), were used 
for verification o f success o f the PCR amplification. Five microlitres o f the PCR product were 
mixed with 1 |il o f  bromophenol blue loading dye (Appendix 1). The samples were subsequently 
loaded in 1% horizontal agarose gels (1 g agarose in 100 ml lxTAE (Appendix 1)) containing 1 
|ig/|al Ethidium Bromide (Appendix 1), and electrophoresed at 70 V for approximately 2 hours in
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lx  TAE electrophoresis running buffer. The samples were co-electrophoresed with Marker X 
(Roche, Germany) (Appendix IV), which was used as a molecular size marker. All gels were 
visualised on a longwave ultraviolet transilluminator (3UV Transilluminator model LMS-26E) and 
a photograph was taken using an ITC camera (Berkenhoff and Drebes, Germany) and a Sony video 
graphic printer (UP-860 CE).
2.3.2.4 Purification of Amplified PCR Products (Concert Rapid PCR Purification System)
The procedure as outlined by Gibco BRL (Switzerland) was followed for the purification of 
amplified PCR products.
The amplification reaction mixture was mixed with 400 jj.1 HI Binding Solution, and subsequently 
loaded into a spin cartridge placed into a 2 ml wash tube. This mixture was centrifuged for 1 minute 
at 14 000 rpm at room temperature in.,a microcentrifuge.. Seven hundred microlitres H2 Wash- 
Buffer was added to  the spin cartridge after the eluate was discarded, and centrifuged at 14 000 rpm 
for 1 minute at room temperature. The eluate was decanted and the residual wash buffer was 
removed by centrifuging at 14 000 rpm for 1 minute. To elute the DNA, the spin cartridge was 
placed in a new 1.5 ml recovery tube and 50 ^1 o f preheated TE buffer (65 - 70°C) was added 
directly to the centre o f the spin cartridge. After incubation o f 1 minute at room temperature, the 
purified PCR product was eluted by centrifugation at 14 000 rpm for 2 minutes.
2.3.2.5 Preparation of Biotinylated Riboprobes
All the M  tuberculosis gene fragments were cloned in the 3 ’ -  5’ orientation, relative to the T7 
promoter (Figure 2.2). The antisense probes, used for the detection o f mRNA, are synthesised using 
T7 RNA polymerase (GibcoBRL, Switzerland), from the T7 promoter using the sense DNA strand 
o f the amplified M  tuberculosis gene fragments as template (Figure 2.2c). For the synthesis o f 
sense probes, as with mRNA synthesis, the antisense DNA strand was used as template (figure 
2.3b) with SP6 RNA polymerase. The antisense probes thus had the complementary sequence to 
that o f the target mRNA, and as a result hybridised to it, while the sense probe showed no 
homology to any RNA species and therefore served as a control. All procedures were done under 
RNase-free conditions. Briefly, biotinylated riboprobes were prepared in sterile 1.5 ml DEPC 
treated Eppendorf microfuge tubes using 1 |ag DNA lx  T7 or SP6 transcript buffer, 1 mM o f each 
dATP, dGTP, UTP and Biotin-14-CTP, 0.5 mM dCTP, 5 mM DTT, 120 U RNase OUT Inhibitor, 
100 U T7 polymerase or 52.5 U SP6 polymerase and DEPC dH20  to a final volume o f 50 p i  The
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polymerase or 52.5 U SP6 polymerase and DEPC d t^O  to a final volume o f 50 pi. The contents 
were briefly spun in a microcentrifuge, and incubated for 90 minutes at 37°C in a waterbath. One 
hundred and fifty microlitres o f cold 100% ethanol (Merck, UK) was added to the reaction mixture 
and incubated for 16 -  18 hours at 20°C to allow for precipitation o f the riboprobes. The following 
day the riboprobes were pelleted by centrifugation at 4°C for 30 minutes at 14 000 rpm in a 
microcentrifuge. The supernatant was discarded and the pellet was washed with cold 70% ethanol 
(Appendix 1). The riboprobes were again pelleted by centrifugation at 4°C for 5 minutes at 7 000 
rpm, and after careful removal o f most o f the ethanol, the pellet was dried in a Speed Vac 
Concentrator (Savant, USA) for approximately 5 minutes. The riboprobes were then resuspended in 
100 |al DEPC d t^O  (Appendix 1) and incubated at 37°C for 30 minutes, then stored at -20°C. 
Concentrations o f the riboprobes were between 0.1 and 0.5 pg/ml.
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(a) Mtb gene fragment SP6
5’
3’
Sense strand
Antisense strand
3’
5’
Sense probe
(b) Sense probes SP6 5’
3’
Antisense strand
T7
T7
Sense strand
(c) Antisense probes SP6
y
T7
3’
Antisense Drobe
Figure 2.2. Synthesis o f Antisense and Sense Oligonucleotide Probes. The (a) double stranded 
M.tuberculosis (Mtb) gene fragment cloned into the pGemT vectors serves as template for the 
synthesis o f the (b) sense probes and the (c) antisense probes.
Biotinylation o f the probes was confirmed by spotting 5 -  10 ^1 o f the respective probes onto 
Hybond N+ membranes (Amersham, UK) followed by detection with streptavidin-conjugated 
alkaline phosphatase in conjunction with the NBT/BCIP substrate (GibcoBRL, Switzerland), as will 
be discussed in detail in section 2.3.3.
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2.4 IN  SITU  HYBRIDISATION
2.4.1 Brief Description
The in situ hybridisation method was designed for non-radioactive detection o f RNA and DNA in 
tissue preparations. This method provides a highly sensitive detection system for biotinylated 
probes that takes advantage of the very high affinity o f biotin for streptavidin. These complexes are 
also extremely stable over a wide range o f temperatures and pH. In brief, a biotin-labelled probe is 
hybridised to target DNA or mRNA in cells or tissues in situ on a microscope slide. A signalling 
group (i.e. alkaline phosphatase) covalently attached to streptavidin is then bound to the 
biotinylated probe. The hybridised probe is detected by incubating the samples with dye substrates 
for alkaline phosphatase. Formation o f a blue signal indicates the location o f the hybridised probe 
(Figure 2.3) which is then viewed under a light microscope.
NBT/BCIP
(substrate)
BLUE PRODUCT
Alkaline Phospatase 
Streptavidin
Target DNA/mRNA
Figure 2.3. In Situ Hybridisation. The hybridisation and detection o f a biotinylated probe on the 
target DNA / mRNA on a microscopic slide
2.4.2 Pretreatment of Tissue for In Situ Hybridisation
Paraffin embedded lymph node tissue was cut into 5 pm sections using a microtome (Department o f 
Anatomical Pathology, Faculty o f Health Sciences, University o f Stellenbosch, Tygerberg, South 
Africa), and consecutive sections were applied to RNase-free slides (Section 2.2). The paraffin 
embedded sections were deparafinised by incubation in two changes o f xylene (MERCK, UK) for 
10 minutes each. Sections were rehydrated through graded ethanols, i.e. in two changes o f absolute 
ethanol (EtOH), 90% EtOH and finally in 70% EtOH for 2 minutes each. The slides were then
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saline (DEPC lxPBS) (Appendix 1) for 5 minutes each. The sections were incubated with 500 jil 
prewarmed (37°C) Proteinase K (1 |Jg/ml) in 10 mM Tris-HCl pH 7.5, 5 mM EDTA for 20 minutes 
at 37°C in a humidified chamber. The proteinase treatment breaks down some of the cross-links 
made by the fixative, thereby enabling access o f probes to the target sequence. DNase I or RNase A 
were only added to those slides to be hybridised with the MTB484 DNA probe. DNase I (10 fig/ml) 
was added together with the proteinase K and incubated as described before. This step was included 
to determ ine whether this probe would bind mycobacterial mRNA. Conversely, to ensure that the 
positive signals obtained when using the MTB484 probe was due to the presence o fM  tuberculosis 
DNA rather than M. tuberculosis mRNA the sections were incubated with Rnase A (20 ng/ml) for 
20 minutes at 37°C prior to hybridisation.
After being washed with DEPC lxPBS for 5 minutes, the sections were immersed in 0.4% 
paraformaldehyde (Appendix 1) in DEPC lxPBS for 5 minutes to inhibit further Proteinase K 
digestion. The paraformaldehyde treatment was also imperative as it refixed the digested tissue. The 
sections were then washed with DEPC d t^O  for 2 minutes and acetylated (with stirring) for 10 
minutes in a 1:400 (vol /  vol) solution o f triethanolomine (Merck, UK) in DEPC dH20 and 750 (j.1 
Acetic Anhydride (Merck, UK) which was added dropwise close to the sections. The acetylation 
procedure prevented non-specific binding of the nucleic acid probes. The slides were then rinsed in 
DEPC lxPBS for 5 minutes and dehydrated through a graded ethanol series, i.e. 2 minutes each in 
70% EtOH, 90%  EtOH and in two changes o f 100% EtOH. The sections were air dried at room 
temperature for 40 -  60 minutes before hybridisation.
2.4.3 Hybridisation of Biotinylated Probes
The In Situ Hybridisation and Detection System (Gibco BRL, Switzerland) was used, as instructed, 
for the hybridisation and detection o f biotinylated probes (see below).
2.4.3.1 DNA:DNA Hybridisation
The hybridisation mixture, which consisted o f 20 |al o f the 20% dextran sulphate solution and 20 |il 
o f the 2x hybridisation buffer, was mixed with 3 |il o f the biotinylated MTB484 probe (2 |a.g/ml) 
and was added to the sections before being covered with a glass coverslip (Sigma, USA). The 
dextran sulphate, as with the acetylation, reduced the possibility o f cellular electrostatic interactions 
and also locally concentrated the probe, thus enhancing the rate of hybridisation. These sections
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were then heated at 95°C for 5 minutes in a Hybaid Omnislide Humidity Chamber (Hybaid Ltd, 
UK) to denature both the MTB484 probe and the target mycobacterial DNA.
2.4.3.2 RNA:RNA Hybridisation
Three |il o f  the antisense (5 pg/ml) or sense biotin-labelled riboprobes (5 pg/ml) were added to the 
hybridisation mixtures (20 pi of 20% dextran sulphate solution and 20 p.1 o f 2x hybridisation 
buffer). The probe mixture was added to the sections and covered with a coverslip. No denaturation 
took place prior to hybridisation.
2.4.3.3 Hybridisation and Stringency Washing
The sections were incubated with the hybridisation mixture containing either the biotinylated 
MTB484 or the biotinylated riboprobes for 16 -  18 hours at 50°C in a humidified chamber. After 
hybridisation the sections were washed twice in 2x SSC (Appendix 1) for 15 minutes at room 
temperature to remove unhybridised probes.
2.4.4 Detection of Hybridised Probes
The tissue sections were covered with 100 (0.1 Blocking Solution (Gibco ISH Kit) and incubated at 
room temperature for 20 minutes. Blocking agents are required to block endogenous enzyme 
activity when using enzyme-based detection methods. A working conjugate solution was prepared 
by mixing 10 |il o f  streptavidin-alkaline phosphatase conjugate (Gibco ISH Kit, Switzerland) with 
90 (j.1 o f  conjugate dilution buffer (Gibco ISH Kit, Switzerland) for each slide. The Blocking 
Solution was removed from each slide by touching absorbent paper to the edge of the slide. Each 
section was covered with 100 pi o f working conjugate solution and incubated in the humid chamber 
at room temperature for 15 minutes. It is also important to measure any endogenous activity with a 
test slide without the streptavidin-alkaline phosphatase conjugate. Production o f signal when 
leaving out the alkaline phosphatase is an indication o f a false positive signal. The slides were 
washed twice in Buffer A (Appendix 1) for 15 minutes each at room temperature, then incubated in 
prewarmed alkaline-substrate buffer, Buffer B (Appendix 1), at 37°C for 5 minutes. Three hundred 
microlitres o f NBT and 249 pi BCIP was added to 75 ml Buffer B prewarmed at 37°C. Levamisole 
(200 pg/ml) (Vector, USA) was added to the alkaline-substrate solution to further inhibit the 
endogenous phosphatase activity. At that concentration, levamisole is a potent inhibitor o f many 
endogenous alkaline-phosphatases, but has no effect on the streptavidin-alkaline phosphatase 
conjugate. The slides were then incubated in the NBT/BCIP solution at 37°C until the desired level
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o f signal was achieved (10 min. to 1 hour), then rinsed briefly in distilled water to stop the 
development o f  further signal.
2.4.5 Counterstaining
Slides were counterstained with methyl green (DAKO, USA), which allowed negative cells to be 
visualised and aided in the identification o f particular cell types. Methyl green, a basic dye, reacts 
with anionic groups o f tissue, including phosphate groups of nucleic acids. Thus, the tissue 
components that were stained with this basic dye were heterochromatin and nucleoli o f the nucleus. 
The slides were immersed in the methyl green solution for 5 minutes, rinsed with 95% EtOH to 
remove excess reagent then dehydrated through graded alcohols (2x 95% and 2x 100% EtOH for 30 
seconds each), and finally incubated twice in xylene for 2 minutes. The slides were then mounted in 
a compatible permanent mounting medium (Entellen, Merck)
2.5 EMMUNOHISTOCHEMISTRY
2.5.1 Brief Description
The reaction between antigen and antibody is the underlying basis of immunohistochemistry. In 
brief, the tissue is first incubated with a primary antibody (1° Ab) that binds only with the specific 
protein under investigation. Tagged secondary antibody (2° Ab) can be used to identify the location 
o f the various bound primary antibodies. Signalling molecules, such as horse-radish peroxidase 
(HRP) or alkaline phosphatase (AP) enzymes, conjugated to link molecules (avidin or streptavidin, 
respectively) are bound to the biotinylated secondary antibodies. The bound antibodies are detected 
by incubating the tissue with the appropriate substrates for the enzymes, such as DAB or Fuchsin- 
substrate-chromogen. Formation of a brown or red signal indicates the location o f the bound 
antibodies (Figure 2.4).
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Figure 2.4. Immunohistochemistry. Recognition o f target cytokines by l°Ab with subsequent 
binding o f labelled 2 °Ab required for detection
2.5.2 Pretreatment of Tissue for Immunohistochemistry
Sections o f paraffin embedded lymph node tissue, applied to pretreated slides (Section 2.2), were 
deparafinised in two changes o f xylene for 10 minutes each. The sections were dehydrated, as in 
section 2.4, through a graded ethanol series and washed in dH20 for 5 minutes. The sections were 
then immersed in 3% H2O2 in methanol (Merck, UK) for 15 minutes to block endogenous 
peroxidase, then rinsed under running tap H2O. For antigen retrieval, the sections were microwaved 
in 0.01 M citrate buffer pH 6.0 (Appendix 1) at high power for 20 minutes, topping up the buffer 
every 5 minutes. Fixation preserves tissues, but also alters the access o f antibodies to antigenic sites 
in the tissue. Formaldehyde fixation forms complex aldehyde-linked protein aggregates in which 
primary and secondary protein structures might be preserved, while tertiary or quaternary protein 
structures, are altered by extensive cross-linking (Merz et al, 1995). To avoid this deleterious effect 
o f fixation there are several retrieval systems, including heat-induced antigen retrieval such as 
microwaving (Cuevas et al, 1994). After microwaving, the slides were left in the heated citrate 
buffer for an additional 20 minutes, and then washed in lx  PBS for 5 minutesat room temperature. 
The sections were then incubated with 100 jj.1 o f 3% rabbit serum in lx  PBS for 10 minutes. This 
was intended to block non-specific binding o f the primary antiserum with tissue structures. The type 
o f serum used depends on the type o f  2° Ab, i.e. serum o f the host that produced the 2° Ab (Table
2.4).
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2.5.3 Binding of Primary and Secondary Antibodies
One hundred (j.1 o f  the cytokine-specific primary antibody diluted in rabbit serum (dilutions listed in 
Table 2.5) was added to each lymph node section and incubated in a humidified chamber overnight 
at 4°C. Negative controls (absence o f primary antibody) were included to confirm specificity of the 
immunoreactions, and were incubated overnight at 4°C with rabbit serum. Non-specific 
immunoreactivity would thus present deposition o f reaction product via unspecific binding of the 
secondary antibody at a site other than the location o f the desired antigen. Such false positivity can 
arise from non antibody-specific binding o f the secondary antibody. The slides were then washed 
three times in lx  PBS for 5 minutes each to remove unbound primary antibodies. The sections were 
incubated with the secondary antibody (Table 2.4) diluted with lx  PBS (1:100 dilution) and placed 
in a humidified chamber for 1 hour at 4°C. The slides were again washed three times in lx  PBS for 
5 minutes each to remove unbound antibody.
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Table 2.5. Primary Antibodies and Dilution Factors
Primary Antibody Secondary Antibody
Cytokines (1° Ab) 1° Ab Dilutions (2° Ab)
IL-4 Goat anti-human EL-4 1:50 Rabbit anti-goat
EL-10 Goat anti-human IL-10 1:100 Rabbit anti-goat
IL-12 Goat anti-humanIL-12 1:50 Rabbit anti-goat
IFN-y Goat anti-human EFN-y 1:100 Rabbit anti-goat
TN F-a Goat anti-human TNF-a 1:100 Rabbit anti-goat
2.5.4 Detection of Bound Antibody Probes
The tissue sections were incubated with avidin HRP conjugate diluted (1:400) in lx  PBS for 30 
minutes at room temperature, then washed three times in lx  PBS for 5 minutes each. The DAB 
substrate (DAKO, USA) yields a brown-colored reaction product at the site of the target antigen. As 
described by the manufactures, 2 drops o f Buffer Stock Solution, 4 drops of DAB Stock Solution 
and 2 drops o f  Hydrogen Peroxide were added to 5 ml dHaO, and mixed well. The lymph node 
tissue sections were incubated with 100 (J.1 freshly prepared DAB substrate and incubated for 5 -  30 
minutes at room temperature. The slides were then rinsed in distilled water after the appearance o f  a 
brown colour to stop the development o f further signal.
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To overcom e the staining difficulty with the IL-12 , the dilution o f the primary antibody was 
decreased to 1:20, and incubated for longer periods, but with the same result.
Counterstaining
The sections w ere counterstained in haematoxylin (DAKO, USA) for 5 minutes, and then rinsed 
well in running tap water until a blue colour reaction occurred. Haematoxylin, while not a basic dye 
like m ethyl green, has staining properties that closely resemble those o f a basic dye. The tissue 
com ponents stained with this dye also included heterochromatin and nucleoli o f the nucleus.
2.6 DUAL LABELING
2.6.1 Brief Description
Dual labeling is the combination o f the immunohistochemistry and ISH staining techniques. This 
allows the staining for both a specific protein (cell receptors) and nucleic acid molecules (M  
tuberculosis DNA or mRNA) in one tissue section. The CD68 molecule, a macrophage receptor 
molecule, was the target for the immunohistochemistry staining. The subsequent ISH was applied 
for the detection o f  M. tuberculosis DNA, as well as for the individual detection o f rpoB, narX and 
icl mRNA in the CD68 stained macrophages.
2.6.2 Immunohistochemistry Staining of CD68 Receptors
2.6.2.1 Pretreatment of Tissue
The tissue w as deparafmised, dehydrated and incubated in 3% H2O2 in methanol, as described in 
section 2.5.1. The sections were rinsed in two changes of DEPC dH20 for 5 minutes each after 
blocking the endogenous peroxidase, and incubated in 100 pi trypsin (Sigma, USA) for 10 minutes 
at room temperature. Trypsin digestion, and not heat induced microwaving, was the preferred 
antigen retrieval method used for the staining of the CD68 molecules. The tissue was again rinsed 
in DEPC dH 20  for 5 minutes, and incubated with 100 pi sheep serum diluted (1:20) in DEPC lx  
PBS for 10 minutes at room temperature.
2.6.2.2 Binding of Primary and Secondary Antibody
One hundred pi o f  the primary antibody, mouse anti-human CD68, diluted (1:50) in the sheep 
serum was added to the lymph node sections and incubated in a humidified chamber at 4°C
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overnight. The tissues were washed three times in DEPC lx  PBS for 5 minutes each to remove 
unbound primary antibody. The sections were incubated with the secondary antibody, sheep anti­
mouse, diluted with DEPC lx PBS (1:100) and placed in a humidified chamber at 4°C for one hour. 
The slides were again washed in DEPC lx  PBS to remove unbound secondary antibody.
The tissue sections were incubated with avidin alkaline phosphatase conjugate diluted (1:400) in 
DEPC lx  PBS for 30 minutes at room temperature, then washed three times in DEPC lx  PBS for 5 
minutes each. The Fuchsin substrate-chromogen (DAKO, USA) yields a fuchsia-colored reaction 
product at the site o f the target antigen. One hundred and twenty (J.1 o f Fuchsin chromogen was 
mixed with 120 |il Activating Agent and incubated at room temperature for 1 minute before the 
Buffered Substrate (1.76 ml) was added, as described by the manufacturers. The lymph node tissue 
sections w ere incubated with 100 |il o f  prepared Fuchsin substrate-chromogen and incubated for 5 -  
30 minutes at room temperature. The slides were then rinsed in two changes o f DEPC dl-kO for 5 
minutes each. - - .......... .......  - • - -
2.6.2 In Situ Hybridisation
The sections were refixed in 0.4% paraformaldehyde at 4°C for 20 minutes, and then rinsed in two 
changes o f  DEPC lx  PBS for 5 minutes each. The sections were incubated with Proteinase K for 10 
minutes, refixed in 0.4% paraformaldehyde and acetylated as described in section 2.4.1. The tissue 
was then rinsed in DEPC lx  PBS for 5 minutes after the acetylation, and incubated with 100 |il 
biotin solution (Vector) for 10 minutes at room temperature, in order to block the biotin activity on 
the bound avidin conjugates. The sections were rinsed well in DEPC dH20  for 5 minutes, thereafter 
dehydrated as described in section 2.4.1.
The technique for the hybridisation and detection of the biotinylated DNA and RNA probes (rpoB, 
narX and 1CL) was followed as described in sections 2.4.2 and 2.4.3, respectively. The slides were 
incubated in the NBT/BCIP solution until the desired level o f signal was achieved (10 -  15 
minutes), then rinsed briefly in dt^O . The slides were then mounted in a compatible permanent 
mounting medium (Faramount, Dako).
For the dual labeling, it is important that the tissue not be counterstained at all, since the 
haematoxylin and methyl green dyes will obscure the staining of the CD68 surface molecule.
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2.7 PHOTOGRAPHY
The images were captured using a Zeiss microscope (Axioskop 2) fitted with a Sony 3CCV video 
camera and the images were saved using Axiovision form Zeiss (Germany).
2.8 ASSESSMENT OF SLIDES
In situ hybridisation and immunohistochemistry are empirical staining techniques and cannot be 
accurately quantitated. For the in situ hybridisation analysis, the staining intensity could not be 
correlated to bacterial load. Staining for the host cytokines was consistent, and granulomas in lymph 
node tissue were therefore scored either negative or positive for the presence o f M. tuberculosis 
DNA or mRNA, and cytokines. It is impossible to accurately determine the number of bacilli 
present in the lymph node tissue, as one blue spot does not necessarily equate to one bacillus 
present in the various cells types o f the granulomas. The same assessing principle was applied for 
the immunohistochemistry technique. The granulomas in the lymph node tissue were scored either 
positive or negative for the various cytokine proteins.
2.9 STATISTICAL EVALUATION OF DATA
The data generated with the in situ hybridisation using various riboprobes, as well as the 
immunohistochemistry staining analysis o f host cytokines were statistically evaluated using the 
Epilnfo 2000 computer program, and P-values < 0.05 were considered as statistically significant. 
These results were not corrected for multiple testing.
2.10 DNA FINGERPRINTING OF ISOLATED CLINICAL STRAINS FROM LYMPH 
NODE TISSUE
2.10.1 Brief Description
The single circular M  tuberculosis chromosome is digested with a restriction endonuclease, 
generating fragments o f varying size (Figure 2.5). These fragments are separated by electrophoresis 
through an agarose gel, and then transferred to a nylon membrane. A DNA probe complementary to 
the 3 ’ region o f  the 1S6110 insertion element was labelled with horse-radish peroxidase. During
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hybridisation the probes bind to the fragments o f M.tb DNA containing the insertion element and 
excess probe is removed by washing. Positive hybrids are detected when the conjugated enzyme 
catalyses the oxidation o f luminol, which generates light that is detected by exposing photographic 
film to the membrane in an X-ray cassette to produce an autoradiograph.
58
Digest with PvuW
Southern 
Transfer 
-------- ►
Fragments separated 
Gel Electrophoresis
Hybridize with IS6110 
Drobe (Bar Code)
Figure 2.5. IS6110 Strain Typing o f M. tuberculosis
2.10.2 Extraction of Mycobacterial DNA
A confluent Lowenstein-Jensen (L-J) slant culture o f Mtb is required for the DNA isolation.
The L-J slant culture was heat inactivated at 80°C for 1 hour and the DNA extraction was done in a 
P2 category laminar flow cabinet. Extraction buffer (3 ml) (Appendix 1) was added to the slant and 
the bacteria were carefully scraped off with a sterile 10 (al loop. The extraction buffer containing the 
cells was then poured off into a sterile 50 ml polyproyplene tube which contained approximately 20 
(5 mm) glass balls. A further 3 ml o f extraction buffer was poured onto the slant. Any remaining 
bacterial colonies were scraped off and the buffer was swirled around in the bottle to wash off 
bacterial matter on the side o f  the bottle, which was poured into the 50 ml tube. The tube was 
vigorously shaken and vortexed to break up the clumps o f bacteria. Five hundred (J.1 lysozyme (50 
mg/ml) and 5 jj.1 RNase A (10 mg/ml) were added to the tube which was then inverted to mix the 
contents and incubated at 37°C for 2 hours. Proteinase K buffer (Appendix 1) and 150 jj.1 Proteinase
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Proteinase K (10 mg/ml) were added, the sample was mixed gently and incubated overnight at 
45°C. Five ml o f  Phenol / Chloroform (Appendix 1) was added to the bacterial preparation and the 
mixture w as shaken gently over a period o f approximately 20 minutes. The sample was centrifuged 
at 3 000 rpm for 30 minutes. The aqueous phase was carefully aspirated, ensuring that none of the 
inter-phase or phenol phase was taken, and was added to 5 ml chloroform / iso-amylalcohol 
(Appendix 1). After thorough mixing, the sample was centrifuged at 3 000 rpm for 10 minutes. The 
aqueous phase was collected and added to 600 jxl 3 M Na-acetate (Appendix 1). The contents were 
mixed and the DNA was precipitated by adding 7 ml cold (-20°C) Isopropanol, after which the tube 
was gently inverted. The DNA pellet was collected on a glass rod and placed in a 1.5 ml eppendorf 
tube that contained 1 ml 70% EtOH for approximately 1 minute to remove the salt. The DNA was 
then transferred to a fresh eppendorf tube and incubated at 65°C for approximately 30 minutes 
which allowed the DNA to dry. Five hundred p.1 o f TE buffer was added to the dry DNA and the 
pellet was allowed to rehydrate to release it from the glass rod. The DNA was dissolved in the TE 
buffer and incubated at 60°C for 1 hour to aid dissolving.
The concentration o f  the extracted DNA was determined as mentioned before (Section 2.3.1.2). 
DNA was stored at -20°C.
2.10.3 Restriction Enzyme Digestion of the DNA
Six ng o f  M. tuberculosis DNA was digested with the restriction enzyme Pvull (Amersham, UK). 
The digestion was done in a total volume o f 100 (xl and the order o f addition was as follows: 10 (il 
lOx Restriction buffer (M for PvmII); H2O to a final volume of 100 (il (according to calculation), 6 
Hg DNA and 2.5 |xl Pvull (5 U per |ag o f DNA). The digestion mixture was then incubated 
overnight at 37°C, or for a minimum of 4 hours. After digestion, the reaction was incubated at 65°C 
for 10 minutes to inactivate any remaining enzyme activity.
A mini ( 5 x 1 0  cm) 0.8% agarose gel (0.8 g in lx  TBE buffer) was prepared to test for completeness 
o f  the restriction digest. Eight 1^ o f the digested sample was mixed with 2 jj.1 6x loading buffer 
(Appendix 1) and loaded onto the gel. The test sample was electrophoresed in lx  TBE buffer 
(Appendix 1) at 100 V for approximately 1 - 2 hours. The gel was stained with Ethidium Bromide 
(5 |il per 100 ml o f  lx  TBE running buffer) for 30 minutes. The gel was visualised on a longwave 
ultraviolet transilluminator (at 245 nm) and a photograph was taken.
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2.10.4 Altering Concentrations of the Restricted DNA
The rem aining restricted DNA was precipitated with absolute EtOH and redissolved in order to set 
the digested samples at the same concentration. Ten pil 3 M Na-acetate (pH5.2) and 300 |il cold (- 
20°C) absolute EtOH was added to the digest to precipitate the restricted DNA. The tube was 
inverted to  mix and incubated at -80°C for 2 hours or overnight at -20°C. The precipitated digested 
DNA w as centrifuged at 4°C in a microfuge at 13 000 rpm for 30 minutes. The supernatant was 
carefully aspirated and 500 p.1 70% EtOH was added to the pellet. Supernatant was carefully 
removed after centrifugation at 13 000 rpm for 15 minutes and the pellet was dried at 65°C. The 
optimal digest o f  6 (ig would have given a lane with an intermediate staining intensity on the 
photograph. The precipitated digested DNA was redissolved in 20 |al o f Loading buffer that 
contained M arker X (Roche, Germany). For digests with a reduced staining intensity the volume of 
Loading buffer was reduced (to a minimum of 10 |_il), while the volume o f Loading buffer was 
increased for samples with a higher staining intensity on the test gel. The correct volume o f Loading 
buffer w ith M arker X was added to each sample and the tubes were incubated at 65°C for one hour, 
with occasional vortexing to ensure that o f the digested DNA was dissolved.
2.10.5 Gel Electrophoresis of Restricted DNA
For fingerprinting, 10 (il o f the (redissolved) restricted DNA was electrophoresed on a 0.8% 
agarose gel (2.4 g agarose in 300 ml lx  TBE). The gel was run overnight at 65 V (33 mAmps) in lx  
TBE running buffer for a distance of 20 cm. The gel was covered to prevent evaporation and to 
ensure an even temperature. The restricted DNA samples loaded contained Marker X (Roche, 
Germany) in the Loading buffer, which acted as an internal marker. The external marker DNA 
(Marker MTB 14323) was loaded in the outside lanes o f the gel to enable integral comparison using 
the software GelCompar 4.1. The gel was transferred to a plastic dish with lx  TBE running buffer, 
to which Ethidium Bromide (0.5 |al per 100 ml) was added. The gel was stained with gentle shaking 
for 30 minutes after which it was photographed to establish how evenly the gel had been loaded.
2.10.6 Southern Transfer of the Fingerprinting Gel
DNA from a successful fingerprinting gel was transferred from the agarose onto a charged Nylon 
membrane (HybondN+, Amersham) by Southern blotting (Sambrook, Fritsch, Miniatis). Briefly 
after the gel was photographed, the DNA was denatured in the gel by covering it with 0.4 M NaOH 
(Appendix 1) for 20 minutes with gentle shaking at 42°C. After denaturing, the gel was washed 
briefly in dH20. Three sheets o f Whatmann blotting paper and a sheet of Nylon membrane were cut 
to the size o f  the fingerprinting gel. The Nylon membrane was marked with a black ballpoint pen to
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allow future recognition. Orientation marks (Appendix 1) were positioned in the comer of the 
membrane to allow future alignment o f resultant autoradiographs.
The Southern transfer was set up as described in “Molecular Cloning” (Sambrook, Fritsch, 
Maniatis). A sheet o f  Whatmann blotting paper, soaked in 20x SSPE pH 7.4 (Appendix 1), was 
placed on the blotting apparatus. The gel was placed on top of the paper in an upside down position 
and the nylon membrane, previously hydrated in H20  then soaked in 20x SSPE, was placed onto 
the gel with orientation dots facing toward the gel. To restrict capillary transfer to the gel only, 
parafilm strips were placed around the gel. The air bubbles were removed and two sheets of 
W hatmann paper soaked in 20x SSPE was placed onto the membrane. Layers o f  tissue paper were 
placed onto the Whatmann paper and covered with a glass plate. An object (± 1 kg) was positioned 
on the plate and the transfer was done overnight at room temperature. The membrane was removed 
and rinsed in a  2x SSC solution to remove non-specifically bound DNA. The membrane was placed 
between 2 sheets o f  Whatmann paper and baked at 80°C for 2 hours to allow the DNA to be 
covalently linked to the membrane. After baking the membrane was hydrated in water and sealed in 
a plastic sleeve until hybridisation.
2.10.7 Labeling of Probes and Hybridisation
Probes used for fingerprinting were labeled using the ECL kit (Amersham, UK) according to the 
manufacturers instructions.
The membrane was sealed in a plastic bag with 35 ml o f the gold buffer (ECL Kit), all the air 
bubbles removed, and prehybridised at 42°C for a minimum o f 1 hour. Prehybridisation and 
hybridisation w as done in a flat-bottomed plastic dish in a shaking waterbath. The hybridisation bag 
(a sealed plastic bag Vi filled with water) kept the membrane in place and also aided in the even 
distribution o f the buffer over the membrane.
The 200 ng o f the IS6110 probe dissolved in H20  (total volume o f 15 p.1) was denatured at 100°C 
for 5 minutes and was immediately put on ice for a further 5 minutes. Fifteen |al o f the Labeling 
Mix (Horse Radish Peroxidase) (ECL Kit) was added to and mixed with the denatured probe, after 
which 15 (j.1 o f  the Glutaraldehyde solution (ECL Kit) was added. This mixture was vortexed and 
incubated at 37°C for 10 minutes. The hybridisation bag was removed from the waterbath and the 
labeled IS6110 probe was added. A pipette was rolled over the membrane in the bag to mix the 
labeled probe and the hybridisation buffer. The bag was resealed in such a way that any air bubbles
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were excluded. The membrane was placed back in the plastic dish under the weight bag and 
incubated overnight at 42°C in the shaking waterbath.
After hybridisation, the membrane was removed from the plastic bag and washed twice at 42°C in a 
plastic dish w ith 400 ml o f the Primary wash buffer (Appendix 1). This was followed by 2 washes 
of 5 m inutes each, at room temperature in 400 ml 2x SSC. The membrane was placed in a new 
plastic sleeve and all excess fluid was removed. Four ml o f the two Detection agents (ECL Kit) 
were m ixed and poured onto the membrane in the bag. The solution was gently spread over the 
membrane for a period of 90 seconds and then pushed out of the bag. The bag was sealed and 
exposed to  X-ray film for an optimal period o f time (varying between 1 minute to 2 hours). The 
film w as initially exposed for a shorter period to assess the strength of the signal. The film was 
immersed in the developing solution (Appendix 1) for 3 minutes, then transferred to the stopping 
solution (A ppendix 1) for 20 seconds and finally to the fixing solution (Appendix 1) for 1 minute, 
whereafter it was washed in running tap water for a 5 minutes. The resulting DNA fingerprint 
consisted o f  a variable number of bands at varying positions along a “lane” on the autoradiograph.
2.10.8 Data Analysis
Autoradiographs were scanned using a Hewlett Packard Scanjet II cx/T scanner. Scanned samples 
were norm alised using the internal markers an compared using GelCompar 4.1 B (Applied Maths, 
Kortrijk, Belgium).
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3.1 PATIENT SELECTION: LYMPH NODE BIOPSIES
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Biopsy samples were collected from 20 patients (8 females; 12 males), between the ages of 3 and 13 
years, at Tygerberg Hospital (Table 3.1). Half o f each tissue sample was submitted for culture 
(BACTEC), and the remaining tissue portions were fixed in formalin and embedded in wax. 
Sections o f  embedded tissue were used for ZN staining and histological analysis. Only 6 o f the 
tissue samples collected were lymph nodes from children diagnosed with tuberculosis. These 
samples are listed in Tables 3.1 and 3.2 as patients LI to L6. One patient was also diagnosed with 
lymphoma (patient L I5). The remaining children presented with cervical swelling caused by 
abscess form ation and no solid lymph nodes were detected. In addition, 3 other samples could not 
be included as consent from a parent or guardian for performing the study was not given (not listed 
in Table 3.1).
The 6 confirmed tuberculosis patients comprised 5 males and 1 female. Patient L2 was the only 
patient that received anti-tuberculosis treatment prior to biopsy. This patient had started his third 
course o f  treatm ent 2 days prior to the biopsy. The diagnosis o f patient L4 was made solely on a 
positive M. tuberculosis culture, as no acid-fast bacilli were detected in the biopsy tissue, i.e. ZN 
staining was negative, and the histological analysis proved inconclusive. The BACTEC culture was 
only positive after 4 weeks of incubation. Unfortunately, an M. tuberculosis culture was not 
prepared from the biopsy tissue o f patient LI, as no tissue sample of this patient was delivered to 
the M icrobiology laboratory, as is standard hospital procedure. Patient L5 was diagnosed with both 
pulmonary and abdominal tuberculosis.
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Tame 3.1 Clinical Data of Patients who Donated Biopsy Tissue. 
Patient Age Sex
LI 6 Male
L2 3 Maie
L3 13 Male
L4 12 Female
L5 12 Male
L6 6 Male
L7 3 Female
L8 3 Female
L9 3 Male
L10 4 Female
L11 4 Female
L12 4 Male
L13 4 Male
L14 5 Female
LIS 6 Male
L16 7 Male
L17 8 Female
L18 8 Male
L19 10 Female
L20 i3 Male
AM patient were HIV negative
Tabie 3.2 Treatment History, ZN and Culture Resuits of Patients L i to L6.
Patient
Previous 
T rtast merts
Start o f  Trs'itussem
ZN Staiituig 
(P o s /N e g )
Culture 
( rO S  / Neg)
LI None After biopsy Positive Negahve
L2 1997, 1999 2 days piiOt biopsy Positive Positive
L3 None Afler biopsy Positive Positive
L4 None After biopsy Negative Positive
L5 None After biopsy Positive. Positive
L6 None After biopsy Positive Positive
Only ihese 6 paiieuis who presenieu with tuberculosis infected iyinpb node were included in die 
study'
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3.2 PROBES USED FOR IN SITU HYBRIDISATION ANALYSIS
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3.2.1 DNA Probes
The biotinylated MTB484 (Warren et al, 1996) probe, used for the detection o f M. tuberculosis 
DNA, contains sequences o f the highly repetitive element, PGRS, which are specific for members 
o f the M  tuberculosis complex (Cole et al, 1998). However, as the M. tuberculosis sequence PGRS 
is an expressed sequence (Espitia et al, 1999), the likelihood that the biotinylated MTB484 probe 
would bind to  M  tuberculosis mRNA existed. In order to resolve whether this was the case, the 
sections w ere treated with DNasel prior to hybridisation. In addition, the probe, but not the tissue 
section, w as denatured, which allowed the single stranded DNA probe to anneal to the mRNA and 
not the double stranded (undenatured) DNA molecules. Therefore, sections probed in this manner 
and which produced a positive signal implied that the biotinylated MTB484 probe was annealing to 
mycobacterial mRNA. To ensure that the biotinylated MTB484 probe would only bind to M. 
tuberculosis DNA, the sections were treated with RNasel prior to hybridisation (see Section 2.4.1).,
3.2.2 Riboprobes
The SP6 and T7 primers were used for the amplification o f various M  tuberculosis gene fragments 
cloned into pGemT-easy plasmids (Promega). All gene fragments were successfully amplified 
(Figure 3.1), the PCR products were purified and subsequently used as templates for the preparation 
o f  biotinylated riboprobes.
The RNA probes do not anneal to bacterial DNA because the denaturation step is omitted, 
preventing denaturation of the DNA and subsequent annealing o f the single stranded RNA probes to 
double stranded DNA. Therefore, the presence o f DNA within the tissue sections did not interfere 
with the binding o f  the biotinylated RNA probes. If the antisense probes produce no signal, then 
either there is no specific mRNA present (i.e. the gene was not transcribed), or the amount of 
mRNA present is below the sensitivity level of detection for this technique.
To confirm the specificity o f hybridisation, the negative controls included hybridisation with the 
biotinlyated RNA sense probe. The synthesised sense probes would consequently have the identical 
sequence as the target mRNA, and would therefore not hybridise to the target mRNA. The sense 
probes were synthesised in a similar manner as mRNA that is by using the antisense DNA strand as 
template.
Stellenbosch University http://scholar.sun.ac.za/
67
Lanes:
1 2 3  4 5  6 7 8 9  10
Figure 3.1. Amplification of the various M. tuberculosis gene fragments. SP6 and T7 primers 
specific for the flanking promoter regions of the pGemT-easy plasmids were used to amplify these 
gene fragments cloned into pGemT-easy vectors. Marker X in lane 1 and 10 served as the standard 
molecular weight marker. The amplified M.tuberculosis gene fragments were loaded on 1% agarose 
gel in the following order: 2 rpoB, 3 katG; 4 narX; 5 icl; 6 mbtB; 1 relM,b; 8 esat-6; 9 PPE
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3.3 REPRODUCIBILITY
The in situ hybridisation staining for the detection o f mycobacterial DNA and mRNA, as well as the 
immunohistochemistry staining o f the host cytokines, were all done in duplicate, producing the 
same results. That is, the granulomas that were either positive or negative for hybridisation signal 
were again positive or negative upon duplicate staining. Serial sections, from tissue that had been 
previously confirmed to contain both DNA and mRNA were used as controls for newly synthesised 
probes. In each case, the signal pattern was similar to that o f the previous hybridisation (Figure 3.2). 
This demonstrates that the hybridisation conditions as well as the preparation o f the sections were 
consistent. The absence o f hybridisation signal for one probe does not indicate the inability o f the 
probe to enter the section as hybridisation with a second probe produced a signal in that region.
3.4 CYTOKINE ANAYLSIS ^
Immunohistochemistry was used to study the host immune response induced by the M  tuberculosis 
infection. This was achieved by analysing the pattern o f cytokine production at the site of infection, 
the human granuloma, using paraffin-embedded lymph node tissue. More specifically, the 
production o f  Thl cytokines IFN-y, TNF-a and IL-12, as well as Th2 cytokines IL-4 and EL-10 
were evaluated. Various goat anti-human (cytokine) antibodies (referred to as the primary 
antibodies) were used to detect the relevant cytokines, as summarised in Table 2.4. The location of 
the cytokine-bound antibodies was revealed by the presence o f a brown product that resulted from 
the enzymatic conversion o f the DAB substrate by the HRP reporter enzyme. Scanning o f the 
lymph node tissue for each cytokine at low-power magnification allowed an overall assessment of 
the relative staining of the tissue.
3.4.1 Cytokine Detection in Granulomas
Figures 3.3 to 3.8 are representative sections o f patient L6 illustrating cytokine patterns. Figure 3.3 
* if 
is a compilation o f representative sections illustrating IL-4 staining. A high level of IL-4 was
detected in the non-necrotic granuloma, with signal mostly localised to the central region o f  the
granuloma (Figure 3.3a). Staining for IL-4 was also detected in the lymphocyte cuff o f this non-
necrotic granuloma. This cytokine was also associated with the necrotic granuloma (Figure 3.3 c).
In these granulomas, the signal was localised predominantly in the lymphocyte cuff.
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Figure 3.2. In situ hybridisation of sections from patient L5. Nuclei stain green, and cells positive 
for Mtb DNA or mRNA stained blue. The in situ hybridisation staining for the detection of 
mycobacterial DNA (a, b) and mRNA (c), were done in duplicate (d-f). Granulomas were repeatedly 
positive, with similar signal patterns. M.tb DNA was detected in the non-necrotic granuloma of 
consecutive sections, with the signal pattern similar to the previous hybridisation (a, b and duplicates 
d, e). Signal for narX (example of riboprobe reproducible staining) was also similar to the previous 
hybridisation (c and duplicate f).
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Giant cells which were detected at the periphery of both the non-necrotic and necrotic granulomas 
(Figure 3.3b, d) also stained positive for IL-4. Figure 3.4 shows representative sections o f IL-10 
staining in non-necrotic and necrotic granulomas. As with EL-4, EL-10 was present at high levels 
within the central region o f the non-necrotic granuloma (Figure 3.4a). The necrotic granuloma also 
stained positive for this anti-inflammatory cytokine, but with a weaker staining intensity (Figure 
3 '4c). Signal w as mostly localised to the periphery and lymphocyte cuff o f the necrotic granuloma. 
The giant cells present at the periphery o f the non-necrotic and necrotic granulomas stained positive 
for EL-10 (Figure 3.4 b and d, respectively).
The staining intensity for the type 1 cytokine IL-12, in patient L6 was weak, as illustrated in Figure
3.5. In the non-necrotic granuloma, DL-12 was detected mostly at the edges o f the granuloma 
(Figure 3.5a). A limited amount o f signal was also detected in the lymphocyte cuff. The giant cells 
present at the edge of the non-necrotic granuloma were associated with IL-12 (Figure 3.5b). No 
detectable signal for IL-12 was observed in this particular necrotic granuloma (Figure 3.5c). The 
giant cells detected at the periphery o f the necrotic granuloma were therefore also negative for this 
cytokine (Figure 3.5d). Figure 3.6 illustrates the high intensity staining for IFN-y. This cytokine was 
detected at very high levels within the central region o f the non-necrotic granuloma and within the 
lymphocyte cu ff (Figure 3.6a, b). The necrotic granuloma also stained very strongly for IFN-y 
(Figure 3.6c, d) Signal in this granuloma was localised predominantly to the periphery and 
lymphocyte cu ff region (Figure 3.6d). Giant cells present in this region also stained positive for 
IFN-y. The strongest staining intensity was observed for this cytokine. Staining for TNF-a was 
similar to that o f  IFN-y. Strong signal for TNF-a was detected in the central region, and within the 
lymphocyte cu ff o f  the non-necrotic granuloma (Figure 3.7a, b). Similar staining intensity was 
observed in the necrotic granuloma (Figure 3.7c, d). Strong TNF-a staining was localised to the 
periphery and lymphocyte cuff of the necrotic granuloma, as was also associated with the giant cells 
present in this region.
Figure 3.8 illustrates the specificity o f the immunohistochemical staining. There was no brown 
signal detected in these sections, which is due to the absence o f  primary antibody and the specificity 
of secondary antibodies. Similar results o f  the cytokine staining were observed for all the patients; 
data summarised in Appendix VI.
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Figure 3.3. Immunohistochemical Staining for IL-4 in a non-necrotic and necrotic 
granuloma. Nuclei stain blue, and the brown staining illustrates the presence of the IL-4. In the 
non-necrotic granuloma (a, b), the signal localised to the central region of the granuloma and the 
lymphocyte cuff (LC). hi the necrotic granuloma the staining was localised predominantly in the 
lymphocyte cuff (c, d). Giant cells (GC) present at the edges of the non-necrotic (b) and necrotic 
granulomas (d) stained positive for IL-4.
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Figure 3.4. Iimnunohistochemical Staining for IL-10 in a non-necrotic and necrotic 
granuloma. Nuclei stain blue, and the brown staining illustrates the presence of the IL-10. In 
the non-necrotic granuloma (a, b), the signal localised to the central region of the granuloma and 
the lymphocyte cuff (LC). In the necrotic granuloma the staining was localised predominantly in 
the lymphocyte cuff (c, d). Giant cells (GC) present at the edges of the non-necrotic (b) and 
necrotic granulomas (d) stained positive for IL-10.
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Figure 3.5. Immunohistochemical Staining for IL-12 in a non-necrotic and necrotic 
granuloma. Nuclei stain blue, and the brown staining illustrates the presence of the IL-12. In 
the non-necrotic granuloma (a, b), the weak signal localised to the central region of the 
granuloma and the lymphocyte cuff (LC) (indicated by arrows). There was no staining detected 
in the necrotic granuloma (c, d). Giant cells (GC) present at the edges of the non-necrotic 
granuloma (b) stained positive for IL-12, and not the giant cell at the edge of the necrotic 
granulomas (d)
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Figure 3.6. lmmunohistochemical Staining for IFN-y in a non-necrotic and necrotic 
granuloma. Nuclei stain blue, and the brown staining illustrates the presence of the INF-y. In 
the non-necrotic granuloma (a, b), the signal localised to the central region of the granuloma and 
the lymphocyte cuff (LC). In the necrotic granuloma the staining was localised predominantly in 
the lymphocyte cuff (c, d). Giant cells (GC) present at the edges of the non-necrotic (b) and 
necrotic granulomas stained positive for INF-y.
Stellenbosch University http://scholar.sun.ac.za/
75
v.
xlOO x200
Figure 3.7. Immunohistochemical Staining for TNF-a in a non-necrotic and necrotic 
granuloma. Nuclei stain blue, and the brown staining illustrates the presence of the TNF-a. In 
the non-necrotic granuloma (a, b), the signal localised to the central region of the granuloma and 
the lymphocyte cuff (LC). In the necrotic granuloma the staining was localised predominantly in 
the lymphocyte cuff (c, d). Giant cells (GC) present at the edges of the necrotic granulomas 
stained positive for TNF-a (c)
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Figure 3.8. Negative control for lmmunohistochemical staining. Nuclei stain biue. The 
absence of brown signal in the non-necrotic and necrotic granulomas is the result of the absence 
of primary antibody. This negative control illustrates the specificity of the secondary antibody 
binding.
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3.4.2 Overall Assessment of Cytokine Expression Patterns
3.4.2.1 Type 2 Cytokines
IL-4 was detected in all the patients analysed, including patient L2 (treated patient). In contrast to 
previous reports, a high number o f granulomas identified stained positive for IL-4. This cytokine 
was detected in all the granulomas of patients L6 and L2 (treated patient), and in most of the 
granulomas for the remaining untreated patients, ranging between 75% in patient L3 to 95.8% in 
patient L5 (Figure 3.9). IL-10 was also detected in all the patients, but with variable expression 
between the patients. The number o f EL-10 positive granulomas ranged between 38.5% (L4) to 
89.5% (L6) (Figure 3.9).
3.4.2.2 Type 1 Cytokines
IFN-y was detected in all the granulomas o f each patient (Figure 3.9). Similarly, TNF-a was 
detected in all the granulomas of patients L3, L5, L6 and in the treated patient L2, and was also 
detected in most o f  the granulomas of patients L4 (76.9%) and LI (87.5%) (Figure 3 .9). There was 
more variation in the expression o f the remaining type 1 cytokine, EL-12. This cytokine was 
detected in all six patients, and the number o f  EL-12 positive granulomas ranged from 48.5% for 
patient L5 to  100% for patient L3 (Figure 3.9).
The overall phenotype for the individual granulomas for each patient demonstrated a predominant 
ThO response (Figure 3.10). That is, both Thl and Th2 cytokines were expressed in the granulomas. 
Patients L6 and L2 (treated) presented a complete ThO response, with all the granulomas staining 
positive for both type 1 and type 2 cytokines. The remaining patients also presented a few Thl 
granulomas (i.e. only Thl cytokines were detected in these microenvironments), ranging between 
4.2% for patient L5 to 32.15% for patient L3. None o f the granulomas that were identified in the six 
patients presented with a Th2 phenotype.
It appears there is a balance in the immune response o f these TB patients, as both type 1 and type 2 
cytokines are expressed. This balance was maintained irrespective of anti-tuberculosis treatment.
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■ LI
■ L3
□ L4
□ L5
■ L6
■  L2
Figure 3.9. Analysis of the Individual Host Cytokine Pattern in each of the Patients. The
percentage of positive staining granulomas was determined for each of the cytokines analysed that 
the (a-b) Th2 cytokines (IL-4, IL-10) and the (c-e) Thl cytokines (IL-12, IFN-g, TNF-a)
Figure 3.10. Th Phenotypes Detected for the Individual Patients
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3.4.3 Stratification of Host Cytokines
The granulomas o f  the individual patients (Appendix VI) were characterized to generate an overall 
assessment to allow for stratification o f the host cytokine expression.
IFN-y was present in all the granulomas in each patient and except for the fact that these cytokines 
were present at elevated levels, no other correlations could be made.
In order to determine whether there were any correlations between IL-4 and other cytokines, the 
data was sorted into IL-4 negative and EL-4 positive granulomas. EL-10 was significantly absent in 
the EL-4 negative granulomas (Table 3.3) and was only expressed in those granulomas positive for 
IL-4 (p = 0.0000006). The expression of the type 1 cytokines was approximately constant in both 
EL-4 subgroups.
The data was also stratified according to the presence or absence o f IL-10 in the granulomas, and 
confirmed the significant correlation between the type-2 cytokines. IL-10 appears to be expressed 
only in granulomas expressing EL-4. A significant correlation was observed with EL-10 and IL-12 (p 
= 0.021). IL-12 was expressed mostly in granulomas expressing IL-10, and was downregulated in 
the absence o f  IL-10.
The data was stratified into subgroups of necrotic and non-necrotic granulomas in order to establish 
whether there was any correlation between cytokine production and the presence o f necrosis. The 
majority o f  granulomas containing caseous necrosis stained positive for IL-10, and those lacking 
this cytokine were mostly non-necrotic granulomas (Table 3.3). Statistical evaluation o f these 
results indicated a significant association between IL-10 and caseous necrosis (p = 0.000046). This 
trend was not observed with IL-4. This cytokine was detected in most granulomas, but with no 
distinction between the necrotic and non-necrotic granulomas (p = 2.06). However, a significant 
association was also observed between TNF-a and caseous necrosis (p = 0.0041). All the 
granulomas negative for TN F-a also lacked necrosis. In addition, a significant correlation in co­
ordinated expression was also detected between the two cytokines associated with necrosis, viz.IL- 
10 and TN F-a (p = 0.0054).
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Table 3.3. Summary of Cytokine Data Stratification
Cytokines
sorting IL-4 IL-10 IL-12 IFN-g TNF-a
IL-4 Neg 0 0 10 14 14
% 0.00 0.00 71.43 100.00 100.00
Pos 93 68 66 93 88
% 100.00 73.12 70.97 100.00 94.62
p-value ns 0.0000006 ns ns ns
IL-10 Neg 25 0 22 39 34
% 64.10 0.00 56.41 100.00 87.18
Pos 68 68 54 68 68
% 100.00 100.00 79.41 100.00 100.00
p-value 0.0000006 ns 0.021 ns 0.0054
IL-12 Neg 27 14 0 31 28
% 87.10 45.16 0.00 100.00 90.32
Pos 66 54 76 76 74
% 86.84 71.05 100.00 100.00 97.37
p-value ns 0.021 ns ns ns
Necrosis Non-necr 27 13 20 34 29
% 79.41 38.24 58.82 100.00 85.29
Necrotic 66 55 56 73 73
% 90.41 75.34 76.71 100.00 100.00
p-value ns 0.000046 ns ns 0.0041
* significant correlations are highlighted 
ns = non-significance
3.5 MYCOBACTERIAL DNA DETECTION
3.5.1 M. tuberculosis DNA Detection in Granulomas
Consecutive sections of lymph node tissue from six TB patients (Table 3.2) were hybridised with 
the MTB484 probe to detect the presence of mycobacterial DNA. A total of 107 granulomas were 
analysed by DNA.DNA in situ hybridisation and 88.8% were found to be positive for M. 
tuberculosis DNA. All the granulomas containing caseous necrosis (73), and 22 of the 34 non- 
necrotic granulomas were positive for M. tuberculosis DNA.
Figure 3.11 shows a representative section of a necrotic granuloma from patient L6. Hybridisation 
signal for the DNA probe occurred mostly in the periphery and in the lymphocyte cuff region of the 
granuloma (Figure 3.11 a b), where cells with the morphology of macrophages were positive for M. 
tuberculosis DNA (blue signal). Hybridisation signals were also detected in the necrotic region of 
the granuloma, which was not cell associated (Figure 3.11c). To detect non-specific binding of 
streptavidin to the sections, hybridisation was also carried out in the absence of the biotinylated 
probe (Figure 3.1 ld-e). The results of these controls demonstrate that the appearance of a positive
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signal w as dependent on specific hybridisation of the biotinylated probes to the target DNA, and 
was not an artefact o f the methodology. Giant cells, located at the periphery o f the granuloma, 
within the lymphocyte cuff, also stained positive for M. tuberculosis DNA (Figure 3.11 a, b). 
Higher magnification of the giant cells (Figure 3.11 f) indicated that the signal was localised to the 
cytoplasm.
Figure 3.12 (a-c) shows representative sections o f a non-necrotic granuloma o f patient L5 
hybridised w ith the M. tuberculosis DNA probe. This granuloma did not contain caseous necrosis, 
and was characterised by intact macrophages in the central region. The signal for this granuloma 
was predominantly localised to the lymphocyte cuff, with less signal detected within the central 
non-necrotic regions (Figure 3.12a, b). The specificity o f the staining was observed by the 
differential staining observed, particularly at higher magnifications, where both negative (green) 
and positive cells (blue) for M  tuberculosis were detected, especially within the periphery and 
lymphocyte cu ff region (Figure 3.12c). To detect non-specific binding o f streptavidin to these 
sections, hybridisation was also carried out in the absence o f the biotinylated probe (Figure 3 .12 d- 
f). Similar results were observed for all the patients; data summarised in Appendix VI.
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Figure 3.11. In situ hybridisation of sections through necrotic granuloma 18 of patient L6.
Nuclei stain green, and cells positive for Mtb DNA stained blue (a-c, f). Cells with the morphology of 
macrophages (M) stained positive for Mtb DNA, which was more distinguishable at higher 
magnifications (c, f). Mtb DNA also localised within the caseous necrosis (CN), not associated with 
any cells, as indicated by the arrows (c). The blue signal localised to a giant cell (GC) detected in the 
lymphocyte cuff (LC). Higher magnification of the giant cell (f) indicated that the signal was 
localised to the cytoplasm. Negative controls were also included (d-e). Total magnification for each 
section is indicated below the panel.
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Figure 3.12. In situ hybridisation of sections through non-necrotic granuloma 16 from patient
L5. Nuclei stain green, and cells positive for M.tb DNA stained blue (a-c). Limited signal was 
detected within the central region of the granuloma, with signal predominantly in the lymphocyte cuff 
(LC) (b). Cells with the morphology of macrophages (M) stained positive for M.tb DNA, which was 
more distinguishable at higher magnifications (c). Cells negative for M.tb DNA were detected within 
the lymphocyte cuff, along with positive staining cells. Negative controls were also included (d-f). 
Total magnification of each section is indicated.
Stellenbosch University http://scholar.sun.ac.za/
3.5.2 Dual Labeling: Co-localisation of CD68 Positive Cells and Mycobacterial DNA
In order to co-localise M  tuberculosis DNA to cells with the morphology o f macrophages, dual 
labelling was performed. That is, surface receptor CD68 molecules specific for macrophages were 
stained to allow co-localisation of th e M  tuberculosis DNA to these specific cells.
CD68-positive cells (pink) stained positive fo rM  tuberculosis DNA (dark blue) (Figure 3.13). The 
specificity o f  the in situ hybridisation staining for M. tuberculosis DNA is demonstrated by the 
differential staining observed, particularly at higher magnifications where CD68 stained cells 
positive and negative fo rM  tuberculosis DNA are easily distinguished (Figure 3.13 b and Figure 
3.14 a). M  tuberculosis DNA was co-localised with CD68-positive giant cells, which are fused 
macrophages. CD68-positive giant cells were detected at the periphery o f necrotic (Figure 3.13 a, 
b), and non-necrotic granulomas (Figure 3.13 c, d). The CD68 staining on the giant cell surface is 
more distinguishable at high magnification (Figure 3.14b).
The results obtained with the hybridisation staining of mycobacterial DNA of the dual labeling, was 
the same as the “single” in situ hybridisation staining.
3.5.3 Overall Assessment of Mycobacterial DNA Detection In Patients
All the patients, with the exception o f patient L4, stained positive for acid-fast bacilli by ZN 
staining (Table 3.2). This patient, however, had a positive (BACTEC) culture, implying that M  
tuberculosis bacilli were present in the biopsy tissue. Interestingly, M. tuberculosis DNA was 
detected in the granulomas of all six patients (LI -  L6) when using the DNA:DNA in situ 
hybridisation technique. The percentage o f granulomas staining positive for each patient is 
summarised in Figure 3.15. The levels o f  DNA detected were comparable between all the patients, 
including the treated patient L2, and the percentage o f positive granulomas ranged from 84.6 -  
94.7%, with the least number of granulomas identified in patient L4, the ZN negative patient.
84
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Figure 3.13. Co-localisation of M. tuberculosis DNA to CD68 positive cells. Co-localisation of 
CD68 macrophages (M) with M. tuberculosis DNA (a-b) results in dark blue staining within the 
macrophages (pink). CD68 stained cells not positive for M. tuberculosis DNA was detected (Neg 
GC), as illustrated above (b). Giant cell (GC) was detected in the non-non-necrotic granuloma (c- 
d) that stained positive for M. tuberculosis DNA
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Figure 3.14. High Magnification Illustrating the Co-localisation of M. tuberculosis DNA to 
CD68 positive (a) Macrophages and (b) Giant Cell, (a) CD68 positive macrophages that stained 
positive for M. tuberculosis DNA was detected, as well as CD68 macrophages that did not stain 
positive for M. tuberculosis DNA (Neg M). (b) The high magnification of the giant cell 
distinguishes between the CD68 staining (pink) and the M. tuberculosis DNA ISH staining (dark 
blue).
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Figure 3.15. Percentage Granulomas Positive for Mycobacterial DNA Detected in Individual 
Patients. The only treated patient, L2, is represented by the pink bar.
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3.6 M. TUBERCULOSIS GENE EXPRESSION
3.6.1 M. tuberculosis Gene Expression in Granulomas
A series o f antisense RNA probes were developed to identify genes required for survival within the 
hostile environment o f  the human granuloma. The in situ hybridisation experiments revealed that 
each granuloma within a patient is a microenvironment in which various patterns o fM  tuberculosis 
gene expression are observed. Scanning the lymph node sections for each RNA probe at low-power 
magnification allowed an overall assessment o f the relative staining in the granulomas in the tissue. 
A total o f  107 granulomas were analysed from the 6 patients collectively, 73 of which contained 
caseous necrosis.
Figure 3.16 (a -  g) shows representative sections o f a necrotic granuloma from patient L5 
hybridised with the individual antisense riboprobes viewed under lOx magnification. Positive signal 
(blue colour) localised predominantly to the periphery and lymphocyte cuff o f necrotic granulomas. 
Signal for certain genes, namely katG, narX, icl and relutb, as well as PPE, were also detected in the 
necrotic regions o f  the granuloma (Figure 3.16 b, c, d, f  and g). This illustrates that the bacteria 
within the restrictive necrotic environment are transcriptionally active. Hybridisation with the 
riboprobes produced varying staining intensities. The riboprobes producing strong staining intensity 
were katG, narX’ icl and relMtb (Figure 3.16 b, c, d and f  respectively). This necrotic granuloma was 
weakly positive for rpoB, and mbtB (Figure 3.16 a, and e, respectively), suggesting that the 
expression o f  these genes were not as upregulated as the other genes analysed. No staining was 
detected for the esat-6 riboprobe in granulomas o f this tissue section, but was detected in other 
patients (data not shown). The sense probes were used as controls for specificity o f  the 
hybridisation, and did not produce any signal, an example o f which is illustrated in Figure 3 .16h.
Figure 3 .17 (a-i) and Figure 3.8 (a-i) shows representative sections o f a non-necrotic granuloma o f 
patient L6 hybridised with the individual riboprobes, viewed under lOOx magnification. 
Hybridisation signals (blue) were localised predominantly in the periphery and lymphocyte cuff 
region o f the granuloma. Different staining intensities were detected for the various riboprobes. 
Cells with the morphology o f macrophages stained positive for the various genes and can be 
detected when viewed under a higher magnification (Figure 3.18 a - i).
Similar results were observed for all patients, as summarised in Appendix VI.
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(Figure 3.16. legend on following page (p 90))
Stellenbosch University http://scholar.sun.ac.za/
90
Figure 3.16. In situ hybridisation of necrotic granuloma number 15 from patient L5 at xlOO 
Magnification. Consecutive sections were probed with the following antisense probes: (a) rpoB, 
(b) katG, (c) narX, (d) icl, (e) mbtB, (f) relMtb, (g) PPE and (h) sense. The region shown is a 
representative granuloma across the lymph node biopsy. The remaining probes produced positive 
(blue) signal, which was localised predominantly to the periphery and lymphocyte cuff (LC) of the 
granulomas. RNA transcripts of katG (b), narX (c), icl (d), relMtb (f) and PPE (g) also localised to 
the necrotic region of the granuloma (as indicated by arrows).
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Figure 3.17. In situ hybridisation of non-necrotic granuloma number 15 from patient L6 at 
xlOO Magnification. Consecutive sections were probed with the following antisense probes: (a) 
rpoB, (b) katG, (c) narX, (d) icl, (e) mbtB, (f) relMtb, (g) esat-6 and (h) PPE, as well as sense probes 
(i). The region shown is a representative granuloma across the lymph node biopsy. The negative 
controls (i). The hybridised probes produced positive (blue) signal, which was localised 
predominantly to the periphery and lymphocyte cuff (LC) of the granulomas.
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(Figure 3.18. legend on following page (p 94))
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Figure 3.18. In situ hybridisation of sections through granuloma 15 from patient L6 at x200 
Magnification. Consecutive sections were probed with (a) rpoB, (b) katG, (c) narX, (d) icl, (e) 
mbtB, (f) relMtb, (g) esat-6 and (h) PPE. Hybridisation signals were localised to cells with the 
morphology of macrophages (M) at the periphery and lymphocyte cuff region of the granuloma. 
Limited signal was detected in the central region of the granuloma. Staining for relMtb (f) was more 
intense than for the other probes, especially when compared to the weak signal intensity for PPE. 
Hybridisation with esat-6 riboprobe (g) did not produce any detectable signal.
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3.6.2 Dual Labeling: Co-localisation of rpoB mRNA to CD68 Positive Cells
M. tuberculosis rpoB mRNA was co-localised to cells with the morphology o f macrophages. 
Surface receptor molecules specific for macrophages were stained to allow co-localisation o f the M  
tuberculosis rpoB mRNA to these specific cells.
M essenger RNA for rpoB (dark blue) was co-localised to the CD68-positive cells (pink), as 
illustrated in Figure 3.19. As with the M  tuberculosis D N A  CD68-positive cells that did not 
contain hybridisation signals for rpoB mRNA were also detected among the positive staining rpoB 
CD68 cells at the edge of the necrotic granuloma (Figure 3.19 a, b). RpoB mRNA also co-localised 
to CD68 positive giant cells detected at the edge o f the non-necrotic granuloma (Figure 3.19 c, d).
3.7.1 Overall Assessment of M. tuberculosis Gene Expression
A consistent level o f  rpoB expression was observed in the untreated patients LI, L3, L4, L5 and L6 
(Figure 3.20). However, for patient L2, who was treated with rifampin (for 2 days), no rpoB mRNA 
was detected. Similarly, katG mRNA was also not detected in the granulomas of treated patient L2, 
who was also treated with isoniazid (Figure 3.20). For the untreated patients, there is a clear 
variability in expression for the katG gene. Considerable variability in gene expression o f the 
persistent factors, and those genes o f unknown function, was observed between the patients, 
including the treated patient, L2 (Figure 3.20). The variability in M  tuberculosis gene expression 
between the patients was more evident with esat-6 staining. Messenger RNA for this gene was 
detected in most o f the granulomas identified for patient LI and interestingly, was absent in the 
granulomas o f patients L4 and L5 (Figure 3.20).
95
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Figure 3.19. Co-localisation of rpoB mRNA to CD68 positive cells. Co-localisation of CD68 
with rpoB mRNA (a, b) results in dark blue staining within the macrophages (M) (pink). CD68 
stained cells not positive for rpoB mRNA was detected, as illustrated above (b). Giant cell (GC) 
was detected in the non-non-necrotic granuoma (c, d) that stained positive for rpoB mRNA
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Figure 3.20. Expression Analysis of the Individual M.tuberculosis Genes. The percentage of 
positive staining granulomas was determined for each of the genes in the individual patients. The 
treated patient, L2, is represented by the pink bar. Messenger RNA for rpoB and katG was not 
detected in the granulomas of the treated patient. RpoB was present at consistent levels in the 
untreated patients, but katG exhibited more variability in expression between the untreated patients. 
The remaining genes also displayed variability in expression all the six patients, including the 
treated patient L2. This variability in gene expression between the patients was more evident with 
esat-6. Messenger RNA for this gene was detected in most of the granulomas identified for patient 
LI and interestingly, was absent in the granulomas of patient L4 and L5.
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3.6.4 Stratification of M. tuberculosis Gene Expression
The granulomas o f the individual patients (Appendix IV) were characterized to generate an overall 
assessment to allow for stratification o f gene expression patterns. The presence and absence of 
signal in the granulomas for all the riboprobes was stratified to determine if  any correlations existed 
in the expression profile o f  the M. tuberculosis genes analysed. The stratification results o f all the 
riboprobes are summarized in Table 3.4.
Review o f  the data showed that co-expression could not be demonstrated for rpoB and any other M  
tuberculosis gene analysed. The term “co-expression” refers to the detection o f mRNA transcripts 
o f two or more mycobacterial genes in the same granuloma. The M. tuberculosis genes were 
expressed at consistent levels with no distinction between rpoB negative or positive granulomas.
Stratification o f the katG expression profile into negative and positive subgroups demonstrated a 
significant co-expression correlation between katG and icl (p = 0.008). The expression o f katG 
occurred mostly in tandem with icl. Similarly, a significant correlation in expression between katG 
and relMth (p =  0.0106), as well as katG and PPE Rv3018c (p = 0.047) was observed.
A significant co-expression correlation was also observed between icl and narX(p = 0.00003). The 
regulation o f  icl expression almost mirrored that o f narX. Similarly, a significant correlation in 
expression between icl and relMtb was observed (p = 0.00003). This suggests that there is a co­
ordinated expression o f katG, icl and relMtb. However, an inverse expression pattern was observed 
between icl and esat-6 (p = 0.043). Most granulomas positive for icl were negative for esat-6, and 
conversely, most granulomas negative for icl were positive for esat-6. It would appear that the 
expression o f  the fatty acid metabolising enzyme, isocitrate lyase, and the ESAT-6 protein occur at 
different stages o f infection.
A significant inverse expression pattern was also observed with mbtB and esat-6 (p = 0.026). The 
downregulation o f mbtB was coupled with an upregulation of esat-6 in most granulomas.
The presence or absence o f caseous necrosis in the granulomas was stratified in order to determine 
if any correlations existed between the expression o f the mycobacterial genes and tissue damage. 
All o f the genes analysed, with the exception o f  narX, were expressed in approximately the same 
proportion o f non-necrotic and necrotic granulomas (Table 3.4). NarX was expressed mostly in 
granulomas containing caseous necrosis (p = 0.0062).
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Table 3.4. Summary of M. tuberculosis Gene Expression Stratification
M. tuberculosis Genes
sorting DNA rpoB katG narX icl mbtB relMtb esat-6 PPE
RpoB Neg 54 0 34 25 35 28 41 11 19
% 100.00 0.00 62.96 46.30 64.81 51.85 75.93 20.37 35.19
Pos 41 41 26 23 26 24 29 It 22
% 100.00 100.00 63.41 56.10 63.41 58.54 70.73 26.83 53.66
p-vahie ns ns ns ns ns ns ns ns ns
KatG Neg 35 15 0 16 16 18 20 9 10
% 100.00 42.86 0.00 45.71 45.71 51.43 57.14 25.71 28.57
Pos 60 26 60 32 45 34 50 13 31
% 100.00 43.33 100.00 53.33 75.00 56.67 83.33 21.67 51.67
p-value ns ns ns ns 0.008 ns 0.0106 ns 0.047
NarX Neg 47 18 28 0 20 30 32 12 21
% 100.00 38.30 59.57 0.00 42.55 63.83 68.09 25.53 44.68
Pos 48 23 32 48 41 22 38 10 20
% 100.00 47.92 66.67 100.00 85.42 45.83 79.17 20.83 41.67
p-value ns ns ns ns 0.00003 ns ns ns ns
Icl Neg 34 15 15 7 0 15 16 14 15
% 100.00 44.12 44.12 20.59 0.00 44.12 47.06 4L18 44.12
Pos 61 26 45 41 61 37 54 8 26
% 100.00 42.62 73.77 67.21 100.00 60.66 88.52 13.11 42.62
p-value ns ns 0.008 0.00003 ns ns 0.00003 0.043 ns
MbtB Neg 43 17 26 26 24 0 29 15 16
% 100.00 39.53 60.47 60.47 55.81 0.00 67.44 34.88 37.21
Pos 52 24 34 22 37 52 41 7 25
% 100.00 46.15 65.38 42.31 71.15 100.00 78.85 13.46 48.08
p-value ns ns ns ns ns ns ns 0.026 ns
RelMtb Neg 25 12 10 10 7 11 0 5 11
% 100.00 48.00 40.00 40.00 28.00 44.00 0.00 20.00 44.00
Pos 70 29 50 38 54 41 70 17 30
% 100.00 41.43 71.43 54.29 77.14 58.57 100.00 24.29 42.86
p-value ns ns 0.0106 ns 0.00003 ns ns ns ns
Esat-6 Neg 73 30 47 38 53 45 53 0 34
% 100.00 41.10 64.38 52.05 72.60 61.64 72.60 0.00 46.58
Pos 22 11 13 10 8 7 17 22 7
% 100.00 50.00 59.09 45.45 36.36 31.82 77.27 100.00 31.82
p-value ns ns ns ns 0.043 0.026 ns ns ns
PPE Neg 54 19 29 28 35 27 40 15 0
% 100.00 35.19 53.70 51.85 64.81 50.00 74.07 27.78 0.00
Pos 41 22 31 20 26 25 30 7 41
% 100.00 53.66 75.61 48.78 63.41 60.98 73.17 17.07 100.00
p-value ns ns 0.047 ns ns ns ns ns ns
necrosis Non 22 13 16 5 10 10 17 6 11
% 100.00 59.09 72.73 22.73 45.45 45.45 77.27 27.27 50.00
Necr 73 28 44 43 51 42 53 16 30
% 100.00 38.36 60.27 58.90 69.86 57.53 72.60 21.92 41.10
p-value ns ns ns 0.0062 ns ns ns ns ns
* significant correlations are highlighted 
ns = non-significance
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3.7 STRATIFICATION OF MYCOBACTERIAL GENES AND HOST CYTOKINES
100
The expression o f  the bacterial genes for the various granulomas was stratified along with the 
cytokine expression also detected in the granulomas (Table 3.5). Stratification was done to 
determine whether any correlations existed between the M. tuberculosis genes and host cytokine 
expression.
Review o f the data showed that a significant correlation existed between the expression of the 
mycobacterial gene, mbtB, and a ThO cytokine response (p = 0.0012). The expression of mbtB 
occurred predominantly in granulomas with an overall ThO phenotype (Table 3.5). Furthermore, 
stratification o f the granulomas into EL-4 positive and IL-4 negative groups showed that a 
significant correlation existed between the expression of EL-4 and mbtB (p = 0.005). The expression 
of this type 2 cytokine and the mycobacterial gene occurred simultaneously in a number of 
granulomas (Table 3.5). It is unclear whether the expression of IL-4 is the result of, or conversely, 
induced the expression of mbtB by infecting bacilli.
Associations between IL-10 expression and any of the mycobacterial genes analysed could not be 
demonstrated. The expression of these genes occurred with no distinction between the absence and 
presence o f EL-10.
An opposite inverse expression pattern for EL-12 and relMtb was detected in most granulomas (p = 
0.0037). This cytokine and mycobacterial gene was hardly expressed in the same granulomas. The 
stringent response, it would appear, is less active in the presence of IL-12. Conversely, a significant 
co-expression correlation existed between IL-12 and esat-6 (p = 0.043). The expression of this 
cytokine and mycobacterial genes occurred in tandem in most granulomas.
3.7.1 Passive vs. Active Transcription
The granulomas were primarily stratified into rpoB negative (passive transcription) and rpoB 
positive groups (active transcription), and were followed by further secondary stratification 
according to the presence and absence of the host cytokines (Table 3.6).
In the granulomas displaying passive transcription, i.e. the rpoB negative granulomas, a significant 
correlation was observed in the ThO cytokine response and the expression of mbtB (p = 0.020).
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Table 3.5. Summary of Host Cytokine and M. tuberculosis Gene Expression Stratification
sorting
M. tuberculosis Genes
DNA rpoB katG narX icl mbtB reUnh esat-6 PPE
Th Thl 13 7 6 6 7 2 9 3 3
% 100. 53.85 46.15 46.15 53.85 15.38 69.23 23.08 23.08
ThO 82 34 54 42 54 50 61 19 38
% 100. 41.46 65.85 51.22 65.85 60.98 74.39 23.17 46.34
p-value ns ns ns ns ns 0.0012 ns ns ns
IL-4 Neg. 13 7 6 6 7 2 9 3 3
% 100. 53.85 46.15 46.15 53.85 15.38 69.23 23.08 23.08
Pos 82 34 54 42 54 50 61 19 38
% 100. 41.46 65.85 51.22 65.85 60.98 74.39 23.17 46.34
p-value ns ns ns ns ns 0.005 ns ns ns
IL-10 Neg 31 14 19 12 18 13 23 5 16
% 100. 45.16 61.29 38.71 58.06 41.94 74.19 16.13 51.61
Pos 64 27 41 36 43 39 47 17 25
% 100. 42.19 64.06 56.25 67.19 60.94 73.44 26.56 39.06
p-value ns ns ns ns ns ns ns ns ns
IL-12 Neg 27 14 19 13 21 19 26 2 16
% 100. 51.85 70.37 48.15 77.78 70.37 96.30 7.41 59.26
Pos 68 27 41 35 40 33 44 20 25
% 100. 39.71 60.29 51.47 58.82 48.53 64.71 29.41 36.76
p-value ns ns ns ns ns ns 0.0037 0.043 ns
* significant correlations are highlighted
ns = non-significance
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AibtB expression occurred predominantly in granulomas with an overall ThO phenotype. Secondary 
stratification o f data according to IL-4 revealed a co-expression correlation between this cytokine 
and mbtB (p = 0.020).
An opposite trend in expression was observed between IL-12 and relMtb This cytokine and 
mycobacterial gene exhibited a weakly significant opposite expression pattern (p = 0.05). That is, 
they seldom occurred in tandem. All these trends observed between host cytokine and 
mycobacterial gene expression in the rpoB negative granulomas, was also detected by single 
stratification o f data (Table 3 .4).
In the granulomas displaying active transcription, i.e. rpoB positive granulomas, more significant 
correlations were detected between host cytokines and mycobacterial genes (Table 3.6). Unlike the 
rpoB negative granulomas, a significant correlation was detected between the ThO cytokine profile 
and katG (p = 0.049). This is presumably as a consequence of the weakly significant co-expression 
correlation between IL-4 and katG (p = 0.049). Another correlation detected in the actively 
transcribing granulomas is that between IL-10 and narX (p = 0.026). These cytokine and 
mycobacterial genes appear to be co-expressed in most granulomas (Table 3.6).
A significant inverse expression pattern was observed between EL-12 and mbtB (p = 0.035), and as 
with the rpoB negative granulomas, between IL-12 and relMtb (p = 0.021). However, unlike these 
two mycobacterial persistence factors, a co-expression correlation existed between IL-12 and esat-6 
(p = 0.021). This correlation, although not observed in the rpoB negative subgroup, was also 
detected when using single stratification analysis (Table 3.5).
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Table 3.6. Stratification of Granuloma into Passive and Active Transcribing Subgroups
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RpoB Negative
Sorting
M. tuberculosis Genes
DNA rpoB katG narX icl mbtB relMtb Esat-6 PPE
Th Thl 6 0 4 4 5 0 6 1 1
% 100.00 0.00 66.67 66.67 83.33 0.00 100.00 16.67 16.67
ThO 48 0 30 21 30 28 35 10 18
% 100.00 0.00 62.50 43.75 62.50 58.33 72.92 20.83 37.50
p-value ns ns ns ns ns 0.020 ns ns ns
IL-4 Neg. 6 0 4 4 5 0 6 1 1
% 100.00 0.00 66.67 66.67 83.33 0.00 100.00 16.67 16.67
Pos 48 0 30 21 30 28 35 10 18
% 100.00 0.00 62.50 43.75 62.50 58.33 72.92 20.83 37.50
p-value ns ns ns ns ns 0.020 ns ns ns
IL-10 Neg. 17 0 11 8 12 6 15 3 8
% 100.00 0.00 64.71 47.06 70.59 35.29 88.24 17.65 47.06
Pos 37 0 23 17 23 22 26 8 II
% 100.00 0.00 62.16 45.95 62.16 59.46 70.27 21.62 29.73
p-value ns ns nsns ns ns ns ns ns ns
IL-12 Ncy- 13 0 9 5 10 7 13 2 6
% 100.00 0.00 69.23 38.46 76.92 53.85 100.00 15.38 46.15
Pos 41 0 25 20 25 21 28 9 13
% 100.00 0.00 60.98 48.78 60.98 51.22 68.29 21.95 31.71
p-value ns ns ns ns ns ns 0.05 ns ns
RpoB Positive
Sorting
M. tuberculosis Genes
DNA rpoB katG narX icl mbtB Rekith Esat-6 PPE
Th Thl 7 7 2 2 2 2 3 2 2
% 100.00 100.00 28.57 28.57 28.57 28.57 42.86 28.57 28.57
ThO 34 34 24 21 24 22 26 9 20
% 100.00 100.00 70.59 61.76 70.59 64.71 76.47 26.47 58.82
p-value ns ns 0.049 ns ns ns ns ns ns
IL-4 Neg. 7 7 2 2 2 2 3 2 2
% 100.00 100.00 28.57 28.57 28.57 28.57 42.86 28.57 28.57
Pos 34 34 24 21 24 22 26 9 20
% 100.00 100.00 70.59 61.76 70.59 64.71 76.47 26.47 58.82
p-value ns ns 0.049 ns ns ns ns ns ns
IL-10 x^- 14 14 8 4 6 7 8 2 8
% 100.00 100.00 57.14 28.57 42.86 50.00 57.14 14.29 57.14
Pos 27 27 18 19 20 17 21 9 14
% 100.00 100.00 66.67 70.37 74.07 62.96 77.78 33.33 51.85
p-value ns ns ns 0.026 ns ns ns ns ns
IL-12 Neg. 14 14 10 8 11 12 13 0 10
% 100.00 100.00 71.43 57.14 78.57 85.71 92.86 0.00 71.43
Pos 26 26 15 14 14 12 15 10 12
% 100.00 100.00 57.69 53.85 53.85 46.15 57.69 38.46 46.15
p-value ns ns ns ns ns 0.035 0.021 0.021 ns
* significant correlations are highlighted 
ns = non-significance
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3.8 STRAIN TYPING M  TUBERCULOSIS CLINICAL ISOLATES
104
The lymph node tissues o f patients L2 to L6 that were cultivated in the BACTEC medium yielded a 
positive M. tuberculosis culture. As stated previously, biopsy tissue of patient LI was not submitted 
for culture. The infecting M  tuberculosis strain could therefore not be classified, as no culture was 
available for mycobacterial DNA extraction. The cultivation of the abscess fluid of patient LI 1 
(Table 3.1) also yielded a positive M  tuberculosis culture. These 6 clinical isolates were then sub­
cultured on LJ-slant agar. The mycobacterial DNA was extracted and the clinical strains were 
classified using the standardised RFLP protocol (Section 2.9). The extracted M  tuberculosis 
genomic DNA was digested with PvuII and fractionated by electrophoresis, along with the marker 
M TB14323. M TB14323 is a standard molecular weight marker used in the DNA fingerprinting 
technique for M. tuberculosis classification (Kamerbreek et al, 1997). The PvuII digested M  
tuberculosis genomic DNA was then transferred to a nylon membrane and hybridised with labeled 
IS6110 probes.
The banding patterns for the 6 clinical isolates clearly illustrate that these strains are genotypically 
unrelated (Figure 3.21, Table 3.7). Both low (< 5 bands) and high (> 5 bands) copy number strains 
were identified. Hybridisation with the IS6110 probe resulted in a 4-banding pattern for the clinical 
isolate L l l ,  and was therefore classified as a low copy number strain. The isolated strains L2 and 
L6 were effectively classified to family 28 and 11, respectively. The IS6110 typing of the 3 
remaining strains proved slightly more complicated. The fingerprint patterns of these strains did not 
bear any resemblance to banding pattern in our database, and were consequently typed as unique 
strains. All these patients, incidentally, resided in various regions of the Western Cape. However, 
the majority o f  the clinical isolates previously classified by \S6110 typing were obtained from the 
high tuberculosis incidence community of Ravensmead / Uitsig. Information on strain diversity in 
other regions o f the Western Cape is incomplete; therefore, by classifying these strains as unique 
simply implies that these clinical isolates have not been identified in the Ravensmead / Uitsig 
community, and does not suggest that these strains are unique to the communities from which the 
patients originate.
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Table 3.7. Strain Typing of Isolated Clinical Strains. M. tuberculosis 
strains were isolated from lymph node biopsy tissue (L2 -  L6) and from 
the abscess fluid of patient LI 1
Patient Culture Strain Family
L2
L3
L4
L5
L6
L ll
28
Unique
Unique
Unique
11
*LCN
1 LCN: Low Copy Number
M L2 L3 L4 L5 L6 L l l  M
Figure 3.21. Strain Typing M  tuberculosis Clinical Isolates
Marker MTB 14323 (M) in the outside lanes served as the standard molecular 
weight marker
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4.1 STUDY SUBJECTS
It is likely that anti-tuberculosis drugs could influence not only theM  tuberculosis gene expression, 
but also the host immune response. Therefore the study population included patients with 
tuberculosis granuloma who had not received any previous treatment.These patients were children 
with lymph node enlargement. Patient L2, the only patient who had a history of previous 
tuberculosis and was also currently on therapy when the biopsy was carried out, was eventually 
included in the study group. The lymph node biopsy tissues used for analysis were obtained from 
patients between the ages o f 3 and 13 years. It is possible that the lymphadenitis of patient LI was 
detected relatively early since this patient was examined on a regular basis for a severe asthmatic 
medical condition. Patient L2 had a history of tuberculosis. It appears that this patient did not 
respond to previous anti-tuberculosis treatment and started the third course of chemotherapy seven 
months after completing the second course. The strong granulomatous response seen in patients L3, 
L5 and L6 could possibly be an indication of a more advanced phase of disease. For patient L6 this 
notion is supported by the partially disintegrated lymph node tissue, and patient L5 was, as 
mentioned previously, diagnosed with disseminated tuberculosis (pulmonary and abdominal TB). In 
the biopsy tissue o f patient L4, who presented more non-caseating granulomas, no acid-fast bacilli 
were detected using the ZN staining technique. Cultivation of the tissue, however, yielded a positive 
BACTEC M. tuberculosis culture. This diagnostic culture technique is at present the most reliable 
and fastest culture system available, yet for this particular patient, a positive culture was only 
detected after four weeks. This data implies that a very low number of bacilli were present in the 
biopsy tissue, which explains both the ZN negative results since this technique will only be 
successful in detecting AFB present in large numbers (for example, 10 000 per ml in sputum), and 
the prolonged cultivation period (Allen and Mitchison, 1992; Heifets, 1997).
4.2 ANALYSIS OF TUBERCULOUS GRANULOMAS
The tuberculous granulomas display spatial arrangements involving host cells, cytokines and 
infecting bacilli. Granulomas are focal mononuclear infiltrations that appear in response to chronic 
inflammatory stimuli and are therefore a hallmark of mycobacterial infection (Dannenberg, 1991). 
It was suggested that in M  tuberculosis infection, granulomatous lesions form to surround and 
envelop infected cells within a wall of epitheloid macrophages to contain and prevent bacterial 
spread (Saunders et al, 1999). Granulomas are an essential component of a co-ordinated anti- 
mycobacterial defence because it is within these structures that T-cell-macrophage co-operation can
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take place, allowing macrophages to display effective bactericidal activities (Dannenberg and Rook, 
1994).
Previous studies have used various techniques to analyse the cytokine production in response to M. 
tuberculosis infection. However, most of these studies analysed the cytokine response using animal 
models or in vitro systems (Brozna et al, 1991; Flesch and Kaufmann, 1991; Juffermans et al, 2000; 
Song et al, 2000)). In this study, we employed the immunohistochemistry technique to analyse the 
cytokine response at the site of disease, that is, in tuberculous lymph node granulomas. It is 
generally accepted that type-1 cytokines (IFN-y, TNF-a, IL-12) are expressed during the protective 
phase o f M  tuberculosis infection (Modlin, 1994). A switch is then later made to the expression of 
type-2 cytokines (IL-4, IL-10) during the resolution phase to re-establish homeostasis once 
infection is under control (Modlin, 1994). The balance between the type-1 and type-2 cytokine 
responses in tuberculosis may in all probability influence mycobacterial growth, as well as the 
immunopathology of infection. The immune response to tuberculosis infection is an intricate and - 
complex process, with many studies reporting conflicting results. At present, only a limited number 
of reports have examined the infection directly at the site of disease. Additionally, the information 
available concerning the cytokine expression in children with tuberculosis is extremely limited.
Analysing the metabolism of bacilli in their natural host environment is important for design of new 
drug targets and vaccines. In this study, we used the in situ hybridisation staining technique for the 
analysis o f bacterial gene transcription in the lymph node granulomas. Demonstration of a particular 
mRNA by in situ hybridisation is a reflection of the rate of gene transcription (measured by rpoB 
transcription) and the metabolic state of the infecting bacilli in the restrictive granuloma (measured 
by the transcription of persistent factors). Thus, this technique allows the identification of factors 
required by the bacilli to adapt to the adverse granuloma environment.
Various studies have focussed on M  tuberculosis gene expression in the hope of elucidating which 
genes are essential for bacterial survival under different growth conditions (Li et al, 1998; Camacho 
et al, 1999; Rodriguez et al, 1999; Ravn et al, 1999). A number of reports have demonstrated that 
certain genes are upregulated under conditions of stress and oxygen deprivation (Wayne and Hayes,
1996; Ravn et al, 1999; Mariani et al, 2000). However, as most of these experiments have focussed 
on genes required for in vitro growth or in animal model systems, it was still unknown whether 
these genes are expressed in vivo in the human host. The credibility of the in vitro synthetic 
cultures, especially, is becoming increasingly more questionable. A number of studies have reported
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that the nature of M. tuberculosis gene expression when analysed in artificial medium culture is 
proving to be erroneous (Segal and Bosch, 1956). Mariani and colleagues (2000) compared M. 
tuberculosis H37Rv gene-expression in synthetic medium and human macrophage with an 
interesting outcome. Of the M  tuberculosis genes analysed, only a few were found to be expressed 
in both environments, some genes were expressed only in the in vitro culture and others only inside 
the macrophage. Even synthetic M  tuberculosis cultures incubated at different conditions showed 
differential gene expression. Florczyk and colleagues (2001) identified mycobacterial proteins that 
were differentially expressed under standing and shaking conditions, thereby demonstrating that 
subtle differences in bacterial cultivation conditions may have important implications for the study 
of gene expression in mycobacteria.
Understanding the transcriptional activity of the bacilli within the tuberculous granuloma is still 
incomplete. We used the in situ hybridisation technique to identify mycobacterial mRNA within 
this restrictive environment. The advantage of using this technique is.that it allows for the analysis 
of gene expression of the infecting bacilli in its natural host. This has become an important aspect in 
tuberculosis research since in vitro conditions do not mimic the human in vivo environment; the 
upregulation o f genes in vitro may not reflect the regulation in vivo. Another advantage of this 
technique is that the morphology of the cells within the tissue sections is preserved, thus providing 
additional information concerning the site of gene expression within the tissue.
The rationale for the choice of genes was firstly to analyse M. tuberculosis specific sequences 
already known to be either involved in mycobacterial metabolism and were also key targets for anti­
tuberculosis drugs, viz. rpoB and katG. RpoB expression, the encoded protein being an essential 
component o f the RNA polymerase enzyme, was taken as an indication of transcriptional activity of 
the infecting bacilli (Sheperd et al, 1980). The expression of katG is a survival mechanism of the 
bacteria in response to reactive metabolites. The expression of certain potential persistence factors 
thought to contribute to the survival o f bacilli in host cells under conditions of stress (narX, icl, 
mbtB and re!km) was also analysed. Finally, the mycobacterial genes analysed in this study also 
i included two potential immunodominant antigens, viz. esat-6 and PPE Rv3018c. The functions of 
these proteins have not been fully elucidated.
The immunohistochemistry and in situ hybridisation staining techniques allows for the localisation 
of host cytokines and M  tuberculosis mRNA in the lymph node granulomas, thereby enabling the 
identification o f interactions between the host and pathogen within these tuberculous lesions.
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4.3 HOST CYTOKINE ANALYSIS
4.3.1 Expression of Type 1 Cytokines in Granulomas
In this study, IFN-y and TNF-a were detected in the lymph node granulomas of all six paediatric 
patients, including the treated patient. Our data confirms numerous other studies that reported an 
increase in IFN-y and TNF-a production in tuberculosis patients (Ogawa et al, 1991; Lin et al, 
1996; Taha et al, 1997; Fenhalls et al, 2000). Gamma-interferon in combination with TNF-a 
enhances the antimycobacterial activity o f macrophages and is involved in granuloma formation 
(Sokal, 1975; Barnes et al, 1990; Kindler et al, 1989; Pearlman et al, 1993). Our data contrasts with 
the study of Aung and colleagues (2000) who reported an absence of TNF-a and IFN-y in 
granulomatous lung lesions of adult tuberculosis patients.
Interleukin-12 was suggested to be a central initiator of the local Thl response in tuberculosis, with 
a crucial role in stimulating IFN-y production by T lymphocytes (Abbas et al, 1996; Zhang et al, 
1994). Previous studies reported that active tuberculosis disease in adults was associated with 
increased EL-12 production that was generally associated with the cell mediated immunity response 
(Lin et al, 1996; Taha et al, 1997). In this study IL-12 was detected in the lymph node granulomas 
of all six patients. However, the number of IL-12 positive granulomas detected between the patients 
was inconsistent. In another primary tuberculosis study, Aubert-Pivert and colleagues (2000) 
observed an increase in IFN-y and TNF-a production, as well as a reduced expression of IL-12 in 
active tuberculosis patients. Additionally, mice with disruption of EL-12 cytokine signaling were 
unable to restrict the growth o fM  tuberculosis and succumbed to infection (Cooper et al, 1997). In 
humans, deficiencies of the IL-12 receptor were reported to be associated with a predisposition to 
mycobacterial infection (Altare et al, 1998). It was suggested that this cytokine might provide a 
crucial link between the two cell populations o f protective immunity, i.e. mononuclear phagocytes 
and T lymphocytes (Cooper et al, 1995). Therefore, depressed IL-12 production as seen in certain 
granulomas, could lead to inhibition of macrophage activation, and thereofore might be involved in 
the immunopathogenesis of human active tuberculosis.
*
V
4.3.2 Expression of Type 2 Cytokines in Granulomas
Although elevated levels of type-1 cytokines IFN-y and TNF-a were present in the lymph node 
granulomas, an overall ThO cytokine pattern was predominant at this site of infection. Only a 
limited number o f granulomas had an overall Thl phenotype. The ThO pattern was the result of 
elevated levels o f type-2 cytokines present in the granulomas, particularly EL-4. This result is 
consistent with prior reports demonstrating heterogeneity in the pattern of cytokines produced in
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response to M. tuberculosis (Bergeron et al, 1997; Somoskovi et al, 1999; Fenhalls et al, 2000; 
Aubert-Pivert et al, 2000). Although in our study, much higher levels of IL-4 were detected in the 
children lymph node granulomas. This data goes against the dogma of type-1 / type-2 cytokine 
expression where it is believed that type-1 cytokines are expressed during the protective phase, and 
a switch is later made to the expression of type-2 cytokines during the resolution phase once the 
infection is under control. Instead of being in a complete protective type-1 phase, or conversely, in a 
complete type-2 resolution phase, there appears to be a balance in the immune response to M  
tuberculosis infection. Interestingly, this balance balance is maintained during the early phase of 
treatment with anti-tuberculosis drugs.
It is generally accepted that a type-2 cytokine expression relates to unfavourable disease outcomes. 
Although, it is still unclear whether this association is a cause or consequence of disease, since the 
functional role for type-2 cytokines in tuberculosis remains speculative. It is possible that high 
levels o f IL-4 and IL-10 are associated with a lower level of resistance to M. tuberculosis. The 
overproduction of the immunosuppressive cytokine IL-10 could reduce the expression of IL-12 and 
inhibit macrophage activation, thereby limiting the development of a protective Thl response 
(Aubert-Pivert et al, 2000). Van Crevel and colleagues (2000) investigated the production of IL-4 in 
patients with tuberculosis in relation to disease severity. Their findings suggested that the type-2 
response with increased production in IL-4 might antagonize host defense and lead to tissue 
necrosis. In an in vitro study Henmandez-Pando and colleagues (1994) reported that TNF-a 
mediated necrosis occurred only in the presence of a mixed ThO response. In contrast, a Thl 
response at the inflammatory site prevented TNF-a mediated damage, whereas a Th2 response 
promoted tissue damage.
Alternatively, the purpose of type-2 cytokine expression could be to minimize local tissue damage 
by downregulating production of Thl cytokines. One possible mechanism of reducing an excessive 
Thl response would be to inhibit the production of IL-12 (D’Andrea et al, 1993). It has been 
hypothesised that an excessively high localised production of TNF-a may be responsible for tissue 
necrosis (Law, 1996). Caseous necrosis results from the killing of macrophages as a result o f the 
tissue damaging delayed-type hypersensitivity response (DTH). Jacobs and colleagues (2000) 
reported an enhanced DTH response in the absence of IL-10. Also, in a study that analysed the 
cytokine pattern in tuberculous lung granulomas of haemoptysis patients, a predominant Thl 
response was observed (Fenhalls et al, 2000). Fenhalls and colleagues reported that a distinction in 
disease progress could not be established between the haemoptysis patients who presented with a 
clear Thl cytokine pattern, to those who also presented with a ThO pattern of cytokine expression.
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This study thus questions the concept of IL-4 expression in tuberculosis patients being indicative of 
an unfavourable disease outcome. We suggest that the presence of IL-4 might be an integral feature 
in containing tissue destruction. Therefore, type 2 cytokines might play a vital role in controlling an 
excessive Thl response that might otherwise have lead to extensive tissue-damage. It is possible 
that the excessive levels of type-2 cytokines, particularly IL-4, detected in the lymph node tissue of 
the six children in this study could be an important element in the rationale as to why cavitation 
rarely occurs in paediatric tuberculosis. It could help clarify why children with tuberculosis cure 
spontaneously.
4.3.3 Interplay between Host Cytokines
Comparison of the cytokine patterns enabled us to identify correlations in expression between 
specific cytokines. The stratification of the granulomas into EL-4 negative and EL-4 positive 
subgroups allowed for the cytokine expression profiles to be statistically evaluated. Previous studies 
have shown that IL-4 induces a type-2 response, which includes the production of IL-10 (Swain et 
al, 1988; Kopf et al, 1993). It was therefore not surprising to find a significant correlation in the 
expression o f EL-4 and IL-10 (p = 0.0000006). EL-10 only occurred in IL-4 positive granulomas. 
There were no correlations observed between IL4 and any of the type-1 cytokines, since the 
expression o f IFN-y, TNF-a and IL-12 occurred proportionally in both IL-4 positive and negative 
granulomas.
The co-ordinated expression pattern observed between IL-10 and IL-12 was however statistically 
significant (p = 0.021). Lin and colleagues (1996) previously reported the production of both IL-12 
and IL-10 in lymph node tissue from tuberculosis patients. These investigators found that 
macrophages rather than Th2 cells produced IL-10. This anti-inflammatory cytokine has a 
regulatoiy affect on EL-12, and hereby the type-1 response on a whole (Hseih et al, 1993; Fulton et 
al, 1998). D’Andrea and colleagues (1993) showed that EL-10 inhibits lymphocyte EFN-y 
production by suppressing IL-12 synthesis in accessory cells. It is possible that IL-10 expression 
attenuates the type-1 cytokine response, limiting tissue damage (Barnes et al, 1990).
Stratification o f granulomas also allowed the identification of the significant association between 
IL-10 and TNF-a (p = 0.0054). Interestingly, a correlation was identified between both these 
cytokines and the presence of caseous necrosis. The majority of the necrotic granulomas stained 
positive for IL-10 (p = 0.000046), a cytokine that had been previously implicated with tissue 
damage. The exact role of IL-10 in the development of necrosis is still unclear, although numerous
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contrasting hypotheses exist about this enigmatic cytokine (Lin et al, 1996; Brown et al, 2000; 
Fortsch et al, 2000). As with IL-12, it could be argued that the expression of IL-10 prevents an 
intense, and potentially destructive type-1 response (Barnes etal, 1990), thereby preventing further 
necrosis. Conversely, one could also speculate that IL-10 is in fact, detrimental to the host by 
augmenting or initiating tissue damage. Hemandez-Pando and colleagures (1994) showed that TNF- 
a  mediated tissue damage only occurred in the presence of type-2 cytokines, including IL-10. The 
association was also demonstrated between the expression of TNF-a and the presence of caseous 
necrosis (p = 0.0041). Previous studies have also implicated this inflammatory cytokine as an 
important factor in the development of tissue damage (Barnes et al, 1990; Law, 1996).
4.4 M. TUBERCULOSIS DETECTION IN HOST TISSUE
The -DNA:DNA in situ hybridisation technique was used to identify mycobacterial DNA within the 
restrictive granuloma environment. In this study, mycobacterial DNA was detected in the lymph 
node biopsy tissue of all six patients. Acid-fast bacilli were detected by ZN staining in only five of 
the six biopsy specimens, however, since the ZN-negative tissue (L4) yielded a positive BACTEC 
M  tuberculosis culture, it indicated that the hybridisation signal observed was due to bacilli present 
in the tissue and was not an artefact of methodology. The reproducibility of the in situ staining 
further confirms the validity of the technique. Although this observation was seen in only one 
patient, it is possible that DNA:DNA in situ hybridisation is detecting cell wall deficient forms of 
M. tuberculosis that cannot be ZN stained. The absence of acid-fast bacilli could suggest that these 
latent bacilli have entered an altered state in which they are no longer acid-fast (Gillespie et al, 
1986). Alternatively, one could assume that the bacilli remained acid-fast, but were in such low 
numbers that they were undetectable when using a technique with poor sensitivity such as ZN 
staining (Heifets, 1997). Both possible rationales suggest that DNA:DNA in situ hybridisation is 
more sensitive than ZN staining for the detection of M  tuberculosis in tissue specimens and 
therefore in future could be an important adjunct in the diagnosis of tuberculosis.
Mycobacterial DNA was detected in ninety-five of the one hundred and seven granulomas 
identified. The hybridisation signal for the DNA probe was detected in every necrotic granuloma, 
but absent in twelve of the non-caseating granulomas. It is possible that, in these granulomas, the 
bacilli was present in such low numbers in the early stage of infection that the in situ hybridisation 
technique, although seemingly more sensitive than the standard ZN staining, was not quite sensitive 
enough to detect this very low number of bacilli. Alternatively, one could assume that the negative
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granulomas are “healed” environments where the bacilli were successfully eliminated by the host 
immune response. Another possibility could be the result of the intense cytokine milieu observed in 
all the tissue specimens which caused a cascade event that resulted in granuloma formation in a 
"bacilli-free" lymph node region.
4.5 M. TUBERCULOSIS GENE EXPRESSION ANALYSIS IN THE GRANULOMA
The presence o f mycobacterial DNA can be interpreted as either viable bacilli or microbial debris. 
RNA:RNA in situ hybridisation was done, using various antisense riboprobes, to identify 
transcriptionally active mycobacteria in the lymph node granulomas. Hybridisation signals using the 
various riboprobes only localised to granulomas associated with mycobacterial DNA. It is generally 
believed that each granuloma in any given organ represents a unique environment (Dannenberg, 
1994). Therefore, the varying conditions in the granulomas would influence the mycobacterial gene 
expression differently. The data obtained in this study supports this concept.
4.5.1 Metabolic Factors: Important Factors for Current TB Therapy
4.5.1.2 RpoB
An antisense RNA probe was developed to identify bacilli actively expressing the rpoB gene as a 
measure o f  active growth (Sheperd et al, 1980), since this gene encodes RNA polymerase p subunit 
and is required for gene transcription. The results of the in situ hybridisation demonstrated the 
spatial location o f the bacilli in the granuloma as well as differentially identifying bacilli actively 
expressing rpoB.
In this study, rpoB mRNA was detected in only five of the six patients with established 
tuberculosis. In contrast, messenger RNA for rpoB was not detected in any of the lymph node 
granulomas o f  patient L2, who had been treated with rifampin two days prior the biopsy. The 
absence o f signal in the granulomas of this patient, as well as in the negative (rpoB) granulomas in 
the five untreated patients, could be attributed to very low levels of rpoB mRNA in those 
microenvironments. Since the RNA polymerase P subunit is essential for M  tuberculosis 
transcription, the presence of this protein cannot be excluded, as inhibition of transcription will 
certainly be bacteriocidal. It is thus possible that the levels o f rpoB mRNA was below the detection 
level o f  the in situ hybridisation technique. Interestingly, the two groups of patients (treated and 
untreated) represent different scenarios; the cause for the reduction of rpoB expression in these
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patient groups might therefore differ. The downregulation of rpoB transcription in the untreated 
patients could be the bacterial response to the onslaught of the host immune response which could 
have affected the bacterial growth phase. This notion is supported by a comparative study where 
Mariani and colleagues (2000) detected a change in the M  tuberculosis rpoB gene expression 
between the infected, non-activated macrophages and those macrophages activated with IFN-y and 
LPS. In contrast, in the treated patient (L2), it is possible that combination of host environment and 
anti-tuberculosis drugs has affected the transcriptional activity of the bacilli. Therefore, the 
reduction in rpoB transcription observed in the granulomas of patient L2 could be a survival 
response mechanism to the rifampin, where the bacilli downregulated the expression of the target 
protein. Alternatively, since the transcription of survival genes occurred in these rpoB negative 
granulomas, we may assume that stable forms of the RpoB protein are present and, therefore, the 
bacilli does not need to transcribe it very often.
Significantly,., no rpoB expression was detected within the-necrotic regions of the positive 
granulomas, but only occurred in macrophages at the central region and periphery of non-necrotic, 
and only in the periphery of granulomas containing caseous necrosis. The necrotic regions are 
presumably very restrictive in nutrients and oxygen, and would therefore have a suppressing effect 
on the M  tuberculosis growth phase and therefore gene expression, more so for the gene involved 
in active growth transcription. Hu and colleagues (1998) reported that the conditions in the 
microaerophillic environments had a suppressing effect on bacterial gene expression. Therefore, the 
fact that rpoB mRNA was found in macrophages in the periphery and not within the necrosis could 
suggest that the bacillus is more transcriptionally active in the macrophages than in other, more 
restrictive areas of the granuloma.
4.5.1.3 katG
The results o f  the in situ hybridisation using the rpoB riboprobe provided evidence that this 
technique could be used to identify genes required for survival within the hostile environment o f the 
human granuloma. The katG hybridisation signals, as with rpoB, were only detected in the 
granulomas of the five untreated patients, with patient L2 again being the exception. This suggests 
that the absence of katG signal in the treated patient L2 could be attributed to, as with rpoB, the 
combination o f the onslaught of the host response and the anti-tuberculosis drugs. This patient was 
also treated with isoniazid, a pro-drug that requires oxidative activation of the catalase peroxidase 
enzyme before exerting a lethal effect. It can therefore be assumed that, as a response to anti­
tuberculosis treatment, the bacilli downregulated the katG expression to levels too low to be
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detected using the in situ hybridisation technique. However, unlike rpoB protein, the catalase 
peroxidase enzyme is not essential for survival. It was also suggested that other proteins, such as the 
AhpC protein, confers protection against hydrogen peroxide mediated damage even in the absence 
of adequate catalase and peroxidase activities (Sherman et al, 1996).
There is a clear variability in expression for katG in the untreated patients. In patients LI, L6 and 
especially L5, the number of katG positive granulomas was elevated. It seems that the host immune 
response did not have much of an inhibiting effect on the transcription of this gene in the 
granulomas of these three patients. In a comparative gene expression analysis between non- 
activated and IFN-y-LPS activated macrophages, katG was one of the few genes that was expressed 
in both these environments (Mariani et al, 2000). It does however appear that the host response in 
patient L3 and L4 was more successful in limiting katG expression. Unlike the three former 
patients, patients L3 and L4 presented fewer katG positive granulomas. One could speculate that the 
low levels of katG detected in these patients could be correlated to the specific M. tuberculosis 
strain infecting these patients. The 756110 typing of the M. tuberculosis clinical isolates revealed 
that these strains were all genotypically unrelated. The objective of DNA fingerprinting the isolates 
was to show that there are different strains involved that may have different expression profiles. We 
therefore cannot exclude the possibility that these clinical strains exhibit different levels of katG 
expression. The reduction in catalase peroxidase activity would not necessarily affect the virulence 
of the infecting strain (Jackett et al, 1978a; O’Brien et al, 1991). It was reported that low levels of 
katG transcription in certain M  tuberculosis strains was compensated by an upregulation of the 
alkyl hydroperoxide reductase (AhpC) protein, encoded by the ahpC gene (Heym et al, 1999), 
which was shown to also mediate resistance to oxidative metabolites. Therefore, M. tuberculosis 
strains with loss of KatG activity could still cause disease.
The katG hybridisation signals detected in the granulomas of the untreated patients were detected in 
the central region and periphery of the non-necrotic granulomas. Also, mRNA for this gene was 
associated with the necrotic regions of the granulomas. This confirms that these bacilli are indeed 
viable cells, and not bacterial debris. It also illustrates that these bacteria are able to adapt to the 
onslaught of reactive oxygen and nitrogen metabolites within the different microenvironments of a 
granuloma.
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4.5.3 Persistence Factors
Numerous studies that have identified genes that are required for persistent tuberculosis infection. 
These genes may be ideal targets for new drugs against M. tuberculosis, since the current anti­
tuberculosis drugs are effective only against actively replicating cells.
To understand how certain genes could influence growth, four genes encoding potential persistent 
factors narX, icl, mbtB and relMtb, were analysed in the lymph node granulomas. Messenger RNA 
for all these genes were detected in the six patients, including the treated patient, L2. Unlike the 
metabolic factors rpoB and katG, there was no distinction in the expression of these genes between 
the untreated patients and treated patients with variability in M. tuberculosis gene expression 
observed in the different granulomas of each individual patient.
4.5.2.2 narX
The narX gene product, a transmembrane protein, has been associated with nitrate reduction during 
anaerobiosis (Cole et al, 1998). In all six patients, narX was found to be associated mostly with 
necrotic granulomas. A significant association was observed between narX and the presence of 
necrosis (p = 0.0062), which suggests that the necrotic granulomas are depleted of oxygen and 
would thus induce the bacteria to adapt by expressing components needed to survive anaerobiosis.
Bacilli expressing narX were detected at the periphery and within the necrotic region of the 
granuloma. The necrotic microenvironment of the granuloma is assumed to be more restrictive, 
especially regarding oxygen availability. However, the expression of narX in the periphery of the 
granuloma suggests that the bacilli residing in the non-necrotic regions of the granulomas are also 
experiencing oxygen deprevation. The expression of this gene was reported to be associated with 
adaptation to the persistent state of the bacilli; one can assume that those granulomas positive and 
negative for narX  could be correlated to different growth phases (Hutter and Dick, 2000).
An alternative explanation could be that narX is not mandatory for anaerobic respiration. The M  
tuberculosis genome project revealed the presence of a number of genes, the products of which 
might be involved in anaerobic respiration and fermentation (Cole et al, 1998). Bacteria are able to 
distinguish the environment in which their replication occurs, and would therefore respond 
differently in terms of gene expression. Since narX expression in mycobacteria has to date only 
been analysed using in vitro systems, it is possible that several other factors might be involved in 
anaerobiosis adaptation in the human host, and were overlooked using these in vitro models In an
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in vitro comparative expression analysis of 23 candidate anaerobic respiratory genes, narX was 
surprisingly the only gene to be upregulated in the anaerobic cultures (Hutter and Dick, 2000). 
Therefore, it is highly probable that narX might not be the ideal solitary marker for monitoring the 
persistence response in tissue, as was suggested by Hutter and Dick (2000).
4.5.2.3 icl
Isocitrate lyase (ICL), an essential enzyme for catabolism of fatty acids, was reported to be required 
for persistence of the tubercle bacilli during the chronic phase of infection in mice (McKinney et al, 
2000).
Hybridisation signals for icl, as with narX, were mostly associated with necrotic granulomas, and 
were also detected within the caseous necrosis. The necrotic environment is likely to be lipid rich 
and mycobacteria are well endowed with suitable enzymes for utilizing lipids as a sole carbon 
source (Cole et al, 1998). Therefore, it is likely that lipid metabolism plays an essential role in
maintaining mycobacterial viability in the absence of robust growth.
)
It has been speculated that icl expression is induced during the initial phase of infection in response 
to the immune response, but is then downregulated during the subsequent phase of infection. 
McKinney and colleagues (2000) also reported that icl was dispensable for bacterial growth in the 
acute phase of infection, but was more important for survival of M. tuberculosis in the lungs of 
mice during the persistent phase. Therefore, the absence of signal in the negative granulomas, 
especially the non-necrotic granulomas, could be the result of the specific phase of infection. 
Alternatively, it could be a response to the host environment prior to the immune response. 
However, the number of icl positive granulomas was generally low, with the exception of patient 
L5, when compared to the expression using the mouse model. The difference between icl 
expression in the human host and animal model systems could be the result of the plasticity of M  
tuberculosis in sensing the environment (including the host immune response) and consequently 
adapting different survival strategies.
4.5.2.4 mbtB
Many pathogenic bacteria secrete iron-chelating siderophores, mycobactins, in the iron-limiting 
environments of their vertebrate hosts. Iron is thought to be an essential metal for various bacterial 
metabolic processes, including growth. MbtB transcripts, unlike the other persistent factors
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analysed, were not detected within the necrotic region, and was limited to the less restrictive 
periphery and lymphocyte cuff region of the granulomas. The importance of iron for bacterial 
metabolism has been demonstrated using an A  mbtB mutant defective for synthesis of high affinity 
siderophores (De Voss et al, 2000). These mutant strains were unable to replicate in cultured 
macrophages. The absence of mbtB signal in the granulomas, could be the result of a very low mbtB 
transcription rate which could be an indication of a slow bacillary growth phase in these 
microenvironments. Alternatively, one could speculate that the negative mbtB granulomas are iron- 
rich environments, which would result in repressed mbtB expression. This notion is supported by 
Gold and colleagues (2001) who showed that mRNA levels of mbtB were induced in M  
tuberculosis cultures starved of iron, but was repressed in iron-rich environment. The transcription 
of mbtB is controlled by IdeR regulator protein that acts as a transcriptional repressor of mbtB.
4.5.2.5 relMtb
Nutrient deprivation, in the form of amino acid and carbohydrate depletion, is likely to coincide 
with the formation of intact granulomas in a process thought to be essential for curtailing growth of 
the microorganism (Cunningham and Spreadbury, 1998). Bacteria adapt to nutritional stress for 
their survival, predominantly through a mechanism termed the stringent response, the hallmark of 
which is the accumulation of ppGpp (Bremer and Ehrenberg, 1995), also called the stringent factor. 
RelM,b ppGpp synthase, encoded by the relMtb gene, is therefore an essential enzyme in the stringent 
response.
RelMtb mRNA localised in the granuloma periphery and lymphocyte cuff region. Hybridisation 
signal was also associated with the nutrient restrictive, necrotic region of the granulomas. This 
environment is assumingly more restrictive in nutrients than the rest of the granuloma and the 
presence of relMtb in the necrosis therefore suggests that the bacilli are capable of adapting to the 
nutrient deprivation. It is possible that the granulomas not staining positive for relMtb could be 
negative as a result of very low levels of mRNA transcripts. This reduction of relMtb expression 
could be a result of the host environment, i.e. the conditions experienced by bacilli in those 
particular granulomas have a repressing effect on relMtb expression.
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4.5.4 Mycobacterial Genes of Unknown Function
4.5.4.1 esat-6
The ESAT-6 antigen has attracted considerable interest in recent years, as it is recognized early 
during infection. The function of this protein, however, remains to be elucidated. Similarly to the 
persistent factors, variability in esat-6 expression was observed in the lymph node granulomas. 
Hybridisation signal for this gene was detected in only four of the six patients, including the treated 
patient (L2). Given that expression of this gene is associated with early infection, the absence of 
esat-6 mRNA in the two untreated patients suggest that these granulomas are in an advanced phase 
of infection. Conversely, the majority of granulomas for patient LI stained positive for esat-6 could 
be indicative of an early infection. Alternatively, the inconsistency in the expression of esat-6 
observed between the individual patients could be correlated to the genotypically unrelated 
infecting strains. It is possible that the M  tuberculosis clinical isolates of patients L4 and L5 simply 
did not express this protein at all.
The hybridisation signal for esat-6, in the four patients, was never detected within the necrotic 
region of the granulomas. This suggests that esat-6 is not essential for survival in the restrictive 
necrotic microenvironment, and therefore not required for persistence.
4.5.4.2 PPE (Rv3018c)
The functions of PPE proteins have not yet been established, although numerous hypotheses exist. 
The PPE gene Rv3018c was suggested to attribute to bacterial survival in the host macrophage 
(Camacho et al, 1999). Variability in the expression of this gene was also observed in the six 
patients, and was one of the genes transcribed in the necrotic regions of granulomas. This suggests 
that the encoded PPE protein might be required for survival in the restrictive necrotic 
microenvironments, thereby implicating the gene as a potential persistence factor.
4.5.5 Interplay of Mycobacterial Genes
To investigate the interplay between the host environment and the expression of M. tuberculosis 
genes, the granulomas were stratified and submitted for statistical assessment.
In this study no significant correlation could be demonstrated between rpoB expression and any 
other mycobacterial gene. A number of significant correlations were observed with the stratification 
of granulomas according to katG expression. Firstly, katG and icl were found to be co-expressed in
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most of the granulomas (p = 0.008). One could speculate that the activated macrophage 
environment in these granulomas, not only induced katG expression, but also the glyoxylate shunt 
pathway. The expression of katG in response to the host onslaught of reactive oxygen and nitrogen 
species also coincides with the expression of relMtb, an essential component in generating the 
stringent response (p = 0.0106). A significant correlation was also observed between katG and PPE 
RV3018c (p = 0.008). It is unclear whether the production of reactive species induced the 
expression of PPE, as it most probably did katG, or if any coinciding environment factor(s) induced 
the expression of this gene.
A significant co-expression correlation was observed between icl and narX (p = 0.00003). This 
suggests that the depletion of oxygen, indicated by the expression of narX, coincides with lipid 
metabolism in the bacilli, as indicated by the expression of the glyoxylate shunt enzyme icl. This 
confirms the previous study by Wayne and Lin (1982) who noted that glyoxylate shunt enzymes 
were activated during the metabolic downshift that accompanies oxygen withdrawal. Lipid 
metabolism in granulomas also coincided with the production of ppGpp, the stringent factor. This is 
indicated by the significant co-expression correlation observed between icl and relMtb (p = 0.00003). 
It is possible that the stringent response could have induced icl expression as part of the bacteria’s 
survival strategy to adapt to nutrient restrictive conditions. One can thus assume that co-ordinated 
expression of katG, relMtb and icl occurred. However, there was no correlation identified in the 
expression between katG, relM,b and narX. We suggest that the varying condition in the individual, 
unique granulomas lead to subpopulations of bacilli, i.e. the various phases of bacillary growth 
observed was induced by the environment. The subpopulations of bacilli observed in the 
granulomas either exhibited a co-ordinated expression pattern of the katG, relmb and icl genes, or 
alternatively, a co-ordinated expression pattern between icl and narX.
Icl was also found to have an opposite expression pattern to that of esat-6 (p -  0.043). This suggests 
that these genes were expressed at different stages of infection. The esat-6 antigen is apparently 
expressed primarily during the early phase of infection, whereas icl was reported to be required only 
during the chronic phase of infection.
Esat-6 expression also occurred inversely to that of mbtB (p = 0.026). This also suggests that these 
mycobacterial genes are required at different phases of infection. It could be that iron-chelators are 
required in a later stage of infection when this metal becomes limited.
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4.8 INTERPLAY OF HOST CYTOKINES AND MYCOBACTERIAL GENES
122
In order to determine if any correlations existed between the host response and mycobacterial gene 
expression the host cytokine data was stratified together with the mycobacterial gene expression 
data. The knowledge on how the cytokine and mycobacterial gene expression affect each other is 
very limited. Cappelli and colleagues (2001) found that the activation of macrophages resulted in 
the upregulation of some mycobacterial genes, and the downregulation of others. However, 
different results were obtained with the use of different M. tuberculosis strains.
In this study we observed a significant association between a ThO cytokine profile and the 
expression of mbtB (p = 0.0012). It is possible that the simultaneous expression of the type 1 and 
type 2 cytokines could have resulted in the reduction in iron availability. This association was the 
result of the co-ordinated expression between IL-4 and mbtB (p = 0.005). Therefore, one could 
argue that the IL-4 cytokine induced environments lead to the expression of the mycobactin 
biosynthetic enzyme.
As previously discussed, the bacteria adapts to the adverse host conditions by the stimulation of the 
stringent response, which results in the production of ppGpp by the relMtb protein. An opposite 
expression pattern was detected between relMtb and IL-12 (p = 0.0037). This suggests that the 
expression of IL-12 results in a more favourable host environment for the infecting bacilli. 
Conversely, a significant correlation was observed between IL-12 and esat-6 (p = 0.043). This type
1 inducing cytokine and the mycobacterial antigen-encoding gene are presumably both expressed 
primarily during the early phase of infection.
4.8.1 Stratification According to Passive and Active Transcription
The granulomas were firstly stratified according to transcriptional activity based on the presence or 
absence of rpoB in the granulomas, which was followed by subsequent stratification according to 
the absence or presence of host cytokines. This was performed in order to assess whether the 
different transcriptional activity of the bacilli, and presumably the different growth phase, resulted 
in different correlations between the mycobacterial genes and host cytokines.
As with the single stratification analysis, a significant correlation was identified in the passively 
transcribing granulomas between mbtB and an overall ThO cytokine profile (p = 0.020) and was 
therefore also detected in expression between IL-4 and mbtB (p = 0.020). It would appear that the
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expression of both type 1 and type 2 cytokines only affected the transcription of mbtB in the 
passively transcribing bacteria.
Unlike IL-4 and mbtB, an opposite expression correlation was observed between IL-12 and relMtb- 
Furthermore, this trend was observed in both the rpoB negative (p = 0.05) and rpoB positive (p = 
0.021) granulomas. Therefore, this correlation occurred irrespective of the transcriptional activity, 
and presumably the growth phase of the bacilli.
In the actively transcribing granuloma subgroup, the katG expression was associated with an overall 
ThO cytokine profile (p = 0.049), and more specifically with IL-4 expression (p = 0.049). It would 
appear that IL-4 expression contributed to the expression of katG only in the actively transcribing 
bacilli.
An interesting correlation observed in the rpoB positive granulomas was that between IL-10 and 
narX (p = 0.026). This cytokine and mycobacterial gene was co-expressed in most granulomas, but 
what makes this correlation interesting is the fact that both IL-10 and narX displayed an association 
with caseous necrosis, and were expressed predominantly in necrotic granulomas.
Another unique correlation observed in the rpoB positive granulomas was the opposite expression 
pattern between IL-12 and mbtB (p = 0.035). Granulomas positive for IL-12 were apparently less 
restricted in iron, hence the downregulation of mbtB, which is required for the synthesis of 
mycobactins, the iron-scavengers. A correlation observed with the single stratification and also 
detected in the rpoB positive granulomas, was the co-expression pattern between IL-12 and esat-6. 
This suggests that these granulomas are at the initial stages of infection, since this cytokine and 
mycobacterial gene are presumably expressed predominantly in the early phase of infection, and 
also the fact that these are actively transcribing bacilli.
4.9 SPATIAL ARRANGEMENT OF MYCOBACTERIAL mRNA
Dannenberg and colleagues (1994) suggested that the development of tuberculosis disease from its 
onset to its various clinical manisfestations be pictured as a series of battles between host and 
invader. They suggested that in any given organ, each tuberculous granuloma is independent, i.e. 
each granuloma (or even parts of larger granulomas) may be engaged in any battle in this series, 
regardless of which battle the other tuberculous granulomas (or parts) are engaged in. The spatial
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regardless of wliich battle die other tuberculous granulomas (or paris) are engaged in. The spatial 
arrangement of mRNA transcripts for the various genes observed in this study confirms die 
hypothesis that different microenvironments exist within a single granuloma. In the analysis of 
signal localization, detailed spatial arrangement of the various gene transcripts in relation to one 
another in the granulomas was not done. However, generally, variations in the signal pattern of the 
riboprobes in the granulomas were observed. Figure 4.1 is a schematic illustration of the variation 
of signaling patterns observed in uie granulomas. The expression, ot talhet, die grouped expression 
of certain genes did not always occur in the same regions of the granulomas.
Future prospects would therefore include a more detailed analysis of the spatial arrangement of the 
various genes in the granulomas, and implementing a more sensitive means of scoring the 
hybridisation signals that would hopefully allow us to measure the varying staining intensities for 
the individual genes. This then could be correlated to the spatial arrangement of RNA transcripts in 
the granulomas.
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Figure 4.1. Schematic Diagram Illustrating Spatial Arrangements of M. tuberculosis Gene 
Expression in the Lymph Node Granulomas
43 SUMMARY OF RESULTS OF THE PRESENT STUDY
Comparing the cytokine profiles for the six patients, we observed a predominant ThO response in 
the lymph node granulomas. This implies that there is a balance between type i and type 2 
cytokines, and therefore goes against the dogma of a type 1 response during ihe initial protective 
phase and a type 2 response during the resolution phase This balance was maintained during the 
initial phase of treatment (2 days).
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Stratification of the cytokine data allowed us to identify various statistically significant associations 
between the host cytokines. A co-ordinated expression correlation was observed between IL-4 and 
IL-10 (p = 0.0000006), IL-10 and IL-12 (p = 0.021) and between IL-10 and TNF-a (p = 0.0054). 
The latter enzymes, viz. IL-10 and TNF-a, were also significantly associated with the presence of 
caseous necrosis in the granulomas (p = 0.000046 and p = 0.0041, respectively).
In our study, mycobacterial DNA was detected in 6 patients using in situ hybridisation. In contrast, 
only 5 of the 6 patients were positive for acid-fast bacilli using standard ZN staining. Although this 
observation was seen in only one patient, it is possible that DNA:DNA in situ hybridisation is more 
sensitive than the ZN staining for the detection of M. tuberculosis in tissue sections.
The analysis of mycobacterial gene expression in the lymph node granulomas of the treated patient 
allowed us to observe a rapid response of bacilli to the anti-tuberculosis drugs, received over a 
period of only two days. Interestingly, the drug targets of rifampin and isoniazid, i.e. the gene 
products of rpoB and katG, respectively, were drastically downregulated to, presumably, elude the 
lethal effects of these drugs.
The presence of mRNA transcripts of certain genes within the necrosis confirms that the 
mycobacterial DNA detected in the necrosis is not just bacterial debris, but transcriptionally active 
cells. It also illustrates that these bacilli are adapting to the anoxic, acidic and nutrient restrictive 
necrotic microenvironment. However, the absence of rpoB mRNA, as well as mbtB mRNA in these 
regions suggests that these bacilli are in a non-replicating phase, since the expression of rpoB is a 
measure of actively growing bacilli, and mbtB is involved in iron uptake, a metal required for 
bacterial growth. This suggests that the development of caseous necrosis was thus successful in 
inhibiting bacterial growth.
Statistical assessment of the mycobacterial gene expression data allowed co-ordinated expression 
correlations to be identified between katG and icl (p = 0.008), katG and relMtb (p = 0.0106) and 
between icl and relMtb (p = 0.00003). It appears that a co-ordinated expression pattern of these three 
mycobacterial genes occurred. A co-ordinated expression pattern was also identified between katG 
and PPE Rv3018c (p = 0.008) and between icl and narX (p = 0.00003). An inverse expression 
pattern was observed between esat-6 and icl (p = 0.043) and between esat-6 and mbtB (p = 0.026). 
A significant association was observed between the expression of narX and the presence of caseous 
necrosis (p = 0.0062). This mycobacterial gene was predominantly expressed in granulomas 
containing necrosis.
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The stratification of M. tuberculosis gene expression data clearly illustrates the existence of 
subpopulations of bacilli in the individual granulomas. Specifically, the varying environments 
induced different phases of bacillary growth and transcriptional adjustment for survival. 
Furthermore, the spatial arrangement of mRNA transcripts for the various genes observed in this 
study confirms the hypothesis that different microenvironments, and therefore different 
subpopulations, exist within a single granuloma.
The stratification of the combined host cytokine and mycobacterial gene expression data revealed a 
significant association between a ThO cytokine profile and the expression of mbtB (p = 0.0021), 
which was the result of the co-ordinated expression pattern between IL-4 and mbtB (p = 0.005). A 
co-ordinated expression correlation was also observed between IL-12 and esat-6 (p = 0.043), and an 
inverse expression pattern between IL-12 and relMtb (p = 0.005).
Stratifying the data according to mode of transcription (passive vs active), allowed us to identify a 
significant association between a ThO cytokine profile and mbtB expression (p = 0.020), as well as 
between IL-4 and mbtB (p = 0.020) in the rpoB negative (passive transcription) subgroup. An 
inverse expression pattern was identified between IL-12 and relMtb in both the rpoB negative (p = 
0.05) and rpoB positive (p = 0.021) subgroups. In the rpoB positive granulomas, a significant 
expression pattern was identified between a ThO cytokine profile and katG expression (p = 0.049), 
and a co-ordinated expression correlation between IL-4 and katG (p = 0.049). A co-ordinated 
expression pattern was also identified between IL-10 and narX (p = 0.026), and an inverse 
expression pattern between IL-12 and mbtB (p = 0.035).
4.9 THE FUTURE OF THIS RESEARCH
The immediate objective for this project is to recruit more patients. The study subjects would 
include untreated and treated patients, as well as a series of patients at various phases of treatment 
in order to analyse and compare the bacterial gene expression in response to the host immune 
response and chemotherapeutic agents. It will also be interesting to determine the influence of 
prolonged treatment on the Thl/Th2 balance.
The aim of DNA fingerprinting the isolated M  tuberculosis clinical strains was to determine 
whether a specific gene expression profile, and possibly also the host cytokine response could be 
correlated to a specific strain type. This was not possible with our limited sample size in which all
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the isolates were genotypically unrelated. A larger sample size may provide insights into the 
relationship between genotype and phenotype.
Future prospects for this research would also include a more detailed analysis of the spatial 
arrangement of the various mycobacterial genes and host cytokines in the granulomas; also the 
implementation of a more sensitive means of scoring the signals that would allow the varying 
staining intensities for the individual genes and cytokines to be accurately quantitated. This then 
could be correlated to the spatial arrangement of both RNA transcripts and cytokines in the 
granulomas.
A primary goal in tuberculosis research is the identification and characterisation of M  tuberculosis 
genes thought to be potential candidates in the develoment of new anti-tuberculosis drugs and 
vaccines. The techniques used in this study could be used to analyse the expression of these novel 
genes in the host tissue. Therefore, this type of study has tremendous potential since it allows us to 
decipher factors controlling gene expression in the human granuloma.
127
Stellenbosch University http://scholar.sun.ac.za/
A P P E N D IX  I 
BUFFERS AND SOLUTIONS
1.1 Standard Buffers and Solutions
1.1.1 lOx Tri-EDTA (TE) Buffer (pH 8.0)
1.21 g Tris base 
0.372 gEDTA 
dH2 0  to 1 1
1.1.2 50x Tris Acetate (TAE) Buffer (pH 8.0)
242 g Tris base
57.1 ml Glacial acetic acid 
18.61 gEDTA
dH20 to 1 1
1.1.3 lOx Tris-Borate EDTA (TBE) Buffer (pH 8.0)
108 g Tris base 
55 g Boric acid
9.3 gEDTA 
dH20 to 1 1
1.1.4 20x SSC
175 gNaCl
88.2 g Trisodium citrate 
dH20 to 1 1
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1.1.5 lOxPhosphate Buffered Saline (PBS)
80 g NaCl
2 g KC1
14.4 g Na2HP04
2.4 g KH2P 04 
dH20  to 1 1
1.1.6 20x SSPE (pH 7.4)
876.5 g NaCl 
138 g NaH2P 04 
37 g EDTA
44 g NaOH 
dH20  to 5 1
1.1.7 depc dH20
100 |_il depc to 1 1 dH20
1.1.8 70% (depc) EtOH
70 ml Absolute EtOH 
30 ml (depc) dH20
1.1.9 90% (depc) EtOH
90 ml Absolute EtOH 
10 ml (depc) dH20
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1.1.10 0.4 M NaOH
16 g NaOH 
dH20 to 1 1
1.1.11 3 M Na-Acetate (pH 5.5)
408.2 g NaAc-3 H20
Adjust pH with glacial acetic acid
dH20  to 1 1
1.2 1 M Citrate Buffer (pH 6.0)
2.1 g Citrate Hydrate 
Adjust pH with NaOH to 6.0
1.3 Chromic Acid
100 g K2Cr20 7  
250 ml H2S04 
dH20  to 1 1
1.4 Sputagest
0.1 g DTT 
0.78 gNaCl 
0.02 g KC1 
0.11 g Na2H P04 
0.02 g KH2P 04 
dH20  to 1 1
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1.5 Fixative Solutions: 2x Formaldehyde Fixation Buffer / 4% Paraformaldehyde
72 ml 1 M NaH2P 0 4 
28 ml 1 M NaH2P 04H20
4 g Paraformaldehyde 
Adjust pH with 1 M NaOH
1.6 Solutions for preparation of competent E. coli cells:
1.6.1 TFB1
100 mM RbCl 
50 mM MnCl2.4H20  
30 mM Potassium acetate 
10 mM CaCl2 
15% glycerol
1.6.2 TFB2
100 mM MOPS, pH 7.0 
100 mM RbCl 
75 mM CaCl2 
15% glycerol
1.7 Liquid and solid media:
Media were autoclaved at 121°C for 20 minutes
1.7.1 Luria-Bertani (LB) medium
10 g Bacto tryptone
5 g Yeast extract 
lOgNaCl 
dH20  to 1 1
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1.7.2 LB-Ampicillin-agar plates
10 g Bacto tryptone
5 g Yeast extract 
10 g NaCl 
12 g Agar 
dH20  to 1 1
1 ml of 50 mg/ml Ampicillin added after autoclaving
1.8 Ampicillin
50 mg/ml in dHaO, filtered and stored at -20°C
1.9 Buffers used in the ISH probe detection:
1.9.1 Buffer A
100 mM Tris-Cl pH 7.5 
150 mM NaCl
1.9.2 Buffer B
100 mM Tris-Cl pH 9.5 
50 mM MgCh 
100 mM NaCl
1.10 Solutions used in the genomic DNA preparation:
1.10.1 Extraction Buffer
50 g Mono Sodium Glutamic Acid
6.06 g Tris base
9.3 g EDTA
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1.10.2 Proteinase K Buffer
6.05 g Tris base
9.3 g EDTA
25 g SDS 
dH20  to 500 ml
1.10.3 Phenol / Chloroform
240 ml Chloroform 
10 ml Isoamyl alcohol 
250 g Phenol crystals 
250 mg Hydroxyquinoline
1.11 Solutions used for DNA fingerprinting:
1.11.1 Primary Wash Buffer
720 g Urea 
8 g SDS 
25 ml 20x SSC 
dH20  to 2 1
1.11.2 Orientation M arker
2 |il Marker X (0.25 |_ig/nl)
2.5 Mtb DNA (H37Rv)
45 |il 0.8 M NaOH
TE to a final volume of 90 (0,1
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1.12 Gel Electrophoresis Loading Dyes:
1.12.1 Bromophenol Blue
50 (il Bromophenol Blue 
3 ml Ficol
TE to a final volume of 20 ml
1.12.2 6x Loading Buffer
30% glycerol
0.25% w/v bromophenol blue 
0.6% w/v SDS in TE (pH 8.0)
1.12.3 Loading Buffer with M arker X
6.6 (il Molecular Weight Marker X (0.25 (ig/(il) 
8 ml 2x Loading buffer
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CONSENT FORM: ENGLISH
Information sheet and consent form for persons participating in the research project: In Situ Hybridisation Analysis of 
Mycobacteria tuberculosis Gene Expression and Identification of Host Immune Responses Induced by Various Infecting Strains.
Project number: 94/107.
Your child has enlarged lymph glands. At the moment the cause of this enlargement is not known and for this reason your child 
needs to have a biopsy taken of the gland. The surgeon will explain to you exactly how this is done and will get permission for the 
surgery. One of the causes of big lymph glands in children can be tuberculosis (TB) which is a curable but an infectious disease. The 
first symptom of TB is usually coughing. TB is spread when a sick adult coughs thereby spreading tiny droplets containing TB germs 
from his/her lungs into the air. Any person who breathes in the air with these droplets can become infected. TB most often affects the 
lungs, but can cause big glands in children. We -  a team of researchers from the University of Stellenbosch -  want to find out the 
type of Mycobacterium tuberculosis strain infecting your child and the type of immune response that he/she exhibits. We would like 
to examine the lymph glands of children who have TB. We want to ask your permission to include your child in this research project. 
For our investigations, we would like to culture the infected lymph nodes, extract the bacteria and classify the infecting strains. The 
type of immune response induced by the infecting strain will also be determined. We also want to do a TB skin test and a chest x-ray. 
For getting the blood samples, a sterile needle will be used to draw 15 ml of blood (3 teaspoons). One of the tests we need to do is a 
test for HIV. If you agree to take part in the research project, you will receive counseling before and after the test. If there are signs in 
the blood that you should be seen by a specialist, we will make an appointment. If the HTV test should be positive we will counsel 
you and refer you and your child to the HIV-clinic, Department of Paediatrics and Child Health, Tygerberg Hospital.
The TB skin test will be done with a small needle, whereby a little amount of fluid will be put into the skin and after 3 days we will 
read the skin test. The chest x-ray will be done before surgery. There is no danger involved in the taking of blood, doing the skin test 
or taking the chest radiograph. The only side effect may be a positive skin test, which may itch or ulcerate, but if this happens we will 
give you a steroid ointment to put on to relieve the itching. If you encounter any problems you can contact Dr Beyers at telephone 
number 9389114.
You are completely free to choose whether you will give permission for your child to be enrolled in this research project. Refusal to 
participate will not involve any penalty or change in the standard of medical attention in the hospital or clinic. We will use the blood- 
and lymph gland samples exclusively for tests on TB and will not do any other research with it. You or your child will not receive 
any financial reward for participating in this study. All personal information from this study is strictly confidential. The results from 
the study will be published in medical journals, but without mentioning the names of any person who donated samples.
Patient Details:
Name and Surname: Date of Birth:
Address:
I, the undersigned doctor/nursing sister hereby declare that I have informed the
patient of the nature, purpose, risks and possible consequences of the research project in his/her own language. I will take full 
responsibility if the study results of this person need follow-up in terms of treatment and/or counselling
Signature of doctor/nursing sister: Date:
Signature of witness: Date:
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I, the undersigned............................................................
(Name o f person giving consent)
hereby give consent for the inclusion of my
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child. in the above research project, in which his/her blood and biopsy
(Name o f child)
samples may be used for tuberculosis research and the culturing of bacteria, and that information from his/her medical records may 
be used for these research purposes, the nature of which has been explained b y .............................................................................
1. The nature of the project has been explained to me
2 .1 understand the implications of the research and the risks involved
3. The following procedures may be carried out as part of the project:
i. Drawing of 15 ml of blood (or 3 teaspoons) for HIV testing and immunological tests related to TB
ii. Tuberculin skin testing
iii. Chest radiograph
iv. Examination and culture of the lymph gland for TB related research.
4 .1 understand that I can withdraw my child at any stage from the project without influencing my or my child's medical treatment.
5 .1 understand that there will be no financial rewards
Signature of person giving consent: ................................................................................................Date: .......................................................
(Name o f doctor/nursing sister)
(0 (ii)
Signature of witness Date Signature of witness Date
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CONSENT FORM: AFRIKAANS
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Informasie blad and toestemmings vorm vir persone wat deelneem in die navorsingsprojek: In Situ Hybridisation Analysis o f 
Mycobacteria tuberculosis Gene Expression and Identification o f Host Immune Responses Induced by Various Infecting Strains.
Projek nommer: 94/107.
Jou kind het vergrote limf kliere. Op die oomblik is die oorsaak van hierdie vergroting onbekend en vir hierdie rede is dit nodig om 
'n biopsie van u kind se klier te neem. Die chirurg sal die prosedure presies aan u verduidelik en sal toestemming kry vir die operasie. 
Een van die oorsake van groot limf kliere in kinders is tuberkulose (TB) wat ‘n aansteeklike maar geneesbare siekte is. Die eerste 
simptoom van TB is gewoontlik hoes en TB word versprei wanneer ‘n siek volwassene hoes en sodoende klein druppeltjies met TB 
kieme van sy / haar longe in die lug versprei. Enige persoon wat die lug met hierdie druppeltjies inasem kan gemfekteer word. 
Gewoontlik affekteer TB die longe, maar kan vergrote kliere in kinders veroorsaak. Ons -  ‘n span navorsers van die Universiteit van 
Stellenbosch -  probeer uitvind die tipe Mycobacterium tuberculosis ras wat jou kind infekteer, en die immuun respons hy / sy 
vertoon. Ons wil graag die limf kliere van kinders wat TB het ondersoek. Om hierdie rede vra ons u toestemming om u kind in 
hierdie navorsingsprojek in te sluit. Vir ons ondersoeke wil ons die geinfekteerde limf knope kweek, die bakteriee ekstraheer en die 
infekterende ras klassifiseer. Die tipe immuun respons wat die infekterende ras veroorsaak sal ook bepaal word. Ons wil ook ‘n TB 
vel toets en ‘n borskas X-straalfoto neem. Om die bloed te trek, sal ‘n steriele naald gebruik word om 15 ml bloed te trek (3 
teelepels). Een van die toetse wat ons sal doen is ‘n toets vir HTV. Indien u toestem om deel te neem aan die navorsingsprojek, sal die 
suster vir u voorligting gee oor HIV voor en na die toets. Indien daar tekens in die bloed is dat u deur n spesialis gesien moet word, 
sal ons ‘n afspraak reel. Indien die HIV-toets positief is, sal ons vir u berading gee en u en u kind verwys na die HIV-kliniek, 
Departement van Paediatrie en Kinder Gesondheids, Tygerberg Hospitaal. Die TB vel toets sal gedoen word met ‘n klein naald wat 
‘n klein hoeveelheid vloeistof onder die vel deponeer en na 3 dae sal ons die vel toets lees. Die borskas X-straalfoto sal voor die 
operasie gedoen word. Daar is geen gevaar betrokke by die bloed trek, die vel toets of die borskas X-straalfoto nie. Die enigste newe- 
etfek mag n positiewe vel toets wees, wat sal jeuk en ulsereer, maar as dit gebeur sal ons u ‘n steroid gee wat die jeuking sal verlos. 
Indien u enige probleme ondervind kan u Dr Beyers by telefoon nommer 9389114 kontak.
U is volkome vry om te besluit of u toestemming sal gee om u kind te laat deelneem aan hierdie navorsingsprojek. Indien u nie 
toestemming gee nie, sal u of u kind in geen opsig benadeel word nie en die standaard van mediese sorg wat u by die kliniek of 
hospitaal ontvang, sal nie verander nie. Die bloed en limf kliere monsters sal slegs vir toetse oor TB gebruik word, en geen ander 
navorsing nie. U sal geen fmansiele vergoeding ontvang vir deelname aan die studie nie. Alle persoonlike informasie verwerf tydens 
hierdie studie is streng vertroulik. Die resultate van die studie sal in mediese joemale gepubliseer word, maar die name van persone 
wat monsters geskenk het, sal nie genoem word nie.
Pasiiint Besonderhede:
Naam en V a n :....................................................................................................................... Geboorte Datum:
Adres:
Ek, die ondergetekende dokter/verpleegster.......................................................................... verklaar hiermee dat ek die pasient van
die natuur, doel, risiko en moontlike gevolge van die navorsingsprojek in sy / haar taal ingelig. Ek sal voile verantwoordelikheid 
neem indien die studie resultate van hierdie persoon nabehandeling, in terme van mediese sorg en berading aandui.
Handtekening van dokter/verpleegster:.................................................................  Datum:
Handtekening van getuies : Datum:
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Ek, die ondergetekende..................................................................
(Naam van persoon wat toestemming geej
gee hiermee toestemming vir die insluiting van my
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kind................................................................................... in die bogenoemde navorsingsprojek, waarin sy/ haar bloed en biopsie
(Naam van kind)
monsters mag gebruik word vir tuberkulose navorsing en die kweking van bakteriee, en dat informasie van sy/ haar mediese rekords
in sodanige navorsing gebruik mag word, waarvan die natuur aan my verduidelik was deur.................................................................
(Naam van dokter/verpleegster)
1. Die natuur van die projek is aan my verduidelik
2. Ek verstaan die implikasies van die navorsing en die risiko betrokke
3. Die volgende prosedure mag uitgevoer word as deel van die projek:
(i) Trekking van 15 ml bloed (of 3 teelepels) vir HTV toetse en immuunologiese toetse verwant aan TB
(ii) Tuberkulin vel toets
(iii) Borskas X-straalfoto
(iv) Ondersoek en kweking van die limf klier vir TB verwante narvorsing.
4. Ek verstaan dat ek my kind op enige stadium van die projek kan onttrek sonder enige invloed op my of my kind se mediese sorg.
5. Ek verstaan dat daar geen tinansieele vergoeding beskikbaar is nie
Handtckcning van persoon wat toestemming gee: ..................................................................... Datum: ........................................
0 ) .................................................................................................... (ii)............................................................................................
Handtekening van getuies Datum Handtekenig van getuies Datum
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APPENDIX ID: 
DIAGNOSTIC TOOLS
Central components of any effective tuberculosis control programme are prompt identification of 
active cases, institution of therapy and completion of therapy. In patients in whom there is a clinical 
suspicion of tuberculosis, the first diagnostic step should be a combination of chest radiograph, 
microscopic examination of clinical material and culture of bacteria. However, the diagnosis of 
tuberculosis can often be difficult. Some of the problems that occur include (i) low number of 
organisms for culture, (ii) slow growth of tuberculosis bacilli, (iii) chest radiograph findings absent 
or misinterpreted, (iv) biopsy material may not be specific, and (v) symptoms and signs of 
tuberculosis may be attributed to another pre-existing disease.
Clinical Specimens used for Diagnostic Tests:
Any specimen should be collected in a sterile disposable container, with maximum precautions to 
avoid its contamination with environmental mycobacteria or non-acid-fast bacilli. Specimens from a 
variety of sites may be appropriate to examine, including sputum, bronchial brushings, gastric 
lavage, various body fluids as well as biopsy and autopsy tissue specimens.
Sputum
Freshly exporated sputum is the best sample to confirm a clinical suspicion of M. tuberculosis. If a 
person is not spontaneously producing sputum, induced sputum is the next best specimen for study. 
This can be obtained by having the patient inhale a warm sterile aerolised 10% Sodium Chloride 
solution (Heifets, L., 1997). A series of a minimum of three sputum specimens should be collected 
preferably on successive days before the start of the antimicrobial therapy (Harvell et al, 2000; 
Heifets, 1997). More than three specimens may be necessary when the smear examination detects 
only a small number of acid-fast bacilli, or if the acid-fast bacilli are not found in all three initial 
specimens. Previous studies have demonstrated incrementally higher recovery rates of M  
tuberculosis with each successive sputum specimen submitted (Levy et al, 1989; Lipsky et al, 
1984).
Before being used in any diagnostic tests, the sputum specimens should foremost be 
decontaminated and processed. Mycobacteria have an extended generation time (20 -  22 hours)
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compared with that of common bacterial flora (40 -  60 minutes). However, the high lipid content of 
the cell wall makes mycobacteria more resistant to strong acids and alkalis compared with other 
bacteria. This property has been used to develop the decontamination procedures to eliminate 
common bacterial flora while keeping the mycobacteria viable. All liquid specimens should also be 
concentrated by centrifugation prior to culturing (Heifets, 1997).
Although sputum digestion, decontamination and concentration have increased the yield for M  
tuberculosis, the organism may be killed if the process is improperly performed, resulting in false- 
negative culture results. Also, in children, tubercle bacilli usually are relatively few and sputum 
cannot be obtained from children younger than about 10 years of age. Diverse, painstaking methods 
are then used for the collection of specimens and are essential for the diagnosis of childhood 
tuberculosis.
Gastric Lavage
Gastric lavage is the specimen of alternative choice when patients cannot expectorate sputum, or if 
the patient swallows the sputum. To collect gastric washings, sterile water should be passed into the 
stomach through a plastic tube and the specimen can be collected through the tube with a syringe 
(Heifets, 1997). As with sputum, gastric washings should also be decontaminated and processed 
before being used in any experimental procedures. Concentration and culture should be performed 
as soon as possible after the collection. Previous studies however showed that M. tuberculosis could 
be isolated from gastric aspirate samples of only 30% to 40% from children and 70% from infants 
with pulmonary tuberculosis (Vallejo et al, 1994; Starke and Taylor-Watts, 1989). Gastric lavage is 
as a consequence not the ideal specimen for the diagnosis of childhood tuberculosis.
Body Fluids
Blood, spinal, pleural, joint and other normally sterile body fluids should be collected aseptically 
when used for the diagnosis of tuberculosis (Heifets, 1997). Blood specimens are the primary 
targets for the bacteriologic diagnosis of disseminated mycobacterial infections, primarily in 
patients with HIV/AIDS. These specimens can be collected in special isolator tubes, or in the 
preferred inexpensive vacutainers.
An examination of spinal fluid is an essential diagnostic procedure in tuberculous meningitis. A 
spinal puncture carries some risk of herniation of the medulla, but if meningitis is suspected, the
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procedure must be performed regardless of risk. The presence of acid-fast bacilli in cerebrospinal 
fluid should be diagnostic for the disease. Unfortunately, acid-fast bacilli can be found in this fluid 
on smear only in a small minority of the patients who have subsequently been shown to have 
tuberculous meningitis (Kennedy et al, 1979). This is not surprising since the number of bacilli 
usually present in the cerebrospinal fluid in tuberculous meningitis is never large.
Tissue Specimens
Before the availability of antituberculosis chemotherapy, various surgical procedures were used to 
collapse tuberculosis cavities in the lungs in an attempt to cure the disease. These days, surgical 
procedures are mainly used in the establishment of definitive diagnosis of tuberculosis after failed 
attempts with non-invasive or less invasive investigative procedures. Small tissue obtained from 
biopsy or during autopsy should be transferred aseptically into sterile screw-cap tubes with various 
specific liquids. Tissue specimens destined for microscopic analysis are usually immersed in 
fixative solutions, such as paraformaldehyde, while those submitted for culture are transferred to 
tubes containing saline (Heifets, 1997).
In the event of doubt in the diagnosis of pulmonary abnormality, a tissue biopsy obtainable by 
surgery is often indicated. Tuberculosis is often represented by single or multiple nodules, which 
can usually be removed by segmentectomy, a surgical procedure that involves excision of a portion 
of a lobe of a lung. Sputum and gastric aspirate cultures are usually negative when used to assess 
lymph node involvement. Consequently, when tuberculous lymphadenitis is suspected, biopsy 
material must be submitted for culture, staining and histological analysis. Ideally, the solid portion 
of the node, or of any other tissue specimen, should be cultured and processed for microscopic 
sections used in staining and histological examinations. Closed-needle biopsy of the pleura has also 
been accepted as the single most useful procedure for diagnosis of tuberculosis pleuritis, even with 
a low diagnostic yield range of 50% to 80%. Invasive procedures are often critical to obtain relevant 
samples for examination for both extrapulmonary and especially paediatric tuberculosis.
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Diagnostic Techniques: 
Culture
Isolation of mycobacteria from clinical specimens represents a challenge because of the prolonged 
period of cultivation required for most of them. The yield of sputum culture for detecting M. 
tuberculosis is higher than that of direct sputum examination, but the delay in obtaining results 
remains a problem. Among 435 positive specimens analysed, Levy and colleagues (1989) reported 
sensitivity and specificity for sputum culture of 81.5% and 98.4%, respectively.
Cultivation of M  tuberculosis and most of the other slowly growing mycobacteria requires special 
culture media. The most popular are Lowenstein-Jensen (LJ), or other egg-based solid media, 
Middlebrook 7H10 / 7H11 agar, Middlebrook 7H9 broth, and the radiolabeled BACTEC medium 
(Heifets, 1997). The egg-based media are the most traditional for isolation of M  tuberculosis, 
although it takes 3 to 8 weeks to achieve visible growth. Well-funded laboratories can detect 
tuberculosis cases within 7 to 14 days using the sophisticated BACTEC liquid culturing systems 
(Middlebrook et al, 1977). The BACTEC-460 system can be considered the one most frequently in 
standard use among such systems (Heifets, 1986; Middleton et al, 1997). However, some problems 
inherent to this system have limited its broad use (Heifets, 1997). Among them are (i) the need for 
disposal of large volumes of low-grade radiolabeled material, (ii) labour time associated with the 
necessity o f loading and unloading of the vials incubated separately, and (iii) manual transfer of the 
growth index (GI) daily readings to the laboratory worksheet. To elude these drawbacks, Heifets 
and colleagues (2000) evaluated two manual liquid medium systems, the Mycobacteria Growth 
Index Tube (MGIT) and MB Redox tube systems, in comparison to the radiometric BACTEC-460 
semi automated systems for recovery from sputum specimens.The results illustrated that the 
BACTEC system was the most reliable for accurate and rapid diagnosis of active disease, which are 
the central components of any effective tuberculosis control program.
Despite the documented enhanced ability of the BACTEC-460 system, when the clinical material 
used for diagnostic examinations are respiratory specimens, three sequential samples are still 
required for a definitive diagnosis of pulmonary tuberculosis (Harvell et al, 2000). For the isolation 
o fM  tuberculosis, Harvell and colleagues reported a recovery rate of 82% from the first specimens 
collected (// = 143), 10% for the second (92% cumulative rate) and 8% from the third batch of 
specimens (100% cumulative rate).
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Most laboratories in developing countries, if cultures are attempted at all, use solid media such as 
LJ and Ogawa because of their low cost. This traditional culture method, as stated before, takes an 
average of 3 weeks under optimal conditions, and the specificity of detection is not as high as with 
the liquid medium. To circumvent this obstacle, Caviedas and colleagues (2000) developed a new, 
efficient, reliable and inexpensive method that permits simultaneous M. tuberculosis detection as 
well as drug susceptibility in less than 2 weeks. This assay, unlike other rapid detection systems, 
does not require either radioactive isotopes or fluorescent indicators, and is particularly well suited 
for use in developing countries.
Microscopic Analysis:
(i) Staining of Mycobacteria in Clinical Specimens
Mycobacteria are aerobic gram-positive biologically as well as acid-fast bacilli. This term is related 
to the fact that the mycobacteria cell wall has low permeability to the basic dyes, and it requires a 
prolonged exposure or heating of the smear to achieve colorisation of the bacteria (Heifets, 1997). 
Once mycobacteria are stained through these efforts, they retain dyes during the subsequent 
decolorisation with acids or a mixture of acids and alcohol. One of the most popular acid-fast 
staining procedure is the Ziehl-Neelsen (ZN) method in which staining with a solution that contains 
basic fuschin and phenol is combined with heating. The smear is decolorised with a mixture of 
hydrochloric acid and ethanol, followed by a counter stain with methylene blue. Microscopic 
examination under the oil immersion objective reveals slender rods on a blue background.
A provisional diagnosis of tuberculosis can be based on the detection of acid-fast bacilli (AFB) in 
specimen smears in conjunction with certain clinical symptoms or radiological findings. Smear 
examination is indeed a rapid method for detection of mycobacteria in clinical specimens. Ease of 
performance, widespread availability, low cost, and a considerable diagnostic yield makes smear 
examination an essential component of any diagnostic evaluation. Tuberculosis control programmes 
in developing countries rely predominantly upon results of stained sputum smears for diagnosis of 
tuberculosis (De Cock and Wilkinson, 1995). It is much less sensitive than culture isolation 
(Heifets, 1997; Harvell et al, 2000) and it is estimated that the limit of sensitivity is about 10 000 
acid-fast bacilli per ml of specimen (Zhoa et al, 1997; Wilkinson, 1998). Levy and colleagues 
(1989) reported sensitivity and specificity for sputum smears of 53.1% and 99.8%, respectively. If 
AFB are found in the smear, that finding is an indication that the patient is highly infectious, given 
the aforementioned sensitivity limits of this method.
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False-positive results of the smear examinations are the main problems plaguing laboratories using 
this diagnostic method. Because of the low specificity, using acid-fast bacilli contaminated 
solutions during the processing or staining manipulations can cause false-positive results, especially 
with a small number of AFB. Also, the probability of finding acid-fast bacilli in specimens other 
than sputum is much lower. Negative smear results, however, does not exclude the possibility that 
the patient may have tuberculosis, which can be confirmed by other methods, such as by culture.
(ii) Histological Analysis of Tissue Specimens
Histological confirmation of disseminated tuberculosis is best sought by biopsy of the lung, liver, 
bone marrow, or specific tissue that clinically appears involved, such as skin and lymph nodes. The 
histological features of tuberculosis are characteristic and similar in all sites of infection. Certain 
foreign agents stimulate a characteristic pattern of reaction in the infected tissue, which allow a 
diagnosis of disease to be made on biopsy specimens.
Tuberculosis is the most common and important cause of granulomatous inflammation. This is a 
type of chronic inflammation histologically characterised by the presence of granulomas that are 
collections of activated macrophages with epitheloid morphology, macrophage derived giant cells 
(Langerhans giant cells) and surrounding infiltrate of lymphocytes, plasma cells and granulocytes. 
The histology of mycobacterial adenitis may include non-specific lymphoid infiltrates, small 
noncaseating granulomas, or typical Langerhans giant cells in areas of extensive necrosis (Huhti et 
a!, 1975). However, tuberculous and non-tuberculous mycobacteria-infected lymph nodes cannot be 
differentiated histologically (Reid et al, 1969), and distinction from other granulomatous diseases 
may be difficult (Huhti et al, 1975). In addition, histological examination of transbronchial lung 
biopsy obtained via the fiberoptic bronchoscope was shown to give a diagnostic yield of smear- 
negative pulmonary tuberculosis in only 30% to 58% of cases (So et al, 1982; Fujii et al, 1992). 
Histological analysis should therefore be combined with culture examination before a definitive 
diagnosis can be made.
Polymerase Chain Reaction (PCR)
Staining for AFB is known to be the most rapid and economic method for detecting mycobacteria. 
However, given that half of the new cases of tuberculosis are smear negative (WHO Tuberculosis 
Report 2001), diagnosis of many patients cannot be confirmed at the time of presentation. This 
leads to delays in initiating appropriate treatment and / or the use of invasive procedures to firmly 
establish the diagnosis.
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The drawbacks of conventional diagnosis could be solved by application of PCR, which allows in 
vitro amplification of target DNA to a detectable level within a matter of hours (Saiki et al, 1988). 
Various studies have employed this technique for the rapid detection of M. tuberculosis, and most 
have reported a high degree of sensitivity in detecting M. tuberculosis in clinical samples by means 
of DNA amplification (Brisson-Noel et al, 1989; Cousins et al, 1992; Eisenach et al, 1991; 
Miyazaki et al, 1993).
In principle, PCR is a simple test for the detection of microorganism in a clinical sample, however, 
in practice many problems have been encountered with this method, the most significant being the 
generation of false positive reactions due to the amplification of contaminating DNA. Clinical 
materials such as sputum and blood may also contain components that interfere with the 
amplification of DNA leading to under estimation of disease. Inter-laboratory comparisons of PCR- 
based diagnosis have highlighted the difficulty of obtaining reproducibility with such a sensitive 
technique, and in particular the high rate of false positives which is unacceptable. Noordhoek and 
colleagues (1994) evaluated the viability of PCR for the detection of mycobacteria in clinical 
samples, and reported high levels of false-positive PCR results and widely ranged levels of 
sensitivity. These results again emphasised the requirement of an effective system for monitoring 
sensitivity and specificity of the PCR technique before it could be used reliably in the diagnosis of 
tuberculosis.
Sandin (1996) reviewed a number of systems with potential use in the diagnosis of M. tuberculosis. 
They included the Amplified M. tuberculosis Direct test (MTD) and the Amplicor M  tuberculosis 
test, which are the only tests approved by the USA Food and Drug Administration. The MTD test 
uses a transcription-mediated amplification (TMA) system. This method, however, was only 
approved for use on smear-positive concentrated respiratory specimens obtained from untreated 
patients.
The Amplicor was evaluated by Bergmann and Woods (1996) using both smear-positive and smear- 
negative respiratory tract specimens and compared results with those of the culture and medical 
history. They found that although the specificity was high for all the specimens, the sensitivity was 
97.6% and 40% for acid-fast bacilli smear-positive and negative specimens, respectively. This test 
was approved for use with the same group of clinical specimens as for the MTD test, namely smear- 
positive respiratory specimens. Nested amplification, compared with conventional single-step PCR, 
can enhance sensitivity approximately 1 000 fold, but with a high risk of contamination (Liu et al, 
1994). In order to increase the yield of the amplification reaction, and to improve the sensitivity of
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detection o f the M  tuberculosis complex in smear-negative specimens, Garcia-Quintanilla and 
colleagues (2000) developed a single tube balanced heminested PCR. This technique showed a 
higher sensitivity than the standard nested PCR without loss of specifity and with a minimum of 
cross-contamination.
The nucleic acid amplification methods may provide rapid results, but are not “stand-alone” tests 
and should still be used in conjunction with conventional cultures. The amplified tests, in general, 
offer great potential, but the cost of these tests is excessive, and therefore is not an option for 
laboratories in developing countries, where rapid, inexpensive diagnostic tools are urgently needed.
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DETAILED COMPARISON O F M  TUBERCULOSIS GENE EXPRESSION AND 
CYTOKINE PATTERN OF A SINGLE PATIENT
Untreated Patients:
Patient LI
(i) M. tuberculosis Detection and Gene Expression
The diagnosis of this 6 year-old male was based solely on the detection of acid-fast bacilli in the 
biopsy tissue and was confirmed with histological analysis. Unfortunately, for some unidentified 
reason, no biopsy tissue of this patient was submitted for culture, as is standard hospital protocol. 
This patient had no history of previous tuberculosis, and only started anti-tuberculosis therapy when 
the diagnosis was confirmed, after the biopsy (Table 3.2).
A total o f 16 granulomas were identified in the tissue section, as indicated in Figure Al, with 10 of 
these granulomas containing caseous necrosis. Granulomas were scored on the basis of presence (1) 
or absence (0) of signal, and not quantitated for amount of signal per granuloma. M. tuberuculosis 
DNA was detected in 14 of the 16 (87.5%) granulomas (Table Al). M. tuberuculosis DNA was 
associated with all the necrotic granulomas, as well as four of the six non-necrotic granulomas.
Messenger RNA from all the genes analysed was detected in the granulomas of this patient (Table 
A l; Figure A2). Hybridisation signals for mRNA were always associated with those granulomas 
positive for M. tuberuculosis DNA. RpoB mRNA was detected in 6 of the 14 (42.8%) granulomas, 
with granuloma 1 being the only non-necrotic granuloma staining positive for rpoB mRNA. The 5 
other rpoB positive granulomas all contained caseous necrosis. A stronger signal was detected using 
riboprobes specific for katG mRNA, with 10 of the 14 (71.4%) M  tuberculosis DNA positive 
granulomas also stained positive for katG riboprobes, including 4 non-necrotic granulomas. Similar 
hybridisation signals were detected for the persistent factors, narX (4/14) and icl (5/14). For this 
patient, narX mRNA was detected in all the granulomas positive for icl. Messenger RNA of mbtB 
was only detected in the 3 of the 14 (21.4%) M. tuberculosis DNA positive granulomas. Unlike the 
previous 3 persistent factors, the mRNA levels of relytb was one of the highest detected for this
APPENDIX IV
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patient. RelMtb mRNA was detected in 12 of the 14 (85.7%) M. tuberculosis DNA positive 
granulomas, including all four, M. tuberuculosis DNA positive non-necrotic granulomas. Esat-6 
mRNA was restricted to 3 of the 4 non-necrotic (M tuberuculosis DNA positive) granulomas, but 
was on the whole detected in 13 of the 14 (92.8%) granulomas. It was in fact, the highest expressed 
of the M  tuberculosis genes in the tissue of this patient. In contrast, it would seem that PPE 
Rv3018c (3/14), was the one of the weakest expressed.
(ii) Cytokine Analysis
The majority of the 16 granulomas identified in the tissue sections of patient LI presented an 
overall ThO phenotype (81.3%) (Table 3.3). That is, both type 1 and type 2 cytokines were 
simultaneously released in these granulomas. These included all the necrotic (10/16) and 3 of the 4 
non-necrotic granulomas. The granulomas staining positive for Thl type cytokines and were 
deficient in Th2 type cytokines, thereby presenting a Thl phenotype, were the remaining 3 non- 
necrotic granulomas.
IL-4 and IL-10 were not detected in 3 non-necrotic granulomas that were scored as having an 
overall Thl phenotype. IL-4, however, was detected in the remaining 13 granulomas (81.3%), thus 
including every one of the necrotic granulomas (Table Al, Figure A3). IL-10 staining was observed 
in only 9 of the 16 (56.3%) granulomas (Figure A3), including 1 non-caseating granuloma (Table 
Al). LL-12 was detected in 11 of the 16 granulomas identified (68.6%). This included 2 of the 6 
non-necrotic, and 9 of the 10 necrotic granulomas (Table Al). IFN-y was detected in all the 
granulomas of this patient. The tissue-damaging TNF-a was detected in 14 of the 16 (87.5%) 
granulomas, including every necrotic granuloma (10/16) (Figure 3.18). Thus, the granulomas not 
staining positive for this cytokine were 2 non-necrotic granulomas.
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Figure Al Schematic Representation of the Granulomas within the Lymph Node Tissue of 
Patient LI. The spatial arrangement of 16 granulomas identified on 2.5x magnification is indicated 
above. A total of 10 necrotic (•), and 6 non-necrotic (•) granulomas were identified.
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Figure A2. The Expression for the Various M. tuberculosis Genes observed in Patient LI. The
percentage of hybridisation signal occurring in M. tuberuculosis DNA associated granulomas were 
determined for each M.tb gene analysed.
Figure A3. The Pattern of Cytokine Production as observed in Patient LI. The percentage o f
positive staining granulomas for each cytokine was determined.
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(i) M. tuberculosis Detection and Gene Expression Analysis
The diagnosis o f this 13 year-old male was established with a positive ZN stain and M  tuberculosis 
culture, as well as a positive histological evaluation (Table 3.2). This was one of the five study 
patients that did not have a history of previous tuberculosis, and only received treatment after 
biopsy, once diagnosis was confirmed.
This particular patient had a fervent granulomatous response to the M  tuberculosis infection. A 
total of twenty-eight granulomas were identified in the biopsy tissue of which 20 contained 
casesous necrosis and 8 were non-necrotic (Figure A4). M. tuberuculosis DNA was associated with 
all the necrotic granulomas, as well as four of the eight non-necrotic granulomas. Therefore, 24 of 
the 28 (85.7%) granulomas stained positive fo rM  tuberculosis DNA when using the biotinylated 
MTB484 DNA probe (Table A2).
RpoB mRNA was detected in all 4 M  tuberuculosis DNA associated non-necrotic granulomas, as 
well as 8 necrotic ones (Table A2). Therefore, 12 of the 24 (50%) granulomas identified stained 
positive with the rpoB riboprobe (Figure A5). These granulomas were therefore inefficient in 
inhibiting bacterial growth. The hybridisation signal for the katG specific riboprobe occurred in 
only 10 of the 24 (43.4%) granulomas, including one non-necrotic granuloma (gran. 19) (Table
3 .4). The level o f mRNA transcripts for the narX gene was seemingly the highest of all the genes 
analysed for this particular patient. The signal for the narX riboprobe was detected in 13 of the 24 
(54.1%) granulomas (Table A2), including 1 of the 4 M. tuberuculosis DNA associated, non- 
necrotic granulomas (gran. 2) stained. The remaining 12 narX positive granulomas all containing 
caseous necrosis. Similar hybridisation signals were detected for the icl riboprobe. Messenger RNA 
for this gene was detected in 12 of the 34 (52.1%) granulomas identified in the tissue section of this 
patient. As with narX, only 1 non-necrotic granuloma (gran. 1) stained positive for icl, though not 
the same granuloma because narX was positive in granuloma 2 (Table A2). MbtB mRNA was 
detected in only 8 of the 24 (33.3%) granulomas, which included the non-necrotic granulomas 1 and 
2. The relM,b, unlike the previous patient, was restricted to only 8 of the 24 (33.3%) granulomas 
(Table A2). This signal was primarily confined to necrotic granulomas, with granuloma 10 being 
the single non-necrotic granuloma staining positive when using relmb specific riboprobe. The 
hybridisation signals for both esat-6 and PPE Rv3018c occurred at very low levels. The signal for
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esat-6 was observed in 6 of the 24 (25%) granulomas, whilst PPE mRNA was only detected in 5 of 
the 24 (20.5%) granulomas (Table A2).
(ii) Cytokine Analysis
It was estimated that 19 of the 28 (67.9%) granulomas identified in the tissue sections of this patient 
had an overall ThO phenotype (Table A2), which included 6 of the 8 non-necrotic, and 13 of the 20 
necrotic granulomas. The 9 remaining granulomas only stained positive for Thl type cytokines, and 
were therefore scored as Thl granulomas. These Thl microenvironments included 2 of the 8 
remaining non-necrotic, and 7 of the 20 necrotic granulomas.
Although this study subject presented a rather fervent Thl cytokine response, the Th2 type 
cytokines were also detected in the majority of the granulomas (Table A2, Figure A6). Staining for 
IL-4 was observed in 21 of the 28 (75%) granulomas, which included the 6 of the 8 non-necrotic 
granulomas. IL-10, as seen with the previous two patients, was detected in the least amount of 
granulomas (19/28) and like EL-4, was detected in 6 of the 8 non-necrotic granulomas. The Thl type 
cytokines analysed (IL-12, IFN-y and TNF-a) was detected all twenty-eight granulomas identified 
(Table A2; Figure A6). This particular pattern of cytokine production, where each granuloma 
stained positive for each of the Thl type cytokines examined, was unique to this particular patient. 
This colossal Thl cytokine milieu contributed to the less than average number of ThO type 
granulomas observed in this patient in comparison to the other patients.
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Figure A4. Schematic Representation of the Granulomas within the Lymph Node Tissue of 
Patient L3. The spatial arrangement of 28 granulomas identified on 2.5x magnification is indicated 
above. A total of 20 necrotic (»), and 8 non-necrotic (•) granulomas were identified.
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Figure A5. The Expression for the Various M. tuberculosis Genes observed in Patient L3. The
percentage of hybridisation signal, occurring in M. tuberuculosis DNA associated granulomas were 
determined for each M.tb gene analysed.
Figure A6. The Pattern of Cytokine Production as observed in Patient L3. The percentage o f
positive staining granulomas for each cytokine was determined.
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(i) M.tuberculosis Detection and Gene Expression
Patient L4 was the only female patient included in this study and was one of the five patients that 
did not have a history of previous tuberculosis. This patient in addition did not receive anti­
tuberculosis therapy prior to the biopsy. What were interesting about this particular patient were the 
undetectable acid-fast bacilli in the biopsy tissue specimen (Table 3.2). Histological analysis of the 
lymph node tissue was unconvincing, and diagnosis was established exclusively with positive M  
tuberculosis BACTEC culture. This generally rapid culture system was only positive after four 
weeks of incubation.
Thirteen granulomas were collectively identified in the lymph node sections of this patient (Figure 
A7). Unlike any of the other patients, the majority of these granulomas did not contain any caseous 
necrosis (53 .8%), with only 46.2% of the granulomas scored as necrotic. The biotinylated MTB484 
DNA probe hybridised to 84.6% (11/13) of the granulomas identified, including five non-necrotic 
and all o f the necrotic granulomas (Table A3).
The hybridisation signal for rpoB occurred in 5 of the 11 (45.4%), and included 3 of the 7 non- 
necrotic, and 2 o f the 6 necrotic granulomas. Signal for katG was limited to only 3 o f the 11 
(27.2%) M.tuberculosis DNA positive granulomas, which were all non-necrotic granulomas. 
Hybridisation signals for narX and icl were also each limited to only 3 of the 11 (27.2%) 
granulomas, and were detected in only necrotic granulomas. MbtB was the highest expressed 
persistent factor for this patient, with mRNA detected in 6 of the 11 (54.5%) granulomas identified 
(Figure A8). Messenger RNA for relMtb was restricted to 5 of the 11 (45.4%) granulomas, o f which
3 were non-necrotic and 2 were necrotic. Interestingly, no detectable signal was observed for esat-6 
riboprobes. The highest level of mRNA detected in these granulomas was that of PPE Rv3018c, 
that was detected in 7 of the 11 (63.6%) M. tuberculosis DNA positive granulomas (Table A3). 
Three of the M. tuberuculosis DNA associated non-necrotic granulomas also stained positive when 
using the PPE specific riboprobe.
(ii) Cytokine Analysis
This patient was unique in having more non-necrotic granulomas than necrotic granulomas in the 
lymph node sections. A number of these non-necrotic granulomas (6/7) presented with a ThO
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phenotype (Table A3). All the necrotic granulomas (6/6) presented with a ThO phenotype. A total of 
92.3% (12/13) granulomas analysed were typed as ThO, concurring with the trend seen in all 6 
patients. The remaining granuloma, a non-necrotic granuloma, presented with a Thl phenotype.
The Th2 cytokine IL-4 was detected in 12 of the 13 (92.3%) granulomas, with the only granuloma 
not staining positive for this cytokine, obviously being the non-necrotic Thl granuloma (Figure 
A9). The IL-10 cytokine staining was limited to only 38.5% (5/13) granulomas. This cytokine was 
absent in most o f the granulomas also lacking necrosis, with the signal detected in 2 of the 7 non- 
necrotic granulomas. The Thl cytokine, IL-12, was observed in 8 of the 13 (61.5%) granulomas 
(Figure A9), which included 4 of the 7 non-necrotic granulomas. IFN-y, as previously 
acknowledged, was detected in every granuloma (Figure A9). Staining for TNF-a was observed in 
10 o f the 13 granulomas (76.9%) (Table A3). Four of the 7 non-necrotic granulomas stained 
positive for this cytokine.
158
Stellenbosch University http://scholar.sun.ac.za/
Figure A7. Schematic Representation of the Gram/iomas within the Lymph Node Tissue of 
Patient L4. The spatial arrangement of 13 granulomas identified on 2.5k magnification is indicated 
above A total o f 6 necrotic {•), and 7 non-necrotic ( • )  granulomas were identified.
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Figure A8. The Expression for the Various M. tuberculosis Genes observed in Patient L4. The
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Figure A9. The Pattern of Cytokine Production as observed in Patient L4. The percentage o f
positive staining granulomas for each cytokine was determined.
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(i) M. tuberculosis Detection and Gene Expression
Patient L5, a 12 year-old male, had no previous history o f tuberculosis. The diagnosis o f  this patient 
was based on a positive culture, detection o f acid-fast bacilli in the biopsy tissue specimen and was 
confirmed with conclusive histological analysis. This patient was diagnosed, in addition to the 
tuberculosis lymphadenopahthy, with pulmonary and abdominal tuberculosis.
As with patient L3, this patient had an ardent granulomatous response. A total o f 24 granulomas 
were identified in the fixed tissue section o f this patient (Figure A10). Seventy five percent (18/24) 
o f these granulomas contained caseous necrosis. M. tuberuculosis DNA was detected in 22 o f the 
24 (91.7%) granulomas (Table A4), which included all the necrotic granulomas and 4 o f  the 6 non- 
necrotic granulomas.
The overall M  tuberculosis gene expression observed using the in situ hybridisation technique was 
generally high, with the exception o f  esat-6. RpoB mRNA was detected in exactly half 50% (11/22) 
o f the granulomas, including 2 o f the 4 M  tuberuculosis DNA positive non-necrotic granulomas 
(Table A4). The katG mRNA was detected in 21 out o f 22 (95.4%) granulomas with the necrotic 
granuloma 22 being the only negative (M  tuberuculosis DNA positive) granuloma (Figure A ll) . 
Hybridisation signals for these genes were detected in all th eM  tuberuculosis DNA associated non- 
necrotic granulomas. The bacilli are possibly still in log phase growth and adapting to immune 
response. NarX mRNA was detected in 12 o f the 22 granulomas (54.5%) identified in the fixed 
tissue sections (Figure Al 1). These signals occurred in 11 o f the 18 necrotic, and in 1 o f the 4 non- 
necrotic M  tuberculosis DNA positive granulomas. ). mRNA transcripts o f icl and relMtb were each 
detected in 100% o f the M tuberculosis DNA positive granulomas (Figure A l 1). The hybridisation 
o f these riboprobes resulted in a ubiquitous signal in the tissue sections o f this patient. MbtB was 
detected in 18 o f  the 22 M. tuberculosis DNA positive granulomas, which included 2 non-necrotic 
and 16 necrotic granulomas. As with the previous patient (L4) esat-6 mRNA was not detected in 
any o f  the granulomas, whereas the level o f  PPE Rv3018c mRNA was elevated. The hybridisaion 
signal for this gene occurred in 21 o f  the 22 (95.4%) granulomas (Figure A ll) . All 4 M  
tuberculosis DNA positive non-necrotic granulomas stained positive for PPE, with only 1 negative 
necrotic granuloma (gran. 22).
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(ii) Cytokine Analysis
Twenty-three o f  the 24 (95.8%) granulomas identified in the tissue sections of this patient (Table 
A4) presented w ith a ThO phenotype. Granuloma number 10, a non-necrotic granuloma, presented 
an overall T h l phenotype.
IL-4 was absent from only 1 non-necrotic granuloma, which was incidentally also the only Thl 
granuloma identified. Staining for this cytokine was observed in 23 o f the 24 (95 .8%) granulomas 
(Figure A12). IL-10 was detected in 12 o f the 24 (50%) granulomas, which included 11 o f the 18 
necrotic and only 1 o f 6 non-necrotic granulomas. The Thl type cytokine IL-12 was detected in 11 
o f the 24 (48.5% ) granulomas (Figure A12). This included 9 of the 24 necrotic, and only 2 of the 6 
non-necrotic granulomas. Along with IFN-y, staining for TNF-a was detected in all the 24 
granulomas (Table A4). In fact, these were the only two cytokines detected in the granuloma.
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Figure A10. Schematic Representation of the Granulomas within the Lymph Node Tissue of 
Patient L5. The spatial arrangement of 24 granulomas identified on 2.5x magnification is indicated 
above. A tola! of 18 necrotic (•), and 6 non-necrotic (•)  granulomas were identified.
Stellenbosch University http://scholar.sun.ac.za/
166
rpoB katG narX icl mbtii relMtb csat-6 PPE 
M.tb Genes
Figure A ll. The Expression for the Various M. tuberculosis Genes observed is Patient L5. The
percentage ot hybridisation signal, occurring in M. tuberuculosis DNA associated granulomas were 
determined for cach M.ib gene analysed.
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Figure A12. The Pattern of Cytokine Production as observed in Patient L5. The percentage of
positive staining granulomas for each cytokine was determined.
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(i) M. tuberculosis Detection and Gene Expression
The last patient in this study was a 6 year-old male with no previous history o f tuberculosis. This 
patient was not on any anti-tuberculosis medication, and only started treatment once diagnosis was 
established. Acid-fast bacilli were detected in the biopsy tissue, and cultivation of the infected tissue 
yielded a positive M. tuberculosis culture.
Figure A13 illustrates a schematic representation o f the lymph node segments excised from the 
cervical region from this patient. A total o f nineteen granulomas were identified in the 7 tissue 
fragments (Table A5). Thirteen (68.4%) o f these granulomas contained caseous necrosis. M  
tuberuculosis DNA was detected in 18 o f the 19 (94.7%) granulomas, with only the non-necrotic 
granuloma 2 not staining positive fo rM  tuberculosis DNA (Table A5).
Only 7 o f  the 18 (38 .8%) granulomas contained hybridisation signal for the riboprobes specific for 
rpoB mRNA (Figure A 14). This included 4 o f the 13 necrotic and 3 o f the 5 non-necrotic 
granulomas. Staining for katG mRNA was relatively prominent, with signal for hybridised katG 
riboprobes detected in 16 o f the 18 (88 .8%) granulomas (Table A5). Signal for katG was detected in 
12 o f  the 13 necrotic and 4 o f the 5 non-necrotic granulomas. NarX mRNA was detected in 13 o f 
the 18 (72.2% ) granulomas, including 2 non-necrotic and 11 necrotic granulomas also positive for 
M. tuberuculosis DNA. Messenger RNA for the glyoxylate shunt enzyme, icl, was detected in 17 o f 
the 18 (94.4% ) M. tuberuculosis DNA positive granulomas (Table A5). Signal for icl was detected 
in all the necrotic and in 5 o f the 6 non-necrotic granulomas. MbtB mRNA, like the rest o f  the 
persistent factors, was detected in a number o f granulomas (77.7%). As with patient L5, relMtb 
mRNA was detected in all the M. tuberuculosis DNA positive granulomas (100%). The mRNA 
levels for both esat-6 and PPE Rv3018c were low. The mRNA for these genes were detected in 
only three various granulomas. Signal for both these riboprobes were detected in 1 necrotic, and in 
2 o f the 6 non-necrotic granulomas, with granuloma 16 staining positive for both.
(ii) Cytokine Analysis
This patient, as with the previous patient, also exhibited a strong granulomatous response, the 
majority o f  granulomas contained caseous necrosis (68.4%). Similarly to patient L2, only
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granulomas with an established ThO phenotype were observed in the fixed tissue sections o f this 
patient (Table A5).
The pattern o f cytokine production observed was very similar to patient L2, precisely so for IL-4, 
IFN-y and TNF-a. These 3 cytokines were detected in every one o f the granulomas identified 
(Table A5, Figure A15), thus resulting in only ThO granulomas. IL-10 was detected in 17 of the 19 
(89.5%) granulomas (Figure A15). The only granuloma lacking signal for this cytokine were 2 non- 
necrotic granulomas. As for IL-12, only 12 o f the 19 (63.2%) granulomas stained positive for this 
macrophage secreting cytokine. This included 3 of the 5 non-necrotic and 9 of the 13 necrotic 
granulomas.
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Figure A13 Schematic Representation of the Granulomas within the Lymph Node Tissue of 
Patient L6. The spatial arrangement o f 19 granulomas identified on 2.5x magnification is indicated 
above. A total o f 13 necrotic (•) , and 6 non-necrotic ( • )  granulomas were identified.
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Figure A14. The Expression for the Various M. tuberculosis Genes observed in Patient L6. The
percentage of hybridisation signal, occurring in M. tuberuculosis DNA associated granulomas were 
determined for each M.tb gene analysed.
Figure A15. The Pattern of Cytokine Production as observed in Patient L6. The percentage of
positive staining granulomas for each cytokine was determined.
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(i) M. tuberculosis Detection and Gene Expression
The biopsy material o f this 3 year-old male was both ZN and culture positive (Table 3.2). This 
patient, unlike the other 5 patients included in the study, had a history o f previous tuberculosis. The 
patient had first received treatment at the age o f 9 months and then again at the age o f 2 years. This 
patient also started his third anti-tuberculosis course o f treatment two days prior to the biopsy.
A total o f  seven granulomas were identified in the fixed tissue section o f this patient, as indicated in 
Figure A16. Six (85.7%) o f these granulomas contained caseous necrosis. The M  tuberuculosis 
DNA was only associated with these necrotic granulomas (Table A6). No signal was detected in the 
non-necrotic granuloma.
The M. tuberculosis gene expression observed for this patient was different from the 5 untreated 
patients. No signal was detected for both the rpoB and katG riboprobes (Table A6, Figure A16). In 
fact, the level o f  mRNA transcripts for the remaining M. tuberculosis genes analysed in this 
particular tissue section was generally low, with the exception o f relMtb mRNA (Figure A16). A 
total o f  5 o f  the 6 (83.3%) granulomas were positive for relM,b mRNA, with granuloma 5 being the 
only M  tuberuculosis DNA positive granuloma not staining positive for this gene (Table A6). As 
with the previous patient (LI), hybridisation signals for narX (3/6) and icl (2/6) were very similar, 
with all the narX  positive granulomas also staining positive when using the icl specific riboprobe 
(Table A6). MbtB mRNA was also detected in 3 o f the 6 (50%) granulomas. The remaining genes, 
namely esat-6 and PPE Rv3018c, were detected in 2 o f the (33.3%) granulomas (Figure A17).
(ii) Cytokine Analysis
Every one o f the 7 granulomas identified presented a ThO phenotype (Table A6).
The cytokine milieu was generally quite high. IL-4, IFN-y and TNF-a were detected in all 
granulomas identified (Figure A18). The two remaining cytokines, IL-10 and IL-12 were each 
detected in 6 o f  the 7 (85.7%) granulomas (Table A6). Staining for IL-10 was absent in the only
Treated Patient:
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non-necrotic granuloma identified for this patient (granuloma 4), whereas IL-12 staining was not 
detected in granuloma 6, a necrotic granuloma (TableA6).
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Figure A16 Schematic Representation of the Granulomas within the Lymph Node Tissue of 
Patient L2. The spatial arrangement of 7 granulomas identified on 2.5x magnification is indicated 
above. A total of 6 necrotic (•), and 1 non-necrotic (•)  granulomas were identified.
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Figure A17. The Expression for the Various M. tuberculosis Genes observed in Patient L2. The
percentage of hybridisation signal, occurring in M. tuberuculosis DNA associated granulomas were 
determined for each M.tb gene analysed.
Figure A18. The Pattern of Cytokine Production as observed in Patient L2. The percentage of
positive staining granulomas for each cytokine was determined.
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OVERALL STRATIFICATION OF GRANULOMAS
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APPENDIX V:
Table A7. Stratification of Granulomas According to Expression of Cytokines (e.g. EL-4)
Granuloma
Subgroups
Necrotic
OWN) IL-4 IL-10 IL-12 IFN-y TNF-a
Neg. EL-4: N 0 0 0 1 1
N 0 0 0 1 1
N 0 0 1 1 1
N 0 0 1 1 1
N 0 0 1 1 1
N 0 0 0 1 1
N 0 0 0 1 1
Y 0 0 1 1 1
Y 0 0 1 1 1
Y 0 0 1 1 1
Y 0 0 1 1 1
Y 0 0 1 1 1
Y 0 0 1 1 1
Y 0 0 1 1 1
Pos. IL-4 N 1 0 0 1 0
N 1 0 0 1 0
N 1 0 1 1 0
N 1 0 1 1 0
N 1 0 0 1 0
N 1 0 0 1 1
N 1 0 1 1 1
N 1 0 1 1 1
N 1 0 0 1 1
N 1 0 1 1 1
N 1 0 0 1 1
N 1 0 0 1 1
N 1 0 0 1 1
N 1 0 1 1 1
N 1 1 1 1 1
N 1 1 1 1 1
N 1 1 1 1 1
N 1 1 1 1 1
N 1 1 1 1 1
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N
N
N
N
N
N
N
N
Y 1 0 1
Y 1 0 0
Y 1 0 1
Y 1 0 1
Y 1 0 0
Y 1 0 1
Y 1 0 1
Y 1 0 1
Y 1 0 0
Y 1 0 0
Y 1 0 0
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
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Y 1 1 1 1 1
Y 1 1 0 1 1
Y 1 1 0 1 1
Y 1 1 0 1 1
Y 1 1 0 1 1
Y 1 1 1 1 1
Y 1 1 0 1 1
Y 1 1 1 1 1
Y 1 1 0 1 1
Y 1 1 0 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 0 1 1
Y 1 1 0 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 0 1 1
Y 1 1 0 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
Y 1 1 0 1 1
Y 1 1 1 1 1
Y 1 1 1 1 1
IL-4 Neg - 0 0 10 14 14
(%) - (0) (0) (71.4) (100) (100)
IL-4 Pos. - 93 68 66 93 88
(%) - (100) (73.1) (70.9) (100) (94.6)
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Table A8. Stratification of Granulomas According to Expression o fM  tuberculosis genes (e.g. 
rpoB)
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Necrotic
(Y/N) DNA rpoB katG narX icl mbtB relMtb esat-6 PPE
Negative RpoB N 1 0 1 0 0 0 1 1 0
N 1 0 1 0 0 0 1 1 1
N 1 0 1 0 0 0 1 0 0
N 1 0 1 0 0 0 0 0 1
N 1 0 0 0 1 1 0 0
N 1 0 1 0 1 0 1 0 1
N 1 0 1 1 1 0 1 0 1
N 1 0 1 1 1 0 1 0 0
N 1 0 1 0 1 1 1 0 0
Y 1 0 1 0 0 0 1 1 0
Y 1 0 1 0 0 0 1 1 0
Y 1 0 1 1 0 1 1 0
Y 1 0 1 0 1 0 1 1 0
Y 1 0 1 0 0 1 1 1 0
Y 1 0 1 0 0 0 1 1 0
Y 1 0 1 0 1 0 1 0 0
Y 1 0 1 0 1 1 0 0 0
Y 1 0 0 0 0 1 0 0 1
Y 1 0 0 0 0 1 0 1 0
Y 1 0 0 0 1 1 1 0 0
Y 1 0 0 1 1 0 1 0 0
Y 1 0 0 1 1 0 1 0 0
Y 1 0 1 1 1 0 1 0 0
Y 1 0 1 1 0 0 0 0 1
Y 1 0 1 1 1 0 0 0 0
Y 1 0 0 1 1 0 0 0 0
Y 1 0 1 1 0 0 0 0 0
Y 1 0 0 0 0 0 0 0 0
Y 1 0 0 0 0 1 0 0 1
Y 1 0 0 1 1 0 0 0 1
Y 1 0 0 1 0 0 0 0 1
Y 1 0 0 0 1 1 1 0 0
Y 1 0 1 0 1 1 1 0 1
Y 1 0 1 0 1 1 1 0 1
Y 1 0 1 0 1 1 1 0 1
Y 1 0 1 0 1 1 1 0 1
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Y 1 0 1 0 1 1 1 0 1
Y 1 0 1 1 1 0 1 0 1
Y 1 0 1 1 1 1 1 0 1
Y 1 0 1 1 1 1 1 0 1
Y 1 0 1 1 1 1 0 0
Y 1 0 1 1 1 1 0 0
Y 1 0 1 1 1 1 1 0 0
Y 1 0 1 1 1 1 1 0 0
Y 1 0 1 1 1 1 1 0 0
Y 1 0 1 1 1 1 0 0
Y 1 0 1 1 1 1 1 0 0
Y 1 0 1 1 1 1 1 0 0
Y 1 0 1 1 1 1 1 1 0
Y 1 0 0 0 0 1 0 0
Y 1 0 0 0 0 1 1 0 0
Y 1 0 0 0 0 0 1 0 0
Y 1 0 0 1 1 0 1 1 1
Y 1 0 0 1 1 0 1 0 0
Y 1 0 0 1 0 1 1 1 1
Positive RpoB N 1 1 1 1 1 0 1 1 0
N 1 1 1 0 0 0 0 1
N 1 1 0 0 0 0 1 0 0
N 1 1 0 0 1 1 0 0
N 1 1 0 1 0 1 1 0
N 1 1 0 0 0 1 1 0 1
N 1 1 1 0 0 1 1 0 0
N 1 1 1 0 0 0 1
N 1 1 1 0 1 1 1 0 1
N 1 1 1 0 1 1 1 0 1
N 1 1 1 0 1 1 1 1 0
N 1 1 1 1 1 1 1 0 1
N 1 1 0 0 0 0 1 1 1
Y 1 1 1 1 1 0 1 1 0
Y 1 1 0 1 1 0 1 1 0
Y 1 1 1 0 0 0 1 1 1
Y 1 1 0 0 0 1 0 0
Y 1 1 0 0 0 1 0 0 1
Y 1 1 0 0 0 0 0 1 0
Y 1 1 0 0 0 1 0 0 0
Y 1 1 1 0 0 1 0 1 1
Y 1 1 0 1 1 0 0 0 0
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Y 1 1 1 1 0 0 0 1 1
Y 1 1 1 1 1 0 0 0 0
Y 1 1 0 1 0 0 1 1 0
Y 1 1 0 1 1 0 1 0 0
Y 1 1 0 1 1 1 1 0 0
Y 1 1 0 0 1 1 1 0 1
Y 1 1 1 0 1 1 1 0 1
Y 1 1 1 1 1 1 0 1
Y 1 1 1 1 1 1 1 0 1
Y 1 1 1 1 1 1 1 0 1
Y 1 1 1 1 1 1 1 0 1
Y 1 1 1 1 1 1 1 0 1
Y 1 1 1 1 1 1 1 0 1
Y 1 1 1 1 1 1 1 0 1
Y 1 1 1 1 1 1 1 0 1
Y 1 1 1 1 1 1 0 1
Y 1 1 I 1 1 1 1 0 0
Y 1 1 1 1 1 1 1 0 0
Y 1 1 1 1 1 0 1 0 0
RpoB Neg. - 54 0 34 25 35 28 41 11 19
(%) - (100) (0) (62.9) (46.3) (64.8) (51.8) (75.9) (20.3) (35.19)
RpoB Pos. - 41 41 26 23 26 24 29 11 22
(%) - (100) (100) (63.4) (56.1) (63.4) (58.5) (70.7) (26.8) (53.6)
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Table A9. Stratification o f Granulomas According to Expression of Host Cytokines and
181
M. tuberculosis genes (e.g. EL-4)
Granuloma
subgroups DNA rpoB katG narX icl mbtB relMtb esat-6 PPE
Neg. 1 0 1 0 0 0 1 1 0
IL-4. 1 0 1 1 1 0 1 0 1
1 0 1 0 1 0 1 0 0
1 0 0 1 1 0 1 0 0
1 0 0 1 1 0 1 0 0
1 0 1 1 1 0 1 0 0
1 1 1 1 1 0 1 1 0
1 1 1 0 0 0 0 1
1 1 0 0 0 0 1 0 0
1 1 0 0 0 1 1 0 1
1 1 0 0 0 0 0 1 0
1 1 0 0 0 1 0 0 0
1 1 0 1 1 0 0 0 0
Pos. 1 0 1 0 0 0 1 1 1
IL-4 1 0 1 0 0 0 1 0 0
1 0 1 0 0 0 0 1
1 0 0 0 1 1 0 0
1 0 1 0 1 0 1 0 1
1 0 1 1 1 0 1 0 0
1 0 1 0 1 1 1 0 0
1 0 1 0 0 0 1 1 0
1 0 1 0 0 0 1 1 0
1 0 1 1 0 1 1 0
1 0 1 0 1 0 1 1 0
1 0 1 0 0 1 1 1 0
1 0 1 0 1 1 0 0 0
1 0 0 0 0 1 0 0 1
1 0 0 0 0 1 0 1 0
1 0 0 0 1 1 1 0 0
1 0 1 1 0 0 0 0 1
1 0 1 1 1 0 0 0 0
1 0 0 1 1 0 0 0 0
1 0 1 1 0 0 0 0 0
1 0 0 0 0 0 0 0 0
1 0 0 0 0 1 0 0 1
1 0 0 1 1 0 0 0 1
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1 0 0 1 0 0 0 0 I
1 0 0 0 1 1 1 0 0
1 0 1 0 1 1 1 0 1
1 0 1 0 1 1 1 0 1
1 0 1 0 1 1 1 0 1
1 0 1 0 1 1 1 0 1
1 0 1 0 1 1 1 0 1
1 0 1 1 1 1 0 1
1 0 1 1 1 1 1 0 1
1 0 1 1 1 1 1 0 1
1 0 1 1 1 1 0 0
1 0 1 1 1 1 0 0
1 0 1 1 1 1 1 0 0
1 0 1 1 1 1 1 0 0
1 0 1 1 1 1 1 0 0
1 0 1 1 1 1 0 0
1 0 1 1 1 1 1 0 0
1 0 1 1 1 1 1 0 0
1 0 1 1 1 1 1 1 0
1 0 0 0 0 1 0 0
1 0 0 0 0 1 1 0 0
1 0 0 0 0 0 1 0 0
1 0 0 1 1 0 1 1 1
1 0 0 1 1 0 1 0 0
1 0 0 1 0 I 1 1 1
1 1 0 0 1 1 0 0 0
1 1 0 1 0 1 0 1 0
1 1 1 0 0 1 1 0 0
1 1 1 0 0 0 0 1
1 1 1 0 1 1 1 0 1
1 1 1 0 1 1 1 0 1
1 1 1 0 1 1 1 1 0
1 1 1 1 1 1 1 0 1
1 1 0 0 0 0 1 1 1
1 1 1 1 1 0 1 1 0
1 1 0 1 1 0 1 1 0
1 1 1 0 0 0 1 1 1
1 1 0 0 0 1 0 0 0
1 1 0 0 0 1 0 0 1
1 1 1 0 0 1 0 1 1
1 1 1 1 0 0 0 1 I
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1 1 1 1 1 0 0 0 0
1 1 0 1 0 0 1 1 0
1 1 0 1 1 0 1 0 0
1 1 0 1 1 1 1 0 0
1 1 0 0 1 1 1 0 1
1 1 1 0 1 1 1 0 1
1 1 1 1 1 1 0 1
1 1 1 1 1 1 1 0 1
1 1 1 1 1 1 1 0 1
1 1 1 1 1 1 1 0 1
1 1 1 1 1 1 1 0 1
1 1 1 1 1 1 1 0 1
1 1 1 1 1 1 1 0 1
1 1 1 1 1 1 1 0 1
1 1 1 1 1 1 0 1
1 1 1 1 1 1 1 0 0
1 1 1 1 1 1 1 0 0
1 1 1 1 1 0 1 0 0
IL-4 Neg 13 7 6 6 7 2 9 3 3
(%) (100) (53.8) (46.1) (46.1) (53.8) (15.4) (69.2) (23) (23)
IL-4 Pos 82 34 54 42 54 50 61 19 38
(%) (100) (41.4) (65.8) (51.2) (65.8) (60.9) (74.4) (23.1) (46.3)
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APPENDIX VI
Absolute Ethonal 
Acetic Anhydride 
Acetone 
Agarose
3-aminopropyltriethoxysilane 
Avidin-HRP 
Axioscope 2 Microscope 
BCIP
Bio-11-UTP
Biotin- 14-CTP
3CC Video Camera
DAB
DEPC
Dnasel
dNTPs
dNTPs (PCR Grade)
DTT 
ECL Kit
Eppendorf Microtubes 
Fuchsi n-sub strate-chromogen 
Goat anti-human 1 ° Ab 
Haemotoxylin 
Hybond N ' Membranes
LIST OF SUPPLIERS
Merck, UK 
Merck, UK 
Merck, UK
Whitehead Scientific, RSA 
Sigma, USA 
DAKO, USA 
Zeiss, Germany 
GibcoBRL, Switzerland 
GibcoBRL, Switzerland 
GibcoBRL, Switzerland 
Sony, Japan 
Vector, USA 
Sigma, USA 
Roche, Germany 
GibcoBRL, Switzerland 
Roche, Germany 
GibcoBRL, Switzerland 
Amersham, UK 
Eppendorf, Germany 
DAKO, USA 
Roche, Germany 
DAKO, USA 
Amersham, UK
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30% Hydrogen Peroxide Merck, UK
ISH and Detection Kit GibcoBRL, Switzerland
Isoproponal Merck, UK
ITC Camera Berkenhoff and Drebes, Germany
Levimisole Vector, USA
Lysozyme Roche, Germany
Marker X Roche, Germany
Methyl Green DAKO, USA
Microfuge Eppendorf, Germany
Microscope Cover Glasses Sigma, USA
Microscopic Slides Sigma, USA
Mineral Oil Sigma, USA
Mouse anti-human CD86 Roche, Germany
NBT GibcoBRL, Switzerland
Nucleobond Kit Amersham, UK
Omnislide Humidity Chamber Hybaid Ltd, UK
PCR Purification System GibcoBRL, Switzerland
PGEMT-eazy System Promega, USA
ProteinaseK GibcoBRL, Switzerland
Pvull (and Buffer M) Promega, USA
Rabbit anti-goat (2° Ab) Roche, Germany
Rabbit Serum Roche, Germany
Rnase A Roche, Germany
RNaseOUT Inhibitor GibcoBRL, Switzerland
Sheep anti-mouse (2° Ab) Roche, Germany
Sheep Serum Roche, Germany
SP6 Polymerase (and SP6 Transcript Buffer) GibcoBRL, Switzerland
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Spectrophotometer 120i Milton Roy, USA
Speed Vac Concentrator Sorvant, USA
Sorvall CentrifugeRC-5B Sorvall, Germany
Streptavidin -  AP DAKO, USA
Streptavidin -  AP Conjugate GibcoBRL, Switzerland
T7 Polymerase (and T7 Transcript Buffer) GibcoBRL, Switzerland
Taq DNA Polymerase (and Buffer) Roche, Germany
Touchdown Thermal Cycler Hybaid Ltd, UK
Triethonalamine Merck, UK
Video Graphic Printer Sony, Japan
Xylene Merck, UK
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APPENDIX VII
COUNTRIES GROUPED ACCORDING TO THE W HO TO ESTIM ATE INCIDENCE
Established
Market
Economies
Eastern
Europe
Latin
America
Eastern Africa - low 
Mediterranan HIV
Africa - high 
HIV
South East 
Asia
Western
Pacific
T ren d  E stim ated  From
Australia Albania Anguilla
Austria Armenia Antigua &
Belgium Belarus Barbuda
Canada Croatia Argentina
Czech Rep Esonia Bahamas
Denmark Kazakhstan Barbados
Finland Kyrgyzstan Bermuda
France Latvia Br Virgin Is
Germany Lithuania Cayman Is
Greece Poland Chile
Iceland Romania Cuba
Japan Russia Dominica
Netherlands Slovakia Dominican
New Zealand Slovania Rep
Norway Tajikistan Ecuador
Portugal Turky El Salvador
Singapore Turkmnitan Grenada
Spain Ukraine Guatemala
Sweden Uzbkistan Guyana
Switzerland Yugoslavia Honduras
United Jamaica
Kingdom Mexico
United States Montserrat
Trend Nicaragua
applied to Peru
Azerbaijan Puerto Rico
Bosnia & St Kitts &
Trend Herzegovina Grenadines
applied to Bulgaria Trinidad &
Andorra Georgia Tobago
Isreal Hungary Turks &
Italy Rep Moldova Caicos Is
Luxembourg TFYR Uruguay
Malta Maceonia Venezuela
Monaco 
San Marino
Cyprus Algeria Botswana Bhutan
Jordan Benin Cent Afr Rep India
Lebanon Comoros Cote d’Ivoire Maldives
Morocco Guinea DR Congo Sri Lanka
Oman Madagascar Kenya Trend
Qatar Mali Lesotho applied to
Syria Mauritania Malawi Bangladesh
Tunisia Mauritius Uganda 
UR Tanzania
DPR Korea 
Indonesia
Trend applied Trend ' Zambia Myanmar
to applied to Zimbabwe Nepal
Afghanistan
Bahrain
Angola 
Burkina Faso
Thailand
Djibouti Cameroon Trend
Egypt Cape Verde applied to
Iran Chad Burundi
Iraq Equatorial Congo
Kuwait Guinea Eritrea
Libya Goban Ethiopia
Pakistan Gambia Mozambique
Saudi Arabia Ghana Namibia
Somalia Guinea- Rwanda
Sudan Bissau South Africa
United Arab 
Emirates 
West Bank & 
Gaza 
Yemen
Liberia
Niger
Sao Tome & 
Principe 
Senegal 
Seychelles 
Sierra Leone 
Togo
Swaziland
Trend 
applied to
Belize
Bolivia
Brazil
Colombia
Costa Rica
Haiti
Panama
Paraguay
Suriname
Amercican 
Samoa 
Cambodia 
China, Hong 
Kong SAR 
China, Macao 
SAR 
Cook Is 
Fiji
French 
Polynesia 
Guam 
Kiribati 
Lao PDR 
Malaysia 
Marshall Is 
Micronesia 
N  Mariana Is 
Nuara 
New  
Caledonia 
Niue 
Palau 
Rep Korea 
Samoa 
Solomon 
Tokelau 
Tonga 
Tuvalu 
Vanuatu 
Viet Nam 
Wallis & 
Futuna Is 
Trend 
applied to 
Brunei 
Darussalam 
China 
Mongolia 
Papua New  
Guinea 
Philippines
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Table A l. Individual Granuloma Assessment of Patient LI. Granulomas are numbered according to FigureAl, and were scored as necrotic (Y) or
non-necrotic (N), and as negative (0) or positive (1) for signal (ISH and Immunohistochemistry)
Gran.
Necrotic
(Y/N) DNA rpoB katG narX icl mbtB relMtb esat-6 PPE IL-4 IL-10 IL-12 IFN-g TNF-a Th gran.
1 N 1 1 1 1 1 0 1 1 0 0 0 1 1 1 Th-1
2 N 0 0 0 0 0 0 0 0 0 0 0 0 1 1 Til-1
3 Y 1 1 1 1 1 0 1 1 0 1 1 1 1 1 Th-0
4 Y 1 0 1 0 0 0 1 1 0 1 1 1 1 1 Th-0
5 Y 1 0 1 0 0 0 1 1 0 1 0 1 1 1 Th-0
6 Y 1 0 0 1 1 0 1 1 0 1 1 1 1 1 Th-0
7 Y 1 0 1 0 1 0 1 1 0 1 1 1 1 1 Th-0
8 Y 1 1 0 1 1 0 1 1 0 1 1 1 1 1 Th-0
9 N 1 0 1 0 0 0 1 1 0 0 0 1 1 Th-1
10 Y 1 0 1 0 0 1 1 1 0 1 1 1 1 1 Th-0
11 N 1 0 1 0 0 0 1 1 1 1 0 0 1 Th-0
12 N 1 0 1 0 0 0 1 0 0 1 1 1 1 1 Th-0
13 N 0 0 0 0 0 0 0 0 1 0 0 1 Th-0
14 Y 1 1 1 0 0 0 1 1 1 1 1 1 1 1 Th-0
15 Y 1 1 0 0 0 1 0 0 0 1 1 1 1 1 Th-0
16 Y 1 1 0 0 0 1 0 0 1 1 0 0 1 1 Th-0
Total
(%)
10
(62.5)
14
(87.5)
6
(42.8)
10
(71.4)
4
(28.5)
5
(35.7)
3
(21.4)
12
(85.7)
13
(92.8)
3
(21.4)
13
(81.3)
9
(56.3)
11
(68.6)
16
(100)
14
(87.5)
ThO = 13 
Thl = 3
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Table A2. Individual Granuloma Assessment of Patient L3. Granulomas are numbered according to Figure A4. and were scored as necrotic (Y) or non-necrotic (N), and as
negative (0) or positive (1) for signal (ISH and Immunohistochemistry)
Grail.
Necrotic
(Y/N) DNA rpoB katG narX icl mbtB relMU) esat-6 PPE IL-4 IL-10 IL? 12 IFN-g TNF-a Tli gran.
1 N 1 1 0 0 1 1 0 0 0 1 1 1 1 1 Th-0
2 N 1 1 0 1 0 1 0 1 0 1 1 1 1 1 Th-0
3 Y 1 1 1 1 0 0 0 1 1 1 1 1 1 1 Th-0
4 Y 1 1 0 1 0 0 1 1 0 1 1 1 1 1 Th-0
5 N 0 0 0 0 0 0 0 0 0 1 1 1 1 1 Th-0
6 N 0 0 0 0 0 0 0 0 0 1 1 1 1 1 Th-0
7 Y 1 0 1 1 0 0 0 0 1 1 1 1 1 1 Th-0
8 Y 1 0 0 0 1 1 1 0 0 1 1 1 1 1 Th-0
9 Y 1 1 1 0 0 1 0 1 1 1 1 1 1 1 Th-0
10 N 1 1 0 0 0 0 1 0 0 0 0 I 1 1 Th-1
11 Y 1 1 0 0 0 0 0 1 0 0 0 1 1 1 Th-1
12 Y 1 0 1 1 1 0 0 0 0 1 1 1 1 1 Th-0
13 Y 1 0 1 0 1 1 0 0 0 1 1 1 1 1 Th-0
14 N 0 0 0 0 0 0 0 1 1 1 1 1 Th-0
15 Y 1 0 0 1 1 0 1 0 0 0 0 1 1 1 Th-1
16 Y 1 0 1 0 1 0 1 0 0 0 0 1 1 1 Th-1
17 Y 1 1 0 1 1 0 0 0 0 0 0 1 1 1 Th-1
18 Y 1 0 0 1 1 0 1 0 0 0 0 1 1 1 Th-1
19 N 1 1 1 0 0 0 0 1 0 0 1 1 1 Th-1
20 Y 1 1 0 1 1 0 1 0 0 1 1 1 1 1 Th-0
21 Y 1 0 0 1 1 0 0 0 0 1 1 1 1 1 Th-0
22 Y 1 1 1 1 1 0 0 0 0 1 1 1 1 1 Th-0
23 Y 1 0 0 0 0 1 0 0 1 1 1 1 1 1 Th-0
24 Y 1 0 1 1 0 0 0 0 0 1 1 1 1 1 Th-0
25 Y 1 1 0 0 0 1 0 0 0 0 0 1 1 1 Th-1
26 Y 1 0 0 0 0 1 0 1 0 1 1 1 1 1 Th-0
27 Y 1 0 1 1 1 0 1 0 0 0 0 1 1 1 Th-1
28 N 0 0 0 0 0 0 0 0 0 1 1 1 1 1 Th-0
Total
(%)
20
(71.4)
24
(85.7)
12
(50)
10
(41.6)
13
(54.1)
12
(50)
8
(33.3)
8
(33.3)
6
(25)
5
(20.8)
21
(75)
19
(67.9)
28
(100)
28
(100)
28
(100)
ThO = 19 
Thl = 9
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Table A3. Individual Granuloma Assessment of Patient L4. Granulomas are numbered according to Figure A7, and were scored as necrotic (Y) or non-necrotic (N). and as
negative (0) or positive (1) for signal (ISH and Immunohistochemistry)
Gran.
Necrotic
(Y/N) DNA rpoB katG narX icl mbtB relMtb esat-6 PPE IL-4 IL-10 IL-12 IFN-g TNF-a Th gran.
1 N 0 0 0 0 0 0 0 0 0 1 0 1 1 0 Tli-0
2 N 1 0 1 0 0 0 0 0 1 1 1 1 1 1 Th-0
3 N 0 0 0 0 0 0 0 0 1 0 1 1 0 Th-0
4 N 1 1 1 0 0 1 1 0 0 1 0 0 1 1 Th-0
5 N 1 0 0 0 0 1 1 0 0 1 0 0 1 Th-0
6 Y 1 1 0 1 1 1 1 0 0 1 1 0 1 1 Th-0
7 Y 1 1 0 0 1 1 1 0 1 1 1 0 1 1 Th-0
8 N 1 1 0 0 0 1 1 0 1 0 0 1 1 Th-1
9 Y 1 0 0 0 0 0 0 0 0 1 1 1 1 1 Th-0
10 Y 1 0 0 1 1 0 0 0 1 1 0 1 1 1 Th-0
11 N 1 1 1 0 0 0 0 0 1 1 0 1 1 1 Th-0
12 Y 1 0 0 1 0 0 0 0 1 1 1 1 1 1 Th-0
13 Y 1 0 0 0 0 1 0 0 1 1 0 1 1 1 Th-0
Total
(%)
6
(46.2)
11
(84.6)
5
(45.4)
3
(27.2)
3
(27.2)
3
(27.2)
6
(54.5)
5
(45.4)
0
(0)
7
(63.6)
12
(92.13)
5
(38.5)
8
(61.5)
13
(100)
10
(76.9)
ThO = 12 
Thl = 1
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Table A4. Individual Granuloma Assessment of Patient L5. Granulomas are numbered according to Figure All), and were scored as necrotic (Y) or non-necrotic (N). and as
negative (0) or positive (1) for signal (ISH and Immunohistochemistry)
Gran.
Necrotic
(Y/N) DNA rpoB katG narX icl mbtB relMtb esat-6 PPE IL-4 IL-10 IL-12 IFN-g TNF-a Th gran.
1 Y 1 1 1 1 1 1 1 0 1 1 1 0 1 1 Th-0
2 Y 1 0 1 1 1 1 1 0 1 1 1 1 1 1 Th-0
3 Y 1 1 1 1 1 1 1 0 1 1 1 1 1 1 Th-0
4 N 0 0 0 0 1 0 1 1 1 Th-0
5 N 1 1 1 0 1 1 1 0 1 1 0 1 1 1 Th-0
6 Y 1 1 1 1 1 1 1 0 1 1 1 0 1 1 Th-0
7 Y 1 0 1 0 1 1 1 0 1 1 1 0 1 1 Th-0
8 Y 1 1 1 1 1 0 1 0 1 1 0 0 1 1 Th-0
9 Y 1 0 1 1 1 0 1 0 1 1 0 1 1 1 Th-0
10 N 1 0 1 1 1 0 1 0 1 0 0 1 1 Th-1
11 N 1 0 1 0 1 0 1 0 1 1 1 0 1 1 Th-0
12 Y 1 0 1 0 1 1 1 0 1 1 1 0 1 1 Th-0
13 Y 1 1 1 0 1 1 1 0 1 1 1 0 1 1 Th-0
14 Y 1 1 1 1 1 1 1 0 1 1 1 1 1 1 Th-0
15 Y 1 0 1 0 1 1 1 0 1 1 0 1 1 1 Th-0
16 N 1 1 1 0 1 1 1 0 1 1 0 0 1 1 Th-0
17 Y 1 0 1 0 1 1 1 0 1 1 0 1 1 1 Th-0
18 Y 1 0 1 0 1 1 1 0 1 1 1 1 1 1 Th-0
19 Y 1 1 1 1 1 1 1 0 1 1 1 1 1 1 Th-0
20 Y 1 1 1 1 1 1 1 0 1 1 1 1 1 1 Th-0
21 Y 1 1 1 1 1 1 1 0 1 1 0 0 1 1 Th-0
22 Y 1 0 0 1 1 1 0 1 0 0 1 1 Th-0
23 Y 1 0 1 1 1 1 1 0 1 1 0 0 1 1 Th-0
24 N 0 0 0 0 0 0 0 0 1 0 0 1 1 Th-0
Total 18 22 11 21 12 22 18 22 0 21 23 12 11 24 24 ThO = 23
(%) (75) (91.7) (50) (95.4) (54.5) (100) (81.8) (100) (0) (95.4) (95.8%) (58%) (48.5%) (100%) (100%) Thl = 1
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Table A5. Individual Granuloma Assessment of Patient L6. Granulomas are numbered according to Figure A13. and were scored as necrotic (Y) or non-necrotic (N). and as
negative (0) or positive (1) for signal (ISH and Immunohistochemistry)
Gran.
Necrotic
(Y/N) DNA rpoB katG narX icl mbtB relMtb esat-6 PPE IL-4 IL-10 IL-12 IFN-g TNF-a Th gran.
1 Y 1 0 1 1 1 1 1 0 0 1 1 1 1 1 Th-0
2 N 0 0 0 0 0 0 0 0 1 0 0 1 1 Th-0
3 N 1 0 1 1 1 0 1 0 0 1 0 0 1 1 Th-0
4 Y 1 1 1 1 1 1 0 1 1 1 1 1 1 Th-0
5 Y 1 1 1 1 1 1 1 0 0 1 1 1 1 1 Th-0
6 Y 1 0 1 1 1 1 1 0 0 1 1 1 1 1 Th-0
7 Y 1 0 1 1 1 1 1 0 0 1 1 1 1 1 Th-0
8 Y 1 0 1 0 1 1 1 0 0 1 1 1 1 1 Th-0
9 Y 1 0 1 1 1 1 1 0 0 1 1 1 1 1 Th-0
10 Y 1 0 1 1 1 1 1 0 0 1 1 1 1 1 Th-0
11 Y 1 0 1 1 1 1 0 0 1 1 0 1 1 Th-0
12 N 1 1 1 0 1 1 1 1 0 1 1 1 1 1 Th-0
13 Y 1 0 1 1 1 1 1 1 0 1 1 1 1 1 Th-0
14 N 1 0 1 0 1 1 1 0 0 1 1 1 1 1 Th-0
15 N 1 1 1 1 1 1 1 0 1 1 1 0 1 1 Th-0
16 N 1 1 0 1 1 1 1 1 1 1 1 Th-0
17 Y 1 0 1 0 1 1 1 0 0 1 1 0 1 1 Th-0
18 Y 1 1 1 1 1 1 1 0 0 1 1 0 1 1 Th-0
19 Y 1 1 1 1 1 0 1 0 0 1 1 0 1 1 Th-0
Total
(%)
13
(68.4)
18
(94.7)
7
(38.8)
16
(88.8)
13
(72.2)
17
(94.4)
14
(77.7)
18
(100)
3
(16.6)
3
(16.6)
19
(100)
17
(89.5)
12
(63.2)
19
(100)
19
(100)
ThO = 19
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T able A 6. Individual G ranulom a A ssessm ent of Patient L2. Granulomas are numbered according to Figure A 16. and were scored as necrotic (Y) or non-necrotic
(N). and as negative (0) or positive (1) for signal (ISH and Immunohistochemistry)
Gran.
Necrotic
(Y/N) DNA rpoB katG narX icl mbtB >'el\itb esat-6 PPE IL-4 IL-10 IL-12 IFN-g TNF-a Th gran.
1 Y 1 0 0 0 0 1 1 0 0 1 1 1 1 1 Th-0
2 Y 1 0 0 0 0 0 1 0 0 1 1 1 1 1 Th-0
3 Y 1 0 0 1 1 0 1 1 1 1 1 1 1 1 Th-0
4 N 0 0 0 0 0 0 0 0 0 1 0 1 1 1 Th-0
5 Y 1 0 0 0 0 1 0 0 0 1 1 1 1 1 Th-0
6 Y 1 0 0 1 1 0 1 0 0 1 1 0 1 1 Th-0
7 Y 1 0 0 1 0 1 1 1 1 1 1 1 1 1 Th-0
Total 6 6 0 0 3 2 3 5 2 2 7 6 6 7 7 ThO = 7
(%) (85.7) (85.7) (0) (0) (50) (33.3) (50) (83.3) (33.3) (33.3) (100) (85.7) (85.7) (100) (100)
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